Characterisation of Conus venom using polypeptide separation methods and mass spectrometric analysis. by Gerrits, A.J.
REFERENCE ONLY
UNIVERSITY OF LONDON THESIS
Degree iPV\o Year " p o o 5” Name of Author 1
COPYRIGHT
This is a thesis accepted for a Higher Degree of the University of London. It Is an 
unpublished typescript and the copyright is held by the author. All persons consulting 
the thesis must read and abide by the Copyright Declaration below.
COPYRIGHT DECLARATION
I recognise that the copyright of the above-described thesis rests with the author and 
that no quotation from it or information derived from it may be published without the 
prior written consent of the author.
Theses may not be lent to individuals, but the Senate House Library may lend a copy 
to approved libraries within the United Kingdom, for consultation solely on the 
premises of those libraries. Application should be made to: Inter-Library Loans, 
Senate House Library, Senate House, Malet Street, London WC1E 7HU.
REPRODUCTION
University of London theses may not be reproduced without explicit written 
permission from the Senate House Library. Enquiries should be addressed to the 
Theses Section of the Library. Regulations concerning reproduction vary according 
to the date of acceptance of the thesis and are listed below as guidelines.
A. Before 1962. Permission granted only upon the prior written consent of the
author. (The Senate House Library will provide addresses where possible).
B. 1962 -1974. In many cases the author has agreed to permit copying upon
completion of a Copyright Declaration.
C. 1976 -1988. Most theses may be copied upon completion of a Copyright
Declaration.
D. 1989 onwards. Most theses may be copied.
This thesis comes within category D.
This copy has been deposited in the Library of — V,..VArr:-------  —
This copy has been deposited in the Senate House Library, Senate House, 
Malet Street, London WC1E 7HU.
LOANS
C:\Documents and SettingsMproctorXLocal SettingsVTemporary Internet Files\OLK8\Copyright - thesis (2).doc

Characterisation of Conus Venom Using 
Polypeptide Separation Methods and 
Mass Spectrometric Analysis
ALBERT J. GERRITS
DEPARTMENT OF BIOCHEMISTRY AND 
MOLECULAR BIOLOGY 
UNIVERSITY COLLEGE LONDON 
GOWER STREET 
LONDON
This thesis is submitted in partialfulfillment of the requirements for the degree of Doctor of Philosophy from
the University of London
UMI Number: U5928B4
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a complete manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
Dissertation Publishing
UMI U592834
Published by ProQuest LLC 2013. Copyright in the Dissertation held by the Author.
Microform Edition © ProQuest LLC.
All rights reserved. This work is protected against 
unauthorized copying under Title 17, United States Code.
ProQuest LLC 
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106-1346
i. Abstract
Abstract
Each of the 500 known Conns species has its own distinctive, complex and peptide rich 
venom. Approximately 100 different peptide toxins, so called conotoxins can be expressed 
with little similarity between the species. An overwhelming majority o f conotoxins are 
probably targeted selectively to specific ion channels. Because conotoxins can discriminate 
between closely related subtypes o f ion channels, many o f the characterised conotoxins are 
used as pharmacological agents in ion channel research. Several have direct diagnostic and 
therapeutic potential. Although the venoms have been studied for the last two decades, 
only a miniscule fraction o f the postulated conotoxins have been identified.
The studies presented in this dissertation were set out with the aim to further characterise 
the relative unknown venom of Conns ventricosns and to explore the protein content of Conns 
venoms in general. In total five different venoms were investigated.
Chapter three describes the analysis of protein content in various Conns venoms. Although 
both one and two-dimensional gel electrophoresis was applied, no known toxin precursors 
were found. Proteins identified are mainly housekeeping proteins, such as actin. One o f the 
strategies applied for finding novel conotoxins involved a multi dimensional liquid 
chromatography experiment where a trypsin digest was performed in between two 
separations before mass spectrometric analysis. One putative novel partial conotoxin was 
found.
Chapters five and six describe the mass spectrometric analysis o f Conns ventricosns and textile 
venom after a two-dimensional liquid chromatography separation. With the methods 
applied, besides verifying a number o f putative sequences, several novel conotoxins were 
found, in particular a number o f so called contryphans. One o f these contryphans found 
contained a number o f post-translational modifications, amongst them hydroxyproline and 
the very rare brominated tryptophan.
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ii. Samenvatting voor de leek
Samenvatting voor de leek
Conns ventricosns en Conus textile behoren tot de diersoort Conus. Conns zijn zeeslakken die 
voorkomen in sub-tropische wateren over de gehele wereld. Deze zeeslakken voeden zich 
met vissen, wormen en andere zeeslakken. Om de prooien te verlammen en te doden, 
bezitten ze over complexe systemen om gif te injecteren in hun prooi. Dit gif bestaat uit 
een cocktail van kleine eiwitten, conotoxins genaamd. De cocktail is zeer toxisch; zo zijn er 
gevallen bekend van vergiftingen bij mensen met de dood tot gevolg.
Deze peptiden zijn over het algemeen inhibitoren van ion kanalen die ionen zoals natrium 
en kalium transporteren door een membraan. Dit transport van ionen is belangrijk voor de 
elektrische signalen die worden gegenereerd door zenuwen die aan de hersenen moeten 
worden doorgegeven. Door dit proces te verstoren, treden verlammingsverschijnselen op 
die, in het geval van kleine organismen, de dood tot gevolg hebben.
Wetenschappers zijn al decennia lang geinteresseerd in de werking van deze conotoxins, 
maar hebben slechts enkele van de ongeveer 50.000 voorspelde conotoxins ontdekt en 
gekaraktcriseerd.
Met de experimenten die zijn uitgevoerd voor dit promotie onderzoek zijn een aantal 
nieuwe conotoxins gevonden en structured gekarakteriseerd. Conotoxins zijn met behulp 
van chromatografie geisoleerd en met massa spectrometrie gekarakteriseerd. Een aantal van 
de gevonden conotoxins behoren tot de subgroep contryphans. Dit zijn, met een disulfide 
brug gebonden peptiden met veel modifikades. Een zeer zeldzame modifikade is 
gebromeerde tryptofaan, deze werd, samen met gehydroxyleerde proline aangetroffen op 
een van de contryfaans.
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iii. Abbreviations
are subdivided in four categories: General; Chemicals; Mass spectrometry; Instrumentation 
and techniques. The meaning of the abbreviation is also given the first time used in the 
main text. Abbreviations o f amino acids can be found in appendix 1.
Abbreviations
General
Da Dalton
LASER Light Amplification by Stimulated Emission o f Radiation
Mw Molecular Weight
mmu millimass units
pi Isoelectric point
ppm parts per million
RPM Revolution per Minute
RT Room Temperature
UV Ultra Violet
Chemicals
ABC Ammonium bicarbonate -  NH4H C 03
ACN Acetonitrile
ACTH Adrenocorticotropic Hormone
APS Ammonium Persulphate
BPB Bromophenol Blue
C l8 Octadecyl silane packing material
CCB Colloidal Coomassie Blue
CHAPS (3- [(3-cholamidopropyl) dimethylammonio] -1 -propanesulfonate)
CHCA Alpha cyano 4-hydroxy-cinnamic acid
Cy2 3-(4-carboxymethyl)phenylmethyl)-3’-ethyloxacarbocyanine halide N-
hydroxy-succinimidyl ester 
Cy3 l-(5-carboxypentyl)-T-propylindocarbocyanine halide N-hydroxy-
succinimidyl ester
Cy5 l-(5-carboxypentyl)-T-methylindodicarbocyanine halide N-hydroxy-
succinimidyl 
DHB 2,5-dihydroxybenzoic acid
DTT Dithiothreitol
FA Formic Acid
LAM Iodoacetamide
SDS Sodium Dodecyl Sulphate
TCEP Tris(2-carboxyethyl)phosphine
TEMED N ,N ,N ’,N ’-T etramethylethylenediamine
TFA Trifluoroacedc Acid
Tris Tris-(hydroxymethyl)aminomethane
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iii. Abbreviations
Mass spectrometry
Cl Chemical Ionization
CID Collision Induced Dissociation
DE Delayed Extraction
ESI Electrospray Ionization
FAB Fast Atom Bombardment
FT Fourier Tranformation
ICR Ion Cyclotron Resonance
MALDI Matrix-Assisted Laser Desorption/Ionization
[MH]+ [M+H]+ - Singly charged protonated ion
[M2H]2+ [M+2H]2+ - Doubly charged protonated ion
m /z Mass to charge ratio
MS Mass Spectrometry
MS/MS Tandem mass spectrometry
OaTOF Orthogonal Acceleration Time O f Flight
PSD Post-source Decay
Q-TOF Quadrupole Orthogonal Acceleration Time O f Flight
TIC Total Ion Count
TOF Time O f Flight
Instrumentation and techniques
IDE One-Dimensional Gel Electrophoresis
2DE Two-Dimensional Gel Electrophoresis
2D-LC Two-Dimensional Liquid Chromatography
BVA Biological Variation Analysis
DIA Difference In-gel Analysis
DIGE 2D-difference gel electrophoresis
HPLC High Performance Liquid Chromatography
IEF Iso-Electric Focussing
IPG Immobilised pH Gradient
LC Liquid Chromatography
LC-MS Liquid Chromatography coupled online with Mass Spectromety
PAGE Polyacrylamide Gel Electrophoresis
RP Reversed Phase
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1. Introduction
1 Introduction
Marine snails from the genus Conus are venomous molluscs found in (sub-)tropical waters. 
These snails use small, structured peptide toxins (conotoxins) for prey capture, defense and 
competitor deterrence (Terlau and Olivera, 2004). Each o f the known 500 Conus species 
can express approximately 100 different conotoxins, with little overlap between species 
(Rockel et al., 1995). Conotoxins that have been characterised so far display incredible 
specificity towards ion channels. Because o f this specificity and the ability to discriminate 
between closely related subtypes o f ion channels, these conotoxins are widely used as 
pharmacological agents in ion channel research, and have direct diagnostic and therapeutic 
potential. It is thought that an overwhelming majority o f the predicted 50,000 conotoxins 
are targeted to specific ion channels.
1.1 An overview  o f Cone snails and conotoxins
Cone shells are found in all habitats from shallow to moderate depths mainly in (sub­
tropical oceans around the world, although some smaller species have been found on the 
southern coast of Australia *, where the water temperature is only 5 — 12 °C. The sand- 
dwelling species possess very clean shells while those that live on top o f sand or among 
rocks or rubble have a layer called a periostracum. Figure 1.1.1 shows the images o f shells 
of two Conus species, namely Conus ventricosus and Conus textile.
1.1.1 Conus anatomy and life style
Cone shells are mainly nocturnal or crepuscular (i.e. they are active at twilight or just before 
dawn). Most Conus species (>150) prey on polychaete worms (vermivorous), some 70 feed 
upon gastropods including Conus (molluscivorous) while approximately 70 species prey on 
fish (piscivorous) (Jones and Bulaj, 2000). Some other Conus species prey on hemichordates. 
Hemichordates are distinguished by a tripartite (threefold) division o f the body (Olivera, 
1997). To make up for the lack of speed compared to their swift preys, especially the 
piscivorous species, these gastropods have developed an effective mechanism for 
immobilizing their prey. The piscivorous species can be divided into two groups, namely 
the “hook-and-line” fishing snails, which use a tooth like mini harpoon. And the “net-
* Source: http://gnmwade.biochem.unimelb.edu.au/cone/indexl.html
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fishing” cone snails. An image of the latter is included in the bottom  panel o f Figure 1.1.2. 
With this technique, fish or a small school o f fish are caught by extending its probosis like a 
net to catch multiple fish. In both cases the solution to the snail's lack o f physical agility has 
been the development of a highly potent mixture o f neuronal toxins which it uses to 
paralyze its prey.
Figure 1.1.1 Images of Coaus shells.
Images o f  two Conus species are shown in this figure. In the left hand panel that o f  Conus ventricosus and in the 
right hand panel Conus textile. Conus ventricosus is found in the Mediterranean Sea and is classified as a 
molluscivorous species, while the piscivorous Conus textile is found in the Indo-Pacific Ocean. Images are 
courtesy o f Eddie Hardy (http://w w w .gastropods.com ).
To paralyze and capture their prey, this genus has developed a specialised venom apparatus. 
A modified radular tooth, which is used to inject the venom into the prey, functions as a 
disposable hypodermic needle (see Figure 1.1.2). The actual production and transfer of 
venom to the prey involves 3 broad steps: (i) synthesis, processing and packaging of 
peptide toxins, (ii) Generation and storage of radular teeth and transfer o f a tooth to the tip 
o f the proboscis, (iii) The final insertion of the tooth and injection o f venom (Marshall et 
al., 2002). All these processes are operated by the venom apparatus in combination with the 
front part o f the digestive tract. See Figure 1.1.2 for a schematic o f the venom apparatus.
(i) The venom is produced in a long venom duct, often several times the length of 
the snail itself. The venom is pushed through the duct towards the proboscis by 
the muscular bulb, which is located at the posterior end of the tubular duct.
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However, the sites of synthesis, and where the peptides are post-translationally 
modified remain unclear.
(ii) The teeth that are used for the injection o f venom are made in the long arm of 
the radular sac. The completed teeth are stored in the short arm of the radular 
sac. A single tooth is transported to the pharynx. Finally the proboscis extends 
with the harpoon in the tip.
(iii) The current hypothesis is that the muscular bulb provides the force necessary 
to pierce the needle into the prey. This is done by forcefully pumping the 
venom into the needle, which is enclosed by the proboscis (Kohn and Hunter, 
2001). However the exact mechanism is unclear.
Conus venom peptides were first isolated and characterised by Cruz et al. more then 20 years 
ago. Each o f the approximate 500 species has its own unique and complex venom (Rockel 
et al., 1995). It contains an array o f neurotoxins, so called conotoxins or conopeptides, that 
block a wide spectrum of ion-channels and neuronal receptors (Jones and Bulaj, 2000). 
The venoms contain up to 50 - 200 different peptides (Olivera, 1997), potentially leading to 
over 50,000 biologically active peptides. To date approximate 500 conotoxin sequences are 
published*. However many of the sequences are predicted sequences from cDNA libraries 
and only a few have been studied in detail.
t  Source: http://au.expasy.org/cgi-bin/sprot-search-dePconotoxin
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Figure 1.1.2 Anatomy and the catch . . .
The top left o f the figure shows a schematic o f the venom apparatus o f  Conus snails. T)isposable hypodermic 
needle’ are generated and stored in the radular sac. A scanning electron micrograph image of, the tip o f the 
harpoon-like tooth o f  Conus obscurus is shown on the top right o f  the figure. The barbed, hollow tooth is used 
for injecting venom  into the fish prey. One needle at the time is moved to the proboscis. It is thought that 
the force with which the muscular bulb is compressed, the venom  is forced into the needle which then 
dislodges and is ‘shot’ towards the prey like a mini harpoon. The bottom  o f  the figure shows an image o f  the 
capture o f a fish by Conus ffographus (The tip o f the tail is just visible at the right hand side). Conus geographus is 
one o f  the m ost deadly species o f Conus. The 'Geography Cone' uses its distended rostrum  as a net to capture 
fish. Multiple fish may be engulfed simultaneously and then individually envenomated. The figure on the left 
is adapted from Marshall et al. (Marshall et al., 2002), and the right hand side figure is taken from  M cIntosh et 
al. (M cIntosh and Jones, 2001).
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The venom of some Conus species can be lethal to humans. The species most frequently 
associated with human envenomations are Conus textile and Conus geographus (McIntosh and 
Jones, 2001). Symptoms from cone snail stings vary to some degree depending on the 
species involved, severe pain, (local) paralysis, difficulty in breathing and swallowing have 
been reported. Also depending on the severity o f the envenomation, gag and other reflexes 
are absent, other reported symptoms were blurred and double vision. Recovery time, if any, 
may vary from a few hours to several weeks (Cruz and White, 1995).
1.1.2 Conus venom, the case of conotoxins
Components present in Conus derived venom are mainly made up of proteins and small 
peptides. These peptides are the active components when it comes to paralysing and killing 
their prey. The peptides found in Conus venom can initially be divided into two broad 
groups, namely non-disulfide rich and disulfide rich. Disulfide bridges are the most 
important post-translational modifications. The otherwise small peptides, typically 10 to 30 
amino acids long, are shaped into rigid globular peptides. The ‘Non-Disulfide-Rich’ group 
contains those peptides with one or no disulfide bonds, while the ‘Disulfide-Rich’ group 
contains the so called conotoxins with two and more disulfides.
Conotoxins are named according to a systematic nomenclature, first proposed by Olivera et 
al (Cruz et al., 1985) and later reviewed and updated by the same group (Gray et al., 1988). 
More recently it was updated by McIntosh and Olivera (McIntosh et al., 1999). This system 
of nomenclature was designed to provide information about the mechanisms o f action, 
disulfide connectivity and species from which the toxin is derived. Some examples of 
conotoxin names are given in Figure 1.1.3.
p - GIIIB to - MVIIA 5 - TxVIA
Figure 1.1.3 Examples of conotoxin nomenclature.
This figure shows a number o f examples o f conotoxin nomenclature. From left to right: mu conotoxin IIIB 
from Conus geographus, omega conotoxin VIIA from Conus magnus and delta conotoxin VIA from Conus textile. 
The middle peptide is also known as SNX-111 or Ziconotide and is currently under investigation in a stage 
III medical trial by Elan Pharmaceuticals (CA, USA).
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The first letter (Greek alphabet) identifies the family to which the toxin belongs. For 
instance toxins in the sub-group of the M-superfamily that target sodium channels are 
classified as a mu-conotoxin. The second set o f letters, or letter indicate the species from 
which the toxin was isolated (G = geographus; M = magnus, Tx = textile). The roman 
numerals indicate the disulfide connectivity. In general these refer to the superfamilies, I 
and II to the A-superfamily, III to the M-superfamily, IV refers to the T-superfamily, VI 
and VII denote the O-superfamily and VIII the S-superfamily. Figure 1.1.4 shows an 
overview o f the classifications of conotoxins (Jones and Bulaj, 2000).
For peptides that have not been pharmacologically characterised, Olivera et al. developed a 
comparable naming strategy (Olivera et al., 1985), namely that all letters are substituted by 
lowercase letters and roman numerals are replaced by conventional letters. For example p- 
GIIIB would be named as g3b. The Greek letter would, at this point is not assigned, as the 
molecular target is still unknown.
CONOPEPTIDES
Non-Disulfide-Rich
N o s-s Single S-S
Conantokin Conorfamide Conopressin ContryphanFamily Contulakin
Disulfide-RichK & C a
VI/VII
C-C-CC-C-C
VIII
10 x CCC-C-C-CC CC-C-C CC-C-C-C-C CC-CC CC-CPC 6 x C C-C-CC-CC-C-C
Ca
Channel
nACh
Channel
Conotoxln
Family kM k AaA
Figure 1.1.4 An overview of conotoxins
Peptides from Conus derived venom are divided into two broad groups, namely non-disulfide rich and 
disulfide rich. Members o f  each superfamily o f conotoxins (multiple disulfide bridges) have a common highly 
conserved signal sequence in their precursors. The family members within the superfamily have a distinctive 
disulfide arrangement in the mature part o f the toxin. The penultimate conotoxin family is defined by the 
target o f the specific toxin. This figure is taken from Terlau and Olivera (Terlau and Olivera, 2004)
The importance of the strict disulfide arrangement to the survival of the species became 
clear after a study by Conticello et al. (Conticello et al., 2000). In this study 53 conotoxin
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sequences derived from a cDNA library, were aligned. Not surprisingly the cysteines of the 
mature toxins show a high degree of conservation as did the signal peptides of the entire 
toxins. However, when examining the codons used for encoding the cysteine, something 
remarkable was revealed. It turns out that Conns have developed a mechanism where, the 
normal hypervariable conotoxins, there is specific codon preservation in specific regions of 
the toxin. For instance, the first cysteine in a CxxCxxCCxxCxxC scaffold was for 100% 
encoded by TGC. Cysteine can be encoded by two codons, namely TGC and TGT. In total 
five out o f the six cysteines were coded by a specific codon. For four out o f five, TGC was 
favoured over TGT. This site specific codon bias has only been reported in the variable 
regions of immunoglobulins (Wagner et al., 1995). It is not known to date how this 
mechanism functions and which or how many partners are involved.
1.1.3 Conotoxins; receptor and ligand interaction
A number of hypotheses are proposed to explain the interaction o f the toxins with 
receptors such as ion channels (Mok and Han, 1999; Olivera, 1997; Olivera et al., 1991b). 
One of the hypotheses deals with the question of how different primary sequences can 
bind with very high affinity to the same binding site. Olivera proposed the Conus toxin 
macrosite model. This is illustrated in Figure 1.1.5. Within the macrosite are potential 
microsites to which a conotoxin can bind. In a normal situation the endogenous ligand 
(orange litde blobs) can bind to its receptor (orange pocket), which is represented by panel 
A in the schematic. A conotoxin (blue) blocks the macrosite using three microsites (panel 
B). Panel C shows a number of possibilities for different conotoxins to bind the same site 
(blue, red, black).
18
1. Introduction
b _
Figure 1.1.5 Conotoxin ion channel binding model.
The schematics in this figure represent the macrosite binding model. Panel A the binding site o f  a receptor 
with a num ber o f microsites which are potential inner contacts for conotoxins, the endogenous ligand agonist 
are the orange blobs. Panel B shows a conotoxin blocking the ligand binding site using three microsites. Panel 
C shows the same ligand binding site blocked by several conotoxins, making use o f  the microsites. This 
figure is reproduced from Olivera, BM et al. (Olivera et al., 1991a).
1.1.4 Conotoxins as molecular tools and m edicine
A small number of Conns venom derived peptides have made it past the laboratory as 
pharmacological tools and are being developed as pro drugs for the treatment o f a range of 
neurological conditions (Alonso et al., 2003). a-conotoxin Vc.l from Conus victoriae 
(molluscivorous) is a competitive blocker of selected neuronal-type nicotinic ACh receptors 
by Metabolic Pharmaceuticals, Melbourne Australia (Sandall et al., 2003). a-conotoxin TLA 
from Conus tulipa (piscivorous) acts as a reversible noncompetitive inhibitor of a-1 
adrenergic receptors, developed by Xenome Ltd, Brisbane Australia (Sharpe et al., 2001). w- 
conotoxin CVID from Conus catus (piscivorous) blocks N-type calcium channel specific 
sub-type and is being developed by AMRAD, University o f Queensland Australia 
(Blanchfield et al., 2003). oconotoxin MVIIA (from Conus magnus a piscivorous species) is 
also known by several commercial names, SNX-111, C1002, Ziconotide and Prialt™. This 
was the first peptide from Conus venom to be utilized as potential pain relief drug. It also 
blocks N-type calcium channels and it is being developed by Elan Pharmaceuticals, CA 
USA (Atanassoff et al., 2000; Bowersox and Luther, 1998; Levin et al., 2002; Penn and 
Paice, 2000). %-conotoxin MrLA/B from Conus Marmoreus (molluscivorous), acts as
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reversible noncompetitive inhibitors of the neuronal noradrenaline transporter. These are 
being developed by Xenome Ltd, Brisbane Australia (Sharpe et al., 2001). Cognetix Inc, 
Salt Lake City USA is developing the three peptides Contulakin-G and Contokin-G both 
from Conus geographus (piscivorous) and Conantokin-T from Conus tulipa (piscivorous) 
(Malmberg et al., 2003).
1.1.5 Conotoxins, contryphans and post-translational modifications
Amoung the conopeptides (i.e with few disulfide linkages) contryphans are a case on their 
own. Although no target has been found for these peptides, fish that were injected with 
contryphans showed elicit body tremor and mucous secretion (Alonso et al., 2003). 
Therefore they may have a biological function related to endocrine or neuronal function 
(Massilia et al., 2001).
Contryphans are single disulfide linked members of the conotoxin family (Terlau, 2004} 
and were first discovered in the venom of the piscivorous snail Conus tadiatus (Jimenez et al., 
1996). Contryphans are highly post-translationally modified small peptides. Typically only 8 
to 12 amino acids long, these peptides incorporate modifications such as 4-trans-hydroxy- 
proline (Stone and Gray, 1982), Leucine (Jacobsen et al., 1999) and Tryptophan (Jacobsen 
et al., 1998; Jimenez et al., 1996) isomerisation, C-terminus amidation (Nakamura et al., 
1996) and bromination of Tryptophan (Craig et al., 1997; Jimenez et al., 1997). The post- 
translational modification of L- to D-amino acid is catalyzed by a enzyme and has been 
found in several biological systems (Kreil, 1997).
1.2 Polypeptide Separation
1.2.1 Liquid Chromatography
Many of the experiments carried out for the work in this thesis made use of liquid 
chromatography. It was used for sample fractionation and as front-end separation before 
mass spectrometric analysis (both by itself and in combination with gel electrophoresis). 
Molecules can be separated by chromatography using different properties, such as size, 
charge and hydrophobicity.
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1.2.1.1 Si%e exclusion chromatography
Size exclusion chromatography (SEC) is a chromatographic method in which molecules are 
separated based on their size and was first described by Porath et al. (Porath and Flodin, 
1959). This method is most widely used in the analysis of polymer molecular weights (or 
molar mass).
Molecules are separated by whether or not they can fit within the pore size of the packing 
material. When columns are created they are packed with porous beads with a specific pore 
size so that they are most accurate at separating molecules with sizes similar to the pore 
size. As a molecule flows through the column it passes by a number o f these porous beads. 
If the molecule can fit inside the pore then it is drawn in by the force of diffusion. There it 
stays a short while and then moves on. If a molecule can not fit into a pore then it 
continues following the solvent flow. For this reason, in a SEC column, molecules with 
larger size will reach the end of the column before molecules with smaller size. The 
effective range of the column is determined by the pore size o f the packing. Any molecules 
larger than all the pores in a column will be eluted together regardless of their size. 
Likewise, any molecules that can fit into all the pores in the packing material will elute at 
the same time.
The only absolute measure in SEC is volume o f the molecule (hydrodynamic volume), and 
even that measurement has a certain error built into it. Interactions between the solvent, 
packing, and/or the sample will affect the measurement as will concentration due to 
sample-sample interactions (Kostanski et al., 2004)
1.2.1.2 Reversed phase chromatography
In Reversed phase liquid chromatography (RP-LC), molecules are separated according to 
their hydrophobicity (Snyder et al., 1997). Sample mixtures in a hydrophilic mobile phase 
are introduced to a column containing a hydrophobic stationary phase. Elution occurs with 
applications of a hydrophobic phase applied in a fixed (isocratic) or variable (gradient) 
concentration.
Depending on the hydrophobicity of the analyte, different stationary phases can be used. 
More hydrophobic species, such as proteins can be separated by relatively hydrophilic 
alkylsilane stationary phases such as butyl (C4) or octyl (C8) (i.e. chromatographic silica
beads derivatised with aliphatic chains containing 4 or 8 carbon atoms) containing relatively
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large pore sizes. In contrast, small peptides are better separated with columns packed with 
beads derivatised with octadecyl groups (i.e. C l8) containing relatively small pore sizes 
(Snyder et al., 1983)
1.2.2 H igh performance two-dimensional gel electrophoresis
Two-dimensional polyacrylamide gel electrophoresis (2-DE) is one o f the core technologies 
o f proteome analysis (Hoving et al., 2002). Proteins are separated according to charge (pi) 
by isoelectric focusing (IEF) in the first dimension and according to relative mass (Mr) by 
sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) in the second 
dimension. 2-DE was first described by O’Farrell (O'Farrell, 1975), Klose (Klose, 1975) 
and Scheele (Scheele, 1975). It has become the method of choice for the separation of 
complex mixtures of proteins because of its high resolution, due to the independent 
parameters for the two dimensions. A major drawback for 2-DE for a long time was 
reproducibility. This was mainly due to the instability of the pH gradient formed and the 
limited pH range that could be created (pH 4-8) with carrier ampholytes in the first 
dimension. Furthermore, preparative amounts of proteins could not be separated very well 
on these types o f gels. The introduction of immobilized pH gradient (IPG) gels largely 
overcame the problem of gradient stability and poor sample loading capacity (Bjellqvist et 
al., 1982; Righetti, 1989).
1.2.2.1 The first dimension: isoelectricfocusing
The use o f isoelectric focusing is limited to molecules that can be positively and negatively 
charged in a changing pH environment (Westermeier, 1997). Proteins and peptides are 
such molecules. The net charge of a protein is the sum of all negative and positive charges. 
The three dimensional configuration of proteins does not play a role as the protein is 
assumed to be totally denatured (random coil), because of the chaotropic chemicals used in 
the solubilisation buffer. A post-translational modification, such as phosphorylation has an 
influence on the net charge of a protein, so this is usually seen at a spot train on the gel. 
Isoelectric focusing is in principle an end point method. Once the protein has reached the 
pH where its net charge is zero, it is in equilibrium in a focal zone (Righetti, 1989).
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1.2.2.2 Second dimension SDS-PAGE
After the first dimension (IEF), strips are equilibrated for the second dimension. This 
treatment has three functions. Reduction o f disulfide bonds, acetylation and SDS treatment 
In order to maintain solubilisation in the second dimension, disulphide bonds are once 
more reduced with dithiothreitol (DTT) according to reaction (1) and alkylated (protein- 
CH2-S-CH2-CO-NH2) by iodoacetamide according to reaction (2). Alkylation prevents the 
formation o f new disulfide bonds.
R-CH2-S-S-CH2-R + C4Ht0O2S2 -> 2R-CH2-SH + C4H80 2S2 (1) 
R-CH2-SH + ICH2CONH2 -> R-CH2-S-CH2-CO-NH2 + HI (2)
In the second dimension, the proteins are separated on a 20 by 25 cm gel, accorded to their 
relative molecular weight by SDS-PAGE. The detergent SDS binds to the proteins at a 
ratio of about one SDS molecule per two amino acid residues in such a way, that they al 
have the same net negative charge density and migrate in a gel according only to their 
relative molecular mass. The strips are transferred to second dimension 12 % poly­
acrylamide (PA) gels. An electric field is applied and the proteins migrate towards the 
anode, due to their negative charge. The run is stopped when the tracking dye, 
bromophenol blue, reaches the end o f the gel.
1.2.2.3 Difference Gel Electrophoresis
Difference Gel Electrophoresis (DIGE) is a relatively new ‘staining’ technique and is used 
for relative quantitation of 2DE separated proteins. Proteins are labelled on lysine side 
groups prior to separation with different fluorescent dyes so called CyeDyes (Cy3 and Cy5). 
A pool of both samples is stained with a third dye (Cy2), this acts as an internal standard. 
All samples are then combined and run on the same gel. All tree dyes have distinct and 
non-overlapping excitation and emission spectra enabling their specific detection with a 
multi-wavelength fluorescent detection device. The dyes should be mass and charge 
matched and the dye modification should not perturb the electrophoretic mobility of 
labelled proteins.
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1.3 B ioanalytical M ass Spectrom etry
The determination o f molecular weight is among the first measurements used to 
characterise biopolymers. Up to the end of the 1970s, the only techniques that provided 
this information were electrophoresis, chromatographic or ultracentifugation methods 
(Hoffmann and Stroobant, 2003). The error on the measurement could be 10-100% as all 
of these methods are not only measuring molecular weight, but the measurement is 
influenced by parameters like hydrophobicity and protein folding.
Mass spectrometry (MS) has become the technique of choice over the last two and a half 
decades, for protein identification, and increasingly the investigation and discovery o f post- 
translational modifications (PTM). This is mainly due to a number of instrumental 
advantages, such as sensitivity, low sample consumption, accuracy, possibility to automate 
etc (Baldwin, 2004).
1.3.1 Mass Spectrometer, a quick overview
In essence, a mass spectrometer is used to produce ions and measure their mass to charge 
ratio (m/z) o f ions. A mass spectrometer consists o f three basic parts, namely (i) an 
ionization source, (ii) an analyzer and (iii) a detector.
i. Analyte molecules are converted into gaseous ions. The most used ionization 
sources for biological molecules are Matrix-Assisted Laser Desorption /  Ionization 
(MALDI), where LASER stands for Light Amplification by Stimulated Emission of 
Radiation. The other most used ionization source is Electrospray Ionization or ESI. 
Other ionization methods include Fast Atom Bombardment (FAB), Chemical 
Ionization (Cl), thermal Ionization (TIMS), Secondary Ionization (SIMS) and 
Plasma Desorption (PD).
ii. An electric or magnetic field can deflect charged particles, and since the kinetic 
energy imparted by motion through an electric field gives the particles an inertia 
dependent on the particle's mass, the mass analyser uses these facts to steer certain 
ions to the detector based on their m /z ratios by varying the electrical or magnetic 
field. It can be used to select a narrow range of m /z (for instance to select peptides 
of interest for tandem mass spectrometry (MS/MS)) or to scan through a range of 
m /z to catalog the ions present (survey scan). Examples o f mass analysers are
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quadrupole mass analyzers, time-of-flight (TOF), ion trap (IT), ion cyclotron 
resonance (ICR) and magnetic sector instruments. There are numerous 
combinations o f mass analyzers in so called hybrid instruments. The first three are 
the most commonly used instrument in bioanalytical mass spectrometry, recently 
also very high accuracy mass spectrometry has become commercially available (Ion 
Cyclotron Resonance Fourier Transformation Mass Spectrometry or ICR-FT-MS).
iii. There are numerous ways to detect ions. Routinely these are recorded when an ion 
hits (Multi Channel Plate, or MCP) or passes by a detector plate. As ions hit the 
plate a cascade o f electrons is released, amplifying the single ion detection. As ions 
pass by the detector plate they cause electrons to flow to the plate. This flow is 
called image current and can be detected and amplified. If a scan is conducted in 
the mass analyzer, the charge induced in the detector during the course o f the scan 
will produce a mass spectrum, a record of the m /z values at which ions are present.
1.3.2 Ionization methods
Biological mass spectrometry has and is being developed at a rapid pace since the 
development o f the soft ionization techniques MALDI and ESI. MALDI was developed 
by Karas and Hillenkamp (Hillenkamp et al., 1991; Karas and Hillenkamp, 1988) and 
Tanaka (Tanaka et al., 1988). Electrospray was developed by Fenn (Fenn et al., 1989). Fenn 
received the Nobel Prize for Chemistry in 2002. In the same year Tanaka was awarded the 
Nobel Prize for his contribution to the development of soft ionization methods for mass 
spectrometric analysis of biological molecules.
1.3.2.1 Matrix-Assisted Laser Desorption Ionisation
Lasers found their first application in mass spectrometry in the early 1970s for desorption /  
ionizations of small organic molecules that contained appropriate chromophores (Cotter, 
1984). The rapid energy absorption initiates a phase change in a microvolume of the 
absorbing material from solid to gas, while also inducing ionization. In the late 1980s, it 
was discovered that desorption /  ionization of large, non-volatile molecules such as 
proteins could be similarly effected when such samples were irradiated after being 
deposited together with a large molar excess of an energy absorbing material (Karas et al., 
1987).__________________________________________________________________________
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The initial experiments were conducted with frequency-quadrupled Neodymium-Yttrium- 
Aluminium-Gamet (Nd-YAG) lasers that emit at 266 nm, while other investigators have 
subsequently used longer wavelengths from nitrogen (337 nm) or frequency-tripled Er- 
YAG lasers (355 nm). Infrared (IR) laser radiation (2.94 pm) from carbon dioxide lasers 
has also been employed for MALDI-MS. IR lasers are particularly suited for the analysis of 
labile molecules and protein and peptide modifications (e.g. phosphorylation or 
glycosylation), because they allow for lower energy transfer to analyte. However, this 
occurs at the expense of a very high rate of ablation, meaning that a sample is so rapidly 
desorbed at that frequently that only a single laser pulse can be fired at a particular position 
before the entire sample is ablated (Cramer and Burlingame, 2000; Cramer et al., 1998).
For the most frequently used laser wavelengths (337 and 355 nm) several hundred 
compounds have been selected for their radiation absorbing properties for use as MALDI 
matrices (Ehring et al., 1992; Fitzgerald et al., 1993). Examples of widely used matrices are 
sinapinic acid, 2,5-dihydroxybenzoic acid (DHB) and a-cyano-4-hydrocycinnamic acid 
(CHCA). The chemical structure of the latter two is given in Figure 1.3.1.
HO
OH
HO
HO
Figure 1.3.1 Examples of commonly used MALDI matrices.
Tw o com m only used matrices used in M ALDI mass spectrom etry are 2,5-dihydroxybenzoic acid (DHB) and 
a-cyano-4-hydrocycinnamic acid (HCCA), show  on the left and right respectively. D H B  form s a crystal rim, 
and is relatively salt tolerant. H CCA  form s semi hom ogeneous spo t w hich makes it m ore amenable for 
autom atic acquisition.
DHB is more tolerant to ‘high’ salt concentrations compared to HCCA. DHB crystallizes 
in the form of a spike shaped crystal rim around the centre of the spot. HCCA forms a 
semi homogeneous shaped matrix spot, making it more suitable for automated data 
acquisition. Another major difference between these two matrices is the rate of energy 
transfer to the analyte. DHB is considered a ‘cool’ matrix as the energy transfer is relatively 
low, making it more suitable for the analysis of labile modifications on peptides. HCCA on 
the contrary is a ‘hot’ matrix. Because of the higher transfer o f energy this matrix is more 
suitable to gain structural information (primary sequence) o f peptides. In a recent paper by
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Cramer and Corless (Cramer and Corless, 2005) investigate the use o f liquid matrices in 
light o f the automatic acquisition of MALDI spectra for high throughput protein 
determination. This was originally reported by Sze et aL (Sze et al., 1998). Liquid matrices 
generally are conventional matrices dissolved in a viscous, vacuum stable liquid, such as 
glycerol. The main advantage of this method is that there is no need to sample the entire 
spot, as the sample remains in solution and is no longer fixed to a specific crystal within the 
spot.
Figure 1.3.2 shows a schematic of the MALDI process in positive ion mode. The exact 
mechanism of energy transfer and ionization of analyte molecules is still being debated 
(Karas and Kruger, 2003; Kocher et al., 2005; Pshenichnyuk and Asfandiarov, 2004; 
Zenobi and Knochenmuss, 1998). However it is believed that after laser irridiation of the 
matrix-analyte crystals (h), clusters of matrix-analyte is formed in the so-called plume (d) 
are formed by a complex combination of thermal desorption, sublimation/evaporation, 
and ablation by phase explosion induced by the pulsed laser beam (Dreisewerd, 2003). The 
plume is formed in a so-called field free region before the extraction electrode (E et al.). 
Only after the formation of the plume, a potential is applied (f) to extract the charged ions 
from the plume. The delay of the extraction in the process is known as delayed extraction 
(DE) (Jensen et al., 1996). Not all MALDI instruments are equipped with DE.
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Figure 1.3.2 Schematic representation of the MALDI process
The analyte is co-crystallized with the matrix molecules (h). A pulsed laser (E et al.) is focussed onto the 
target (a) by ion optics (E et aL). A mixture o f matrix and analyte is desorbed into a so called plume (d). The 
now ionized analyte molecules (magenta) are in the field free drift region before the electrode (E et al.). The 
charged molecules are extracted by a high potential (f) into the entrance o f the mass spectrometer (g).
1.3.2.2 Electrospray Ionisation
Electrospray ionisation (ESI) is a very soft ionization method. ESI allows for the formation 
of ions from liquid phase samples. The sample is dissolved in an organic solvent, typically 
methanol or acetonitrille, containing a small concentration of acid (formic acid, 0.1 — 1%). 
The introduction of sample into the mass spectrometer is carried out by a number of 
methods. In the simplest case, sample is directly infused using a syringe and a transfer 
capillary. Another example is the so-called nano-spray sample delivery. In this system, a 
small amount of sample is placed into a needle, which has a very small tapered opening on 
one side. Sample is forced out because of capillary forces and voltage applied to the 
conducting needle. However, the most commonly used method is the coupling of 
electrospray directly with reversed phase chromatography. In this setup the capillary end of 
the chromatographic system is connected to a needle, with typical flow rates of 200 to 500
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nl m in 1 (nanospray). Figure 1.3.3 shows a schematic o f the electrospray ionization process. 
Liquid is forced through a small capillary (typically 75 pm) into a tapered needle. 
Application o f high voltage induces formation o f highly charged analyte-solvent droplets, 
which are extracted under a potential gradient into the skimmer region, in which the 
droplets undergo solvent evaporation. As the volatile solvent component evaporates, the 
magnitude o f the charge-repulsion effect becomes more significant, and at a certain 
charge/solvent composition (termed the Rayleigh limit), Coulomb explosion of the analyte- 
solvent clusters occurs. The clusters become smaller and more highly charged within the 
skimmer region until single molecular ions are formed either by further explosion of 
clusters or by desorption o f molecular ions from the clusters These ions can then be 
analysed according to their mass-to-charge ratios (Gaskell, 1997; Mann and Wilm, 1995) .
High voltage
Figure 1.3.3 Schematic representation of electrospray ionization
This figure shows the schematic representation o f the ESI process. Sample is delivered through a capillary (a) 
and a tapered needle (E et al.). Through a high voltage, droplets are extracted (E et al.). Because o f  the 
evaporation o f  solvent the charge repulsion reaches a critical value (the Rayleigh limit) (d), droplets explode 
(Coulomb explosion), creating generally multiply charged ions (E et al.). These enter the mass spectrometer 
(f) under the applied electric field.
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1.3.3 Mass Analysers and hybrid instruments
Due to the large range of different instruments available, only those mass spectrometers are
After producing ions in the ion source, they need to be separated according to their mass 
to charge ratio. This separation occurs in the mass analyzer part o f the mass spectrometer. 
These mass analyzers can be divided into four general groups (i) time-of-flight (TOF), (ii) 
quadrupole, (iii) ion trap and (iv) ion cyclotron resonance. As briefly mentioned above, a
instrument are discussed below.
1.3.3.1 MALDI-TOF
Because o f the pulsed nature of MALDI ionization, it is most commonly used in 
combination with Time-of-flight (TOF) analyzers. TOF mass spectrometers are 
instruments noted for their nearly unlimited mass range and high sensitivity (Cotter, 1989; 
Roepstorff, 2000). In these mass analyzers, ions are formed by a pulsed ionization process 
in a source region to which an electric field is applied. The electric field accelerates the ions 
into a long field free drift region. The time required for ions to travel this region (TOF) is 
dependent on their mass and is described by the following equations. An ion, which leaves 
the source, with a mass m and total charge q = ze has a kinetic energy (Bjellqvist et al.):
discussed in detail that were relevant to the work of this thesis.
number o f hybrid instruments are commercially available. A few examples of hybrid
m V 2
2
The time needed to fly the distance d is given by:
t  =
d_
V
Replacing V (velocity) by its value in the previous equation gives:
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Where Vs is voltage. When the terms in the parentheses are constant, there is a linear 
relation between the m /z value and time (t2). Therefore, low-mass ions have a shorter flight 
time than heavier ions. The start of the measurement for the TOF is triggered by the 
pulsed laser signal
Because the TOF recorded for a particular ion reflects many different initial conditions 
experienced in the ion source (such as the time /  location of the ion formation and the 
initial kinetic energy distributions), the mass resolution can be relatively low. Resolution is 
defined as the reciprocal of resolving power, which is defined as the smallest mass 
difference between equal magnitude peaks such that the valley between them is a specified 
fraction of either peak height, or
m
<5m
To combat the phenomenon of low mass resolution, modem MALDI-TOF mass 
spectrometers are equipped with a number of hardware features.
To lower the kinetic energy spread among ions with the same m /z ratio leaving the source, 
a time lag or delay between the ion formation and extraction can be introduced. In this case, 
ions are first allowed to expand into a field-free region in the source and after a user 
defined delay (varying from hundreds of nanoseconds to several microseconds) a voltage 
pulse is applied to extract the ions outside the source (Jensen et al., 1996; Kaufmann et al., 
1996). This process /  technique is known as delayed pulsed extraction, or delayed 
extraction (DE).
Another hardware tool, used to improve mass resolution is the electrostatic reflector, or 
reflectron for short. The reflectron consists usually of a series of grids and ring electrodes 
(Cornish and Cotter, 1993). It creates a delaying field that acts as an ion mirror by 
deflecting the ions and sending them back thought the flight tube. The reflector corrects 
the energy dispersion o f the ions leaving the source with the same m /z ratio. Ions with 
more kinetic energy will penetrate the reflectron more deeply. Therefore they reach the 
detector at the same time as slower ions of the same m /z. As discussed above, the major
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advantage is the enhanced mass resolution, but there is a trade-off in terms of sensitivity 
and a limited mass range (Hoffmann and Stroobant, 2003).
In recent years tandem TO F mass spectrometers have been developed. These MALDI 
based instruments are capable of fragmenting ions o f choice in a data dependent manner. 
Figure 1.3.4 shows a schematic overview o f a, so called TO F-TO F mass spectrometer. In 
MS mode, ions are measured as in a conventional MS. In MS/MS, mode an ion o f interest 
is filtered through by the timed ion selector (E et al.), before being collided with a gas in 
the collision cell (d). Fragment ions are re-accelerated by the second ion source (E et al.) 
and analyzed by the second TOF, the MS/MS is based on collision induced dissociation 
(CID).
O 0 -V  o -
TOF TOF
g
n
Figure 1.3.4 Schematic overview of a MALDI T O F/T O F instrument
This figure shows the schematic overview o f a T O F /T O F  mass spectrometer. Ions o f  interest are gated 
through the timed ion selector and fragmented by collision induced dissociation before being analysed by the 
second TO F. The MS consists o f  the following components: (a) ion source 1 (E et aL) laser beam (E et al.) 
timed-ion-selector (d) collision cell (E et al.) ion source 2 (f) reflector detector (g) reflector (h) linear detector. 
The ion path is indicated by the red dashed line.
TO F analyzers are directly compatible with pulsed ionization sources. However, on 
modem hybrid mass spectrometers, TO F can be used with continuous ion sources, such as 
electrospray. In that case, packets o f ions are retarded by a decelerating field. They are then 
extracted into the flight region which is perpendicular to the original ions path (Boyle and 
Whitehouse, 1992).
1.3.3.2 Quadrupolar analysers
The quadrupole principle was first described by Paul et al. (Paul and Steinwedel, 1953). The 
quadrupole, the actual mass analyzer, makes use o f the stability o f the trajectories in
32
1. Introduction
oscillating and static electric fields to separate ions according to their m /z ratio. 
Quadrupole analyzers are made up out o f four perfect parallel inert metal rods. When, for 
instance, a positive ion enters the zone between the rods, it will be drawn towards the 
negative pole. When the potential is altered before the ion collides with the rod, the ion will 
change direction.
Ions travelling along the z-axis are subjected to the influence of a total electric field made 
up of a quadrupolar alternating field superposed on a constant field resulting from the 
application o f the potentials upon the rods:
O 0 = + ( U -  V cos ax) ^  - O 0 = - ( U - V  cosax)
Here 0 O represents the potential applied to the rods o f the quadrupole, u> is the angular 
frequency (in rad s'1) = 2nu, where u is the frequency of the radio frequency (RF), U is the 
direct potential and V and the amplitude of the RF voltage. U typically varies from 500 to 
2000 V and V  from 0 to 3000 V (from -3000 to +3000 V peak to peak) (Hoffmann and 
Stroobant, 2003).
1.3.3.3 Orthogonal Quadrupole TOF
Multiple quadrupoles can be used in a mass spectrometer. Q-TOF type instruments are an 
example of such an instrument, combined with time of flight mass analyzer. The Q-TOF 
was developed by Morris et al. (Morris et al., 1997). The first commercial instrument Q- 
TOF™ was developed by Micromass. These types o f instruments have three tandem 
quadrupoles, of which the second (q2) is an RF-only quadrupole. In RF-only quadrupoles 
there is no direct potential, therefore ions of certain m /z ratio, above a lower limit have a 
stable trajectory, as long as V is within the limit of their stability area. Such a quadrupole 
causes all o f the ions to be brought back systematically to the centre of the rods, even if 
they were deflected by a collision. This is called ion focusing and is important to increase 
the transmission o f ions through the mass spectrometer after collisions. Figure 1.3.5 shows 
a schematic o f a Q-TOF type instrument. As discussed above, in case o f continuous 
electrospray, there is a need to place the TOF orthogonal to the ion path. Packets of ions 
are ‘pushed’ into the flight tube, initialising the start of a time of flight measurement. Many 
manufacturers have also developed a MALDI ionization source for these instruments.
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In general, quadrupoles are indicated by ‘Q ’, while RF-only quadrupole are indicated with 
‘q \ This hybrid instrument consisting on a quadrupole (Ql) and a TO F connected through 
another quadruple (q2) that is used as a collision cell. When scanning a large mass range, 
Q l and Q2 operate in RF mode only so that ions with a wide m /z  range are transmitted to 
a push-pull region were ions are accelerated orthogonally towards the field-free region of 
the TOF. In MS/MS experiments Q l isolates the desired ion and transmits it to q2 where 
it fragments due to collision induced dissociation (CID). Ions o f interest are selected in a 
data dependent manner. For this, parent masses are automatically selected for tandem mass 
spectrometry (MS/MS) when, for instance, the signal in the MS spectrum rises above a user 
defined threshold. Q3 focusses the ions towards the push-puller region (a).
-  a
= ion path 
= inert gas molecule
TOF
Figure 1.3.5 Schematic overview of a qQ-TOF mass spectrometer
This figure gives a simplistic overview o f  an orthogonal Q -T O F mass spectrometer. Quadrupoles are 
generally indicated by letter ‘Q ’ and RF-only quadrupoles with ‘q’. In this experiment q2 is filled with an inert 
gas and functions therefore as a collision cell, a) is a push region that pushes the ions into the orthogonal 
placed TO F. b) reflector and c) detector plate. The ion path is displayed by the dashed red line.
1.4 P eptide Sequencing using Tandem M ass Spectrom etry
The main objective o f tandem mass spectrometry (MS/MS) is to gain structural 
information. Figure 1.4.1 shows a schematic representation o f the possible fragmentation 
o f the peptide backbone. The nomenclature was proposed by Roepsdorff et al. (Roepstorff 
and Fohlman, 1984). Upon fragmentation of a peptide the charge is retained either by the 
N- or C- terminus side of the molecule. Fragments are named a, b or c in the first case or x,
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y or 2 in the latter. Fragmentation induced by high collision energy result in, so called v and 
w ions, that occur on the side chain groups and are not discussed here.
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Figure 1.4.1 Schematic representation of peptide fragment nomenclature.
This figure shows a schematic overview o f the possible fragmentation on the peptide backbone and their 
nomenclature o f resulting fragment ions. Different amino acids are distinguished by the side groups displayed 
in red (R). The nomenclature was proposed by Roepstorff eta/, in 1984. W hen the charge is retained on the 
C-terminal side o f the peptide, fragments are named x, y and z, while when the charge is retained on the N- 
terminus side fragments are named a, b and c type ions. The resulting fragments are dependent on many 
factors, such as the type o f  fragmentation method, analyser principle and primary sequence dependency. Also 
fragmentations on the side chains are possible. These ions are indicated as v and w ions (not shown in this 
figure).
Production o f the different fragment ions observed is dependent on many factors. The 
mobile proton model is a framework for the understanding o f peptide dissociation and was 
described by Wysocki et al. (Wysocki et al., 2000). According to this model, fragmentation 
of most protonated peptides requires a proton to be proximal to the cleavage site. Peptides 
usually fragment at their amide bond (peptide bond) producing b and y ions. The mobile 
proton model also states that the cleavage is initiated by the migration o f the charge from 
the initial site o f protonation. If the side chain on a basic amino acid tightly binds the 
proton, energy must first be delivered to the ion to shift the proton to the peptide 
backbone, which then induces dissociation. The exact amount o f energy required depends 
on the amino acid composition. Arginine containing peptides need more than lysine- 
containing peptides, which, in turn, need more energy than peptides with no basic residues. 
Magnetic sector instruments and tandem time-of-flights (TOF/TOFs) can induce higher 
energy collisions for investigation of these alternative pathways. N ot surprisingly, the
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peptide sequence is the primary determinant o f how much energy is required for optimal 
fragmentation.
Although energy is mostly transferred to ions by the collisions inside the mass 
spectrometer, the way in which peptides are ionized also contributes to their internal 
energy level. Electrospray ionization (ESI) and matrix-assisted laser desorption/ionization 
(MALDI) are used most often. Both of these are called “soft ionization” techniques 
because precursor molecular ions remain intact, for the most part, immediately after 
ionization. ESI precursor ions are multiply-charged, with the distribution of charge states 
dependent upon both peptide structural properties and instrumentation parameters. 
Because MALDI ions are singly-charged for the most part, its fragmentation spectra are 
often dominated by signals arising from cleavage at the acidic residues, and sometimes not 
enough information is present to establish the peptide sequence conclusively.
Two of the most used methods of fragmentation are post-source decay (PSD) and collision 
induced dissociation (CID). PSD is a common side effect, often seen in MAT.DI mass 
spectrometry. As the name indicates, this sort of fragmentation (metastable decay) occurs 
after the formation of the actual ion. PSD was first utilised by Kaufmann et aL (Kaufmann, 
1995; Kaufmann et al., 1993). The process of metastable fragmentation following MALDI 
is employed in PSD analysis, generally using a reflectron time-of-flight mass analyser. 
Fragmentation is maximised by using a ‘hot’ matrix (i.e. a matrix with a high rate of energy 
transfer to analyte, such as HCCA), and by increased laser power, which promotes 
fragmentation. Fragment ions are resolved by altering the focussing o f the reflectron over 
small regions of the m l\ range to maximise the resolution and mass accuracy of the 
fragments. The PSD fragmentation process produces many internal peptide fragment ions 
(bearing neither N- or C-terminus of the peptide), as well as peptide backbone cleavages. 
Such types of ions typically make interpretation of sequence less facile than that of CID 
data. The LIFT-TOF instrument from Bruker Daltonics makes use o f this principle for 
tandem MS. A peptide o f interest and its PSD fragments (both have the same initial 
velocity, independent of mass) are gated through by the timed ion selector. After the first 
TOF tube ions are re-accelerated into the second TOF.
CID is a more widely used fragmentation technique, as is it used both on MALDI and ESI 
ionization mass spectrometers. Peptides of interest are selected for tandem MS and
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accelerated into a collision cell. This is usually filled with an inert gas. After collision ions 
are re-accelerated.
In both cases, a-, b- and y- ions are the predominant fragment ions. Tandem MS data is 
more and more used as a standard to interrogate databases. With the increasing amount of 
genetic data available for different organisms, databases steadily grow in size. In the 
beginning o f the 90s it was often enough to use peptide mass fingerprinting (PMF), this is a 
technique whereby measured masses of peptides generated by proteolytic cleavages are 
searched against a theoretical digest from proteins in a database. Nowadays more accurate 
data is necessary to assign proteins IDs. MS/MS data can also be used to assign novel, 
unknown peptides. This process is referred to as de novo sequencing.
When performing de novo sequencing, many other diagnostic signals from the mass 
spectrum are used. Two of these diagnostic fragment ions are shown in Figure 1.4.2. 
Amino acids like proline and carbamidomethylated cysteine are prone to generate internal 
fragment ions. These are the result o f a double cleavage o f the peptide backbone and the 
central part retaining the charge. When an internal fragmentation occurs on the y- and a- 
ion o f the same amino acid, an immonium ion is generated. A schematic representation is 
shown on the right side o f the Figure 1.4.2.
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Figure 1.4.2 Schematic representation of internal fragments and immonium ions.
This figure shows a schematic representation o f an internal fragment ion (left) and an im monium ion (right). 
Internal fragment ions occur when the peptide backbone is cleaved in two places and the charge is retained 
by the central part o f  the peptide/ion. Amino acids like proline and carbamidomethylated cyteine are prone 
to generate such fragments. An im monium ion is a diagnostic ion specific to an amino acid. It is the result o f 
a y- and a ion cleavage.
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1.5 A im s and scope
The primary aim of this study was to set up a separation and analysis scheme to rigorously 
investigate the components of Conus venom with Mass Spetrometry as a central technique. 
As discussed above, Conus derived toxins are very potent drugs that act mainly on ion 
channels and other cell receptors. Although conotoxins have been investigated for more 
then two decades, only a handful of the estimated 50,000 potential biologically active 
compounds have been characterised at the protein/peptide level. This work is not 
concerned with biological assays of the components of Conus venom.
In this work several strategies have been employed to investigate the complexity of Conus 
venoms. Chapter three is concerned with the analysis o f the protein content of venom 
samples. Both one and two-dimensional gel electrophoresis was used.
Chapters four, five and six describe the analysis of the peptide content of the different 
venoms available. A size exclusion method, followed by LC-MALDI-MS/MS was 
performed on the venom of Conus ventricosus and is described in Chapter four. This method 
revealed several partial conotoxin sequences. Chapter five describes the separation and 
analysis o f Conus ventricosus and Conus textile venom, where size separated fractions were 
further analysed by LC-ESI-MS/MS. Chapter six shows the discovery o f several new 
contryphans in Conus ventricosus venom.
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2 Materials and Methods
2.1 M ass spectrom etry
Mass spectrometry based experiments were carried out using instruments located and 
maintained at the Bioanalytical Chemistry laboratory (Professor Dr R. Cramer, group 
leader) o f the Ludwig Insdtute for Cancer Research (UCL branch, Prof M.D. Waterfield, 
director) or in the Mass Spectrometry Facility of the University of California in San 
Francisco (Professor Dr. A.L. Burlingame, director).
2.1.1 MALDI-TOF MS and M ALDI-TOF/TOF MS/MS
Although a suite of MALDI mass spectrometers is available in both labs, all MALDI data 
presented in this thesis was obtained on a 4700 Proteomics Analyzer MALDI-TOF/TOF 
(Applied Biosystems, Foster City, CA, USA). This is a low pressure MALDI-TOF/TOF 
capable of high collision energy fragmentation in a collision cell located in between two 
TOF analysers.
In MS mode, 50 sub-spectra of 50 laser shots each were accumulated, for MS/MS 400 sub­
spectra o f 50 laser shots each were collected. Automatic MS/MS was stopped before 
reaching the 400 sub-spectra if at least 30 sub-spectra contained 18 or more peaks with 
signal to noise rations above 24. For MS/MS a transmitting window of ± 3 Da was set for 
the precursor ion selection. Each MS spectrum was automatically calibrated using an 
internal standard (ACTH 18-39).
2.1.1.1 Sample preparation for M ALDI analysis
Samples for MALDI-TOF MS analysis were prepared using the dried droplet protocol. In 
short, the sample analyte was mixed with an excess of matrix. Typically, 0.5 pi of sample 
solution was mixed with 1 pi of saturated solutions o f 2,5-dihydroxybenzoic acid (2,5-DHB, 
Bruker Daltonics or Sigma) or a-cyano-4-hydroxycinammic add (CHCA, Agilent 
Technologies). Saturated solutions of 2,5 DHB were freshly prepared just before analysis 
by dissolving an excess o f solid matrix in HPLC grade water. HCCA was purchased as a 
ready made solution in methanol. Samples in DHB were dried under a stream of cold air. 
HCCA matrix used for automatic spotting with the Probot (LC Packings, San Frandsco)
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consists o f 1 part 70 % methanol and 1 part ready HCCA solution (Agilent Technologies) 
ACTH 18-39 is added to a final amount equal to 4 finol per spot.
2.1.2 ESI - QTOF MS
Electrospray MS data for two-dimensional liquid chromatography and ID  gel separation of 
proteins from Conus venom were generated on a QSTAR™ (Sciex /  Applied Biosystems, 
Foster City, CA, USA). Measurements of in-gel digests from 2-DE were performed on a 
Q-ToFM instrument (Micromass, Manchester, UK).
2.1.2.1 Operation of ESI-Q-Tof
The QSTAR™ was equipped with a nanoflow ion source. Samples are introduced either by 
direct infusion by online coupled HPLC through a 20 pm capillary. The Q-ToFM was 
equipped with nanoflow ion sources and a fused silica ESI emitter with 50 pm I.D. tapered 
to 15 pm at the tip (PicoTipTM, New Objective, Woburn, MA). In both methods, the tip 
and the capillary are not coated with conductive material and the high voltage was applied 
at a liquid metal junction about 3 to 5 cm from the tip of the emitter. Flow rates for both 
methods are typically between 200 and 350 nl min'1.
Optimal operation parameters were determined empirically by infusing a standard peptide. 
Typical spray tip potentials were 1800-3500 V depending on the tip o f the emitter and the 
flow rates. Voltages at the orifice of the interface ranged from 40 to 150 V. The QSTAR™ 
and Q-ToFM instruments were calibrated using the m /z values o f the fragment ions 
generated from a MS/MS fragmentation of [Glul]-Fibrinopeptide B.
2.1.3 LC-MALDI-MS
Before MALDI-MS/MS the protein digests were separated on an Ultimate™ HPLC system 
(LC Packings, Amsterdam, Netherlands). This consists of an autosampler (Famos™) that 
loads 5 pi of sample solution at a flow rate of 40pl/min onto a peptide trap column (300 
mm inner diameter, 5 mm length, 100 A particle size PepMap, LC Packings) connected to 
at a switching valve (Switchos™). Peptides loaded in the peptide trap column were washed 
for 2 minutes at 40 pl/min with 0.1% formic add. After this time, peptides were eluted 
using gradient elution at 200 pl/min onto a main analytical column (C18 PepMap, 75 pm x 
15 cm).
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Solvent A was 3% Acetonitrile (ACN) 0.1% formic add and solvent B was 80% (ACN) /  
0.1% formic add. Elution was carried out from 5%B to 45%B in around 60 minutes, after 
which the column was flushed with 100% B. Before starting a new elution, the column was 
equilibrated for 20 minutes with 100% A.
The eluent was spotted onto a stainless steel MALDI plate which was placed on a x-y stage 
robot (Probot, LC Packings\Dionex, San Frandsco). The capillary end of the 
chromatographic system was embedded into a hollow needle. 0.5 pi HCCA matrix (as 
described above) were dispensed every 30 second, in which the eluent flows (30 seconds 
sampling rate). The matrix solution is spiked with an internal standard (IS), namely a 
peptide fragment o f adrenocorticotropic hormone (ATCH 18-39). The samples were 
allowed to dry by air before being analysed. Plates were analysed using the 4700 Proteomics 
Analyzer MALDI-TOF/TOF (PE Biosystems, Foster City, CA, USA) as described above.
The IS was used to calibrate each TOF-MS spectrum automatically. 5,000 shots were used 
to generate each MS spectrum. The 8 most intense peaks o f each TOF-MS spectrum were 
automatically selected for MS/MS, providing that the signal to noise ratio was over 25. 
Parent ions were fragmented for 10,000 shots. The MS/MS was stopped when 18 peaks 
reached a signal to noise ratio above 25.
2.1.4 LC-ESI-QTOF-MS
Nanoflow LC was performed on an Eksigent nanoHPLC pump (Eksigent, Livermore, CA) 
linked to a FAMOS™ autosampler (LC Packings/Dionex, San Francisco, CA) or an 
Ultimate™ HPLC system (LC Packings, Amsterdam, Netherlands).
The Eksigent system, unlike other nanoflow HPLC systems does not use a flow split. The 
flow is controlled by pressure rather then a pump. The Famos™ autosampler delivered 
typically 1 pi sample into the sample loop. This is directly loaded onto the main analytical 
column (C18 PepMap, 75 pm x 15 cm). The Ultimate™ HPLC system were as described 
above. With both systems a similar gradient was used as decribed above.
The eluent of the HPLC runs were analysed on-line by one o f the QTOF mass 
spectrometers described above. When the QSTAR™ or the QTof™ was used they were 
operated in data dependent acquisition, which allows for the automatic switching from MS
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to MS/MS experiments whenever an ion of a predetermined nature is detected. Briefly, a 
MS-survey scan is recorded. When an ion reaches a certain ion count a tandem MS 
experiment is performed, after which the ion (m/z value) is placed in an exclusion list to 
prevent multiple MS/MS on the same ion. This process is then repeated until the end of 
the chromatographic elution.
2.2 L iquid chromatography
2.2.1 Size exclusion chromatography
Size exclusion experiments were carried out on an AKTA HPLC (Amersham Biosciences) 
or a GoldStar (Beckman Coultier). The samples used for the experiment described in 
Chapter 4 were separated on a TSKfel Super SW2000 column (Tosoh Bioscience). Proteins 
were eluted in an isocratic run, with a flow rate of 0.5 ml min'1 using 25 mM Ammonium 
Bicarbonate (ABC). Fractions were collected manually in between two absorbance peaks. 
For all other size exclusion separations, a Tricorn Superdex Peptide 10/300 GL 
(Amersham Biosciences) column was used. The flow rate was set at 0.5 ml min'1 using 150 
mM NaCl /  20 mM Tris (pH 7.2) as the eluting buffer. No gradient was applied. Fractions 
were collected automatically every second minute.
2.2.2 Column packing
For the MALDI-MS experiments, columns were used made in-house. Before packing glas 
capillaries were fritted using potassium silicate solutions that formed a porous plug at the 
end o f the capillary (performed by Dr. Kirk Hansen, UCSF). For this, 300 |il potassium 
silicate solution (SiC^K^O, 21:9, Merk) was mixed with 100 pi formamide, vortexed for 1- 
2 minutes, centrifuged, and the solution positioned inside the capillary by capillary action; 
the end of the capillary was inserted in the solution for 3-4 s. Polymerisation was 
performed by placing the capillary in a heat block at 37°C for 1 h.
A slurry of the reversed phase material was made by mixing a spatula tip o f the material 
with an organic solvent, typically methanol. This slurry was placed at the bottom of a in- 
house constructed pressure cell. The non-fritted end of the capillary was placed at the end 
of a slurry reservoir through the lid of the pressure cell using standard valco connections. 
The whole cell was placed user pressure with nitrogen at approximately 800 psi. While
42
2. Materials and Methods
packing the column, the slurry was mixed with a micro magnetic stirrer and the capillary 
was agitated from time to time.
2.2.3 Reversed phase HPLC
2.2.3.1 Reversed phase clean up of si^ e exclusion fractions
Fractions from size exclusion separation (peptide fractions) were concentrated under 
vacuum from 1 mL to approximately 100 pi. These were loaded onto a peptide “captrap” 
(Michrom BioResources at a flow rate of 0.2 ml min'1 using 3 % ACN /  0.2 % TFA. The 
sample was flushed for 10 to 15 minutes, depending on the UV absorbance (214 nm) 
reaching previous baseline level. Peptides were eluted stepwise with 50 % ACN and 90 % 
ACN. This process was repeated twice.
2.2.3.2 Second dimension reversed phase fractionation of Conus venom
A Vydac Cl 8 reversed phase column (ID 4.6 mm; length 250 mm) was used for second 
dimension separation. At a flow rate of 0.5 ml min'1 peptides were eluted using a standard 
H20/A C N  buffer system. Briefly, the main eluting window is from 10 to 80 minutes were 
the concentration o f ACN is increased from 3 to 50 %. The steepness of the gradient was 
increased by going to 90 % ACN in 10 minutes. Trifluoro acetic acid (TFA) was used as 
the ion pairing agent. The concentration was kept constant throughout the elution at 0.1 %. 
Fractions were collected automatically every 0.6 ml. This fractionation was performed on 
the AKTA HPLC system (Amersham Biosciences).
2.3 G el electrophoresis
One-dimensional gel electrophoretic (IDE) separation o f Conus venom proteins was 
carried out at the mass spectrometry facility in UCSF San Francisco, while the two- 
dimensional separation o f Conus venom was carried out at the Bioanalytical chemistry 
laboratory LICR, UCL. These are briefly outlined below.
2.3.1 One-dimensional SDS-PAGE
1D-SDS-PAGE was performed with commercially available precast 10 — 20 % gradient 
Tris-glycine gels, (BioRad). Protein samples were mixed with sample buffer (Table 2.3.1) 
and boiled for 5 minutes at 100 °C. Gels were run at a constant current o f 50 mA, until the 
Bromo Fenol Blue front reached the bottom of the gel, typically 1 to 2 hours.
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T ab le  2.3.1 C o n cen tra tio n  o f co m p o n en ts  in  ID E  sam ple buffer
Reagent F ina l co n cen tra tio n
Tris pH  6.8 134 mM
4%  (w/v)
B rom ophenol blue (BPB) 0.06% (w/v)
Dithiothreitol (D T I) 6% (w/v)
Glycerol 20% (w/v)
2.3.2 T w o-dim ensional PAGE
Samples for 2D E were dissolved in 8M urea /  2M thiourea /  4% CHAPS /  10 mM Tris 
pH 7.2, mixed with ampholytes and DTT (85 mM final concentration), and applied to 
immobilised pH gradient (IPG) gel strips pH 3-10 (Amersham Biosciences, UK). The 
strips were allowed to rehydrate overnight at room temperature.
For two 2DE, 24 cm long non-linear pH 4-7 immobilised pH gradient (IPG) strips were 
rehydrated with labelled samples. Proteins were separated in the first dimension according 
to their isoelectric point (pi). Iso-electro focusing was performed in a Multiphor II 
apparatus (Amersham Biosciences, UK) using the program in Table 2.3.2
T ab le  2.3.2 P ro g ram  u sed  for th e  isoelectric  focussing  o f p ro te in s in  IP G  strips
Step Time (hours) Conditions
1 0.01 300 V, 5 mA, 10 W
2 0.5 300 V, 5 mA, 10 W
3 3 3500 V, 5 mA, 10 W
4 21 3500 V, 5 mA, 10 W
5 25 500 V, 5 mA, 10 W
After focusing, strips were equilibrated in 6M urea /  0.1 M Tris pH 6.8 /  30% glycerol /  
1% SDS containing 5 m g/m l (65 mM) dithiothreitol D TT for 10 minutes followed by 
incubation in 45 m g/m l (240 mM) iodoacetamide (IAA) in the same solutions.
The second dimension was carried out using an Akta™ gel electrophoresis system 
(Amersham Biosciences) that allowed for running six gels in parallel with dimensions 24 
cm x 25 cm x 1.5 mm. Strips were transferred onto 12% polyacrylamide gels cast between 
low-fluorescence glass plates. Reference markers were placed on one plate prior to bonding
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and casting. Gels were bonded to the inner surface of one plate (with reference markers) at 
casting by pre-treatment with bind-silane solution. The second dimension was run under 
standard SDS gel based conditions, namely 10 mA per gel for the first 30 minutes and 
approximately 50 mA per gel until the bromo phenol blue front run o f the edge o f the gel.
2D gels were scanned between low-fluorescence glass plates. The photomultiplier tube 
voltage was adjusted on each channel (Cy2, Cy3 and Cy5) for preliminary low-resolution 
scans to give maximum pixel values within 5 - 10% for each Cy-image but below the 
saturation level. These settings were then used for high-resolution (100 pm) scans of all 
gels. Images were exported as tiff files for image analysis.
Images were curated and analysed using DeCyder™ software. For DeCyder™ analysis, the 
difference in-gel analysis (DIA) module was first used to define spot boundaries and to 
measure normalised spot volumes of Cy2- ,Cy3- and Cy5-labelled features for calculation 
of difference ratios for samples run on the same gel. Features resulting from non-protein 
sources (e.g. dust particles and scratches) were filtered out. The biological variation analysis 
(BVA) mode o f DeCyder™ was then used to match all pairwise image comparisons from 
DIA for comparative cross-gel statistical analysis. User intervention was required at this 
stage to set landmarks on gels for accurate cross-gel matching. Comparison of test spot 
volumes with the corresponding standard spot volumes gave a standardised abundance for 
each matched spot and values were averaged across triplicates for each experimental 
condition. Strict criteria for selection of spots displaying altered abundance were applied. 
Essentially, only spots displaying a > 5 average-fold increase or decrease in abundance, 
matching across all gel images and having a p value <0.05, were selected for identification.
2.3.3 CyDye™ labeling of Conus venoms
A sample amount o f 150 pg (lyophilised venom) was aliquoted into tubes for CyDye™ 
labelling. Equal amounts o f protein from each sample were mixed to create an internal 
standard which was labelled with Cy2. Enough material was provided to run the internal 
standard on every gel. Samples were labelled by addition o f 4 pmol o f the appropriate 
CyDye™ per pg o f protein (600 pm ol/150 pg). Samples were incubated on ice in the dark 
for 30 minutes. Thorough mixing at all steps was conducted to avoid non-uniform labelling. 
Reactions were quenched by adding a 20-fold molar excess o f L-lysine with incubation on 
ice in the dark for 10 min. A suitable amount (150 pg) of the Cy2-labelled pool was added
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to each gel. Samples were reduced by DTT and carrier Ampholines/Pharmalyte (2%) and 
some bromophenol blue was added. The volume was adjusted to 450 pL with lysis buffer, 
the samples agitated for 2 min at room temperature prior to clean up o f the samples by 
centrifugation at 13000 RPM for 10 mins.
2.3.4 Gel staining and analysis
Proteins in IDE gels were visualised by colloidal coomassie blue using coomassie G-250 
dye as described in Neuhoff et al. [165; 166]. Briefly, gels were fixed from 3 h to overnight 
in 50% (v/v) ethanol /  2% (v/v) phosphoric acid. After washing the gels three times with 
water (half hours per wash), gels were incubated with staining solution (34% (v/v) MeOH 
/  17% (w / v) (N H 4)2S 0 4 /  3% (v/v) phosphoric acid) for lhour, after which time 0.7 g/L  
(solid) Coomassie Blue G-250 was added to the solution. Gels were then left shaking until 
bands o f the required intensity were visible. The end point of labeling is reached after 3-4 
days o f incubation. Sensitivity was thought to be approximately 10-50 ng o f protein (BSA).
2.4 Solubilisation o f  Conus venoms
Venoms from Conus ventricosus and Conus textile were solubilised using artificial sea water 
(ASW). ASW is made up according to Table 2.4.1 (Yoon et al., 2004)
6.3 pg lyophilised Conus ventricosus venom was mixed with 175 pL ASW. It was left shaking 
for 1.5 hours (750 rpm) at 4 °C. The sample was spun down and the supernatant was 
removed. The supernatant had an orange/yellow colour. Another 175 pL ASW was added 
to the pellet and was left shaking for 1 hour (750 rpm) at 4 °C. This process was repeated 
one more time. The supernatants were combined to give approximately 520 pL solubilised 
venom. The same procedure was repeated with 4.6 pg lyophilised Conus textile venom.
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T ab le  2.4.1 C o m p o n en ts  and  co n cen tra tio n s o f artificial sea w ater.
Compound C oncentration (mM L '1)
Sodium Chloride (NaCl) 460
Potassium Chloride (KC1) I io
Calcium Chloride (CaClj) 11
Magnesium Chloride (Mg Clj) 55
Tris pH  7.2 20
2.5  E nzym atic digestion  o f  protein s and p ep tid es with trypsin
Trypsin specifically hydrolyzes peptide bonds at the carboxylic sides o f lysine and arginine 
residues. Trypsin is classified as a serine protease. Unmodified trypsin is subject to autolysis, 
generating fragments that can interfere with protein sequencing, HPLC or mass 
spectrometry analysis o f the peptides. In addition, autolysis can result in the generation o f 
pseudotrypsin, which has been shown to exhibit an additional chymotrypsin-like specificity 
(Keil-Dlouha et al., 1971). Promega's Trypsin has been modified by reductive methylation, 
rendering it extremely resistant to autolytic digestion (Rice et al., 1977). In functional 
stability tests, modified trypsin retains at least twice as much activity as unmodified trypsin 
after 3 hour incubation at 37°C3.
To prevent contamination that interferes with mass spectrometric analysis, mainly keratin, 
gloves and sleeve protectors were worn at all time. The in-gel digestion o f 1D-PAGE was 
performed in a laminar flow hood. Surfaces in the hood, including the outside o f tubes and 
pipettes were cleaned with 70% methanol.
For 2D-IEF-PAGE experiments, sample solubilisation, sample labelling, running o f first 
and second dimension gels, staining, spot excision and digestion were performed in a 
dedicated clean room.
2.5.1 In-gel trypsin d igestion  o f ID  gel bands or 2D gel spots.
In-gel digestion was performed using in-house protocols (Benvenuti et al., 2002; Huang et 
al., 2002) In short in-gel digestion consists o f washing, reducing, alkylating, digesting and 
extracting the peptides from gel bands or plugs. Gel bands were cut into pieces,
3 http ://w w w .prom ega.com /tbs/9p iv51  l/9 p iv 5 1 1.pdf
47
2. Materials and Methods
approximately 1 mm and placed into 0.65 mL siliconized tubes. Gel plugs were washed 
and dehydrated by washing several times with 25mM NH4H C 03 in 50% ACN.
Gel pieces were dried under vacuum and 10 mM DTT in 25 mM NH4H C 03 was added. 
The reaction was left at 56 °C for 1 hour. After removing the supernatant, an equal volume 
of 55 mM iodoacetamide 25 mM NH4H C 03 was added and the reaction was incubated in 
the dark for 45 minutes at room temperature.
The supernatant was removed and the gel pieces were washed/dehydrated with 25 mM 
NH4H C 03 in 50% ACN. Gel pieces were fully dried under vacuum and 5 ng/pL trypsin in 
25mM NH4H C 03 was added just enough to cover the gel pieces. The gel pieces were left 
rehydrating on ice or at 4°C for 1 hour. Enough 25mM NH4H C 03 was added to cover the 
gel pieces. The reaction was incubated at 37°C for at least 4 hours or overnight.
Peptides were extracted by adding 50 pL 50% ACN /  5% formic acid. The extraction was 
carried out by vortexing for 30 minutes before collecting the supernatant collected in a 
separate tube. This process was repeated three times. Sample was dried under vacuum and 
stored at -80 °C until mass spectrometric analysis.
2.5.2 In-solution digestion of 2D-LC fractions
250 pL o f sample was concentrated under vacuum to 50 pL. 10 pL 250 mM NH4H C 03 
were added together with 10 pL Tris(2-carboxyethyl)phosphine (TCEP) in 25 mM 
NH4H C 03. The vial was overlaid with argon. The reaction was left at 70 °C for 30 minutes 
whilst being vortexed at 300 rpm. The solution was cooled down to room temperature and 
10 pL 200 mM iodoacetamide in 250 mM NH4H C 03 were added. The reaction was left at 
room temperature for 1 hour in the dark.
30 pL were taken out for LC-ESI-MSMS analysis. To approximately 50 pL o f solution, 20 
ng of trypsin were added. This was incubated at 37 °C for 4 hours at 300 rpm. The solution 
was stored at -80 °C until further analysis.
2.6 Methanol-Chloroformprecipitation o f proteins
Protein precipitation was done according to (Wessel and Flugge, 1984). This is a procedure 
for precipitating proteins from solution, including detergent solutions.
To 0.1 mL of solution 0.4 mL of methanol was added. The solution was mixed rigorously 
and centrifuged at 9000g for 10 seconds. 0.1 mL of chloroform was added. The solution 
was mixed rigorously and centrifuged at 9000g for 10 seconds. 0.3 mL of water was added
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and mixed vigorously. The mixture was then centrifuged at 9000g for 1 minute. The upper 
phase was removed. 0.3 mL of methanol was added to the lower phase and interphase with 
precipitated protein. This mixture was mixed vigorously and centrifuged at 9000g for 2 min 
to pellet the proteins. Fluid was taken off without disturbing the pellet. The whole mixture 
was dried under vacuum before being resuspended in standard Laemmli buffer (Laemmli, 
1970)
2.7 Preparation of2D -LC samples for mass spectrom etric analysis
To improve the sensitivity and to eliminate the ACN and TFA from the chromatographic 
elution, 250 pL o f each fraction were taken and were concentrated to approximately 50 pL. 
2 pL was taken out for MALDI-TOF MS and tandem MS measurement. 1 pL was spotted 
onto a stainless steel target and 1 pL matrix solution was added. The matrix consisted of 1 
part 70% MeOH, 1 part saturated HCCA, 25 fmol p L 1 ACTH.
The remaining 48 pL were brought back up to approximately 100 pL with 25 mM ABC. 10 
pL 250 mM ABC and 10 pL 20 mM TCEP in 25 mM ABC were added. The solution was 
overlaid with argon and incubated at 70 °C under shaking (300 rpm) for 30 minutes. The 
solution was spun down and was allowed to cool down to room temperature before adding 
10 pL 200 mM LAM in 25 mM ABC. The solution was incubated at room temperature in 
the dark for 1 hour.
30 pL were taken out and cleaned up using the ZipTip protocol (see 2.8). This resulted in 
10 pL cleaned up sample o f which 1 pL was used for MALDI-TOF MS/MS and 1 pL was 
used for LC-ESI-MS/MS analysis. To approximately 70 pL, 20 ng o f trypsin was added. 
The solution was incubated at 37 °C while shaking (750 rpm) for 4 hours. The solution was 
concentrated under vacuum to approximately 10 pL and cleaned up using the ZipTip 
protocol. From the resulting 10 pL, 1 pL was used for MALDI-TOF MS/MS and 1 pL was 
used for LC-ESI-MS/MS analysis.
2.8 Sample clean up using C18pre-packed tips
Throughout the work in this thesis, samples were cleaned up using the ZipTip protocol. 
This name is derived from commercially available tips which are pre-packed with C l8 
material. The clean-up is based on reversed phase clean up. The tips used were both 
ZipTip’s from Millipore (both normal and micro bedding) and Omix tips from Varian.
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Tips from both manufactures where tested using a standard peptide mix and gave very 
comparable results.
The packing material was wetted three times with 10 pL 50 % ACN using a standard 10 pL 
pipette. The tip was washed one time with 0.5 % TFA. The sample solution was let 
through the tip 10 times by slowly aspirating and dispensing without creating air bubbles. 
The tip was washed two times, with a fresh solution, o f 0.5 % TFA. 10 pL 50 % ACN /  0.5 
TFA was aspirated and dispensed into a new siliconised tube. The solution was let pipetted 
up and down the tip another five times.
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3 Analysis o f Conus venom by acrylamide gel electrophoresis 
based protein separation methods
This chapter is concerned with the analysis of the protein content o f several Conus venoms. 
In general research groups only focus on the bio-active peptides. Protein components were 
analysed by acrylamide gel electrophoresis combined with mass spectrometry and database 
interrogations. Conus ventricosus was analysed by conventional SDS PAGE, Conus nussatella 
by two-dimensional gel electrophoresis (2DE), while Conus textile was analysed by both 
techniques. After separation, selected bands and spots were excised and treated with a 
protease. Peptides were extracted from the gel and analysed by mass spectrometry. The MS 
data was searched against the NCBI database.
3.1 Sample origin and preparation.
During the practical work of this thesis, several Conus venoms were used. An overview is 
given in Table 3.1.1. Animals were kept in sea water until they were used for the isolation 
of venom. The outer shells were crushed using a metal vice. The venom ducts were isolated 
using ordinary forceps. The venom was released into ddH20  by gently pressing with a 
pestle. The solution was spun down to remove cellular debris. This process was repeated 
once more with the supernatant. The resulting supernatant was collected, lyophilised and 
stored at -80 °C until further use. Venoms were supplied by Dr. Michael Fainzilber from 
the Weizmann Institute of Science, Rehovot Israel. The venom from Conus nussatella, Conus 
textile and Conus Arenatus was supplied as crude venom and lyophilised powder from the 
void volume peak from a Sephadex G-50, hence supposedly having components above 20 
kDa. Conus ventricosus and Conus nussatella were supplied as crude venom, prepared as 
described above.
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Table 3.1.1 Overview of Conus venoms used.
A m ultitude o f  Conus venoms were used throughout the course o f  this project, an overview is given in this 
table. T he colum n gives information about the name and the abbreviation, the location where the species is 
found and on which organism it preys. Vermivorous prey on worms, Piscivorous on  fish and Molluscivorous 
on snails.
Conus Abbreviation Prey L ocation
ventricosus C.Ventri Vermivorous Mediterranean Sea
textile C.Tex Piscivorous Indo-Pacific
nussatella C.Nuss Molluscivorous Indo-Pacific
arenatus C.Ar Vermivorous Red Sea
The venoms o f Conus ventricosus and Conus textile were pre-separated before being analysed 
by ID  SDS-PAGE using a size exclusion column. The Tricorn Superdex peptide 
10/300GL column (Amersham Biosciences) had an optimal separating range from 100 to 
7,000 Da. By using this column large proteins were separated from the peptide and small 
molecule part o f the venom.
The column was calibrated using a mixture o f proteins and peptides described in Table 
3.1.2. The calibration mixture functioned to test the co-elution o f proteins and to calibrate 
the size column.
Figure 3.1.1 shows an overlay chromatogram o f the calibration mixture and a test sample. 
Independent injection o f Transferrin and BSA (data not shown) illustrated that these two 
proteins have identical elution times. Therefore proteins with a molecular weight greater 
then 66 kDa co-elute (Peak A). The remaining components were separated (Peak B 
through E).
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Table 3.1.2 Constituents o f size column calibration mixture.
This table shows the constituents, approximate molecular weight, am ount loaded on to  the colum n and the 
elution time o f  the mixture used to calibrate the size column. The mixture was designed the test the co­
elution o f  (large) protein and to calibrate the optimal separation range. The corresponding chrom atogram  is 
shown in Figure 3.1.1.
Peak Component Aprox. Molecular 
Weight
Loaded on 
Column (pg)
Elution time 
(m in)
A Transferrin 85 kDa 5.4 35.8
Bovine Serum Albumin 66 kDa 2.9
B Carbonic Anhydrase 29 kDa 4.9 40.3
C Cytochrome C 12.4 kDa 1.5 45.7
D Insulin 4749.5 Da 7.8 I 59.5
E Substance P fragment 1191.5 Da ~ 2.4 77.9
Trypsin digested fetuin (bovine) was prepared according to Medzihradszky et al. 
(Medzihradszky et al., 1994). Briefly, bovine fetuin was dissolved in 6M guanidine HC1/300 
mM N-ethylmorpholine acetate solution (pH 8.3), reduced with D TT and alkylated with 
vinylpyridine. After dialysis against ammonium carbonate, the protein was digested with the 
serine protease trypsin. Roughly 100 pmol was loaded and used to check the performance 
o f the column. Fractions were taken every 1.5 mL, indicated in blue on the X-axis. Masses 
were observed from each fraction with standard LC-ESI tandem MS. The first o f the two 
major peaks in between D and E  contained large glyco-peptides observed by 
Medzihradszky et aL (Medzihradszky et al., 1994). The second o f the two peaks contained 
the ‘normal’ tryptic peptides in the mass range determined by the calibration.
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A = >66 kDa 
B = 29 kDa
C = 12.4 kDa 
D = 4749 Da 
E = 1191 Da
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Figure 3.1.1 Size column calibration and testing.
This figure shows an overlay o f chromatograms o f the UV absorbance (214 nm) o f  size separated calibration 
mixture (blue) and the chrom atogram o f a trypsin digest o f Bovine Fetuin (magenta). (A) is the co-elution o f 
Transferrin (85 kDa) and Bovine Serum Albumin (66 kDa) (E et al.) is Carbonic Anhydrase (29 kDa) (E et 
al.) is Cytochrome C (12.4 kDa) (D) is Insulin (4749 Da) and (E et al.) is Substance P fragment (1191.5 Da). 
Fractions from the fetuin digest run were taken every 1.5 mL (blue).
3.2 1D-SDS PAGE separation and analysis o f  Conus ventricosus 
venom.
Conus ventricosus venom was separated on a size exclusion column. To this, 6.3 pg 
lyophilised Conus ventricosus venom was mixed with 175 pL ASW. It was left shaking for 1.5 
hours (750 rpm) at 4 °C. The sample was spun down and the supernatant was transferred 
to a clean tube. The supernatant had an orange/yellow colour. Another 175 pL ASW was 
added to the pellet and was left shaking for 1 hour (750 rpm) at 4 °C. This process was 
repeated one more time. The supernatants were combined to give approximately 520 pL 
solubilised venom. 90 pL was used to prepare protein samples. The UV absorbance 
chromatogram (214 nm) o f this size separation is shown in Figure 3.2.1.
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Figure 3.2.1 Elution profile from size separation of C onus ventricosus venom.
The figure shows the absorbance over time o f the size separation o f Conus ventricosus venom. The blue line is 
the absorbance at 214 nm. Fractions were taken every 1.5 mL (magenta). Fraction A04, A05, A06 and A07 
were further analysed by 1D-SDS-PAGE.
Proteins from fraction A04 through A07 were precipitated to dispose o f salts from the 
elution buffer (150 mM NaCl, 10 mM Tris). The precipitation was done according to 
Wessel et aL (Wessel and Flugge, 1984). The individual fractions were loaded onto a 
standard SDS-PAGE gel, with a 10-20% acrylamide gradient. See Figure 3.2.2 for the 
colloidal coomassie blue stained gel. The very intense blue colour indicated that all proteins 
co-eluted in fraction A05. Faint coloured bands were visible in lane A04 and A06 (indicated 
by the black arrows), while any form of stained protein was absent in A07.
Lane A05 was cut in 20 equidistant slices. Together with the bands indicated in lane A04 
and A06, these were subjected to in-gel digestion. The in-gel digestion was performed using 
in an house protocol (Benvenuti et al., 2002; Huang et al., 2002).
Each o f the in-gel digestions was subjected to online LC-ESI tandem mass spectrometry. 
Data was acquired in a data dependent matter, where ions above certain intensity are 
automatically selected for fragmentation. The duration o f this fragmentation is dependent
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on the quality o f the fragment data (mainly intensity o f the fragment ions), or is set by a 
default time (3 seconds) if these criteria are not met.
From each run, peak lists (mass and intensity) are created with the mascot.dll script in the 
analyst software. These so-called peak files are searched against theoretically digested 
proteins in the NCBI database, using the Mascot search engine.
Mw
(kDa)
L_
C O
CD
Figure 3.2.2 ID SDS PAGE of size exclusion fractions from Conus ventricosus.
The size exclusion fractions from  the size separation o f Conus ventricosus (Figure 3.2.1) were desalted by 
protein precipitation, concentrated and loaded on different lanes on a 10-20% acrylamide gel. The proteins 
were visualised using a colloidal coomassie blue staining. Bands where excised from  lane A4 and A6, 
indicated by the arrows. Lane A5 was divided in 20 equidistant bands. Proteins in the bands were reduced, 
alkylated, digested with trypsin and extracted. Samples were analysed by LC-ESI-MS\MS.
A complete list o f proteins identified by mass spectrometry can be found in Appendix 2. 
This list is filtered for human keratin and the autolysis products o f modified porcine trypsin 
(Promega). The protein hits displayed from an MS/MS run contained at least one peptide 
with a Mascot peptide score greater than the 5% significance threshold for the NCBI 
database.
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The proteins that were identified were, with the exception of few, from other organisms. 
However, Conus species were underrepresented in databases. To date only 1087 protein 
entries were present for all the 500 known species. Many o f the protein entries are 
predicted precursor conotoxins which fall below the detection limit o f conventional SDS- 
PAGE i.e. with a mass smaller than 7 kDa.
Therefore, proteins were identified by homologous peptides. Hence, it was not surprising 
that many of the protein hits are well known, abundant household proteins, such as actin 
and protein disulfide isomerase. A condensed summary is shown in Table 3.2.1. Proteins 
are sorted according to Mascot protein score. Taking into account database size and 5 % 
threshold for the NCBI database for random hits, scores above 50 are considered 
significant.
Table 3.2.1 condensed summary of identified proteins in Conus ventricosus venom.
This table shows a condensed summary o f the search results from the Conus ventricosus in-gel digests. The full 
summary can be found in Appendix 2. Proteins in this table were sorted according to their Mascot protein 
score. Proteins were listed only if they contained a significant peptide
Accession
Number Protein Description
Mass
(Da)
Sequence
Coverage
(%)
Mascot
Protein
Score
Number
of
Peptides
Pi
3182894 Actin 41683 44.7 564.0 26 5.30
18652793
vitamin K-dependent 
gamma-glutamyl 
carboxylase [Conus textile]
93858 3.5 113.1 3 5.37
19880309 protein disulfide-isomerase 56975 3.9 101.9 4 4.78
112696
14-3-3 protein zeta/delta 
(Protein kinase C inhibitor 
protein-1) (KCIP-1)
27839 13.1 81.1 4 4.77
3318722 Chain E, Leech-Derived Tryptase Inhibitor 23457 12.6 76.5 2 8.26
138531 Vimentins 1 and 2 52812 4.1 71.9 3 5.16
138532 Vimentin 4 53464 4.1 71.9 3 5.08
33591156 thioredoxin peroxidase [Ixodes ricinus] 19134 10.7 71.3 4 6.93
5902072
serine proteinase inhibitor, 
clade B (ovalbumin), 
member 3; squamous cell 44537 5.1 70.0 2 6.35
carcinoma a
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44829400
42523784
16945685
204499
13021648
peroxiredoxin 1 [Ixodes 
ricinus]
thiosulfate sulfurtransferase 
[Bdellovibrio bacteriovorus 
HD100]
disulfide isomerase 
[Ostertagia ostertagi]
glutathione S-transferase Y- 
b subunit (EC 2.5.1.18)
peptidyl-prolyl cis-trans 
isomerase B [Xenopus 
laevis]
18977
31343
54972
21871
11343
10.6
4.3
2.8
4.8
10.6
69.6
68.6
61.5
60.1
52.3
11.80
9.45
4.93
7.82
9.36
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3.3 1D-SDS PAGE separation and analysis o f  Conus textile venom.
Conus textile venom was separated on a size exclusion column as in section 3.2. 90 pL were 
used to prepare protein samples. The UV absorbance chromatogram (214 nm) o f this size 
separation is shown in Figure 3.3.1
1000 -
800 -
g  600 -
-o 400 -
200 -
"*04 | A05 | AOS
0 25 50 75 100
time, minutes
Figure 33.1 Elution profile from size separation of Conus textile  venom.
The figure shows the absorbance over time o f  the size separation o f Conus Texile venom. The blue line is the 
absorbance at 214 nm. Fractions were taken every 1.5 m L (magenta). Fraction A04, A05 and A06 were 
further analysed by 1D-SDS-PAGE.
In a similar fashion to Conus ventricosus, fraction A04, A05 and A06 were desalted by protein 
precipitation, according to Wessel et al. (Wessel and Flugge, 1984). The proteins were then 
dissolved in ID  sample buffer and run on a standard 10-20% gradient gel. Proteins were 
stained using colloidal coomassie blue. The resulting staining pattern is shown in Figure 
3.3.2
59
3. Analysis o f Conus venom by gel based protein separation methods
A4 A6
Figure 3 J .2  ID SDS PAGE of size fraction from Conus textile.
The size fractions from  the size separation o f Conus textile (Figure 3.3.1) were desalted by protein 
precipitation, concentrated and loaded on different lanes on a 10-20% acrylamide gel. The proteins were 
visualised using a colloidal coomassie blue staining. Bands were excised from  lane A5 (20 equidistant slices) 
and the obvious bands were excised from A6. Proteins in the bands were reduced, alkylated digested with 
trypsin and extracted. Samples were analysed by LC-ESI-MS\MS.
A short summary o f selected proteins can be found in Table 3.3.1. Among the proteins 
found was a previously reported (in Conus textile) carboxylase (Stanley et al., 1997). Protein 
disulfide isomerase, a protein involved with protein folding and formation o f disulfide 
bridges was also found. Arginine kinase (AK) belongs to a class of kinases that play a role 
in the maintenance o f ATP levels by the phosphorylation o f the so called "phosphagens". 
This also has been previously identified.
Table 3.3.1 Condensed summary of proteins identified from Conus textile  venom.
This table shows a condensed summary o f the search results from  the Conus textile in-gel digest. The full 
summary can be found in Appendix 3. Proteins in this table were sorted according to Mascot protein score. 
Only proteins with a significant peptide were listed.
Accession 
Number
10834855 Actin
23463261
Protein Description
vitamin K-dependent 
carboxylase [Conus textile]
(Da) Coverage
22879
93905
40.1
7.8
Mascot Number
Protein of Pi
Score Peptides
343.6 12 4.92
272.6 6 5.37
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42523784
thiosulfate sulfurtransferase 
[Bdellovibrio bacteriovorus 
HD100]
31343 4.3 103.6 1 9.45
27806081 peroxiredoxin 1 [Bos taurus] 22151 8.5 102.5 2 8.81
202547 iodothyronine 5"- monodeiodinase 30136 4.9 97.0 4 5.09
3183057 ARGININE KINASE (AK) 39077 9.5 87.7 3 7.12
9965598 peroxidoxin-2 [Litomosoides sigmodontis] 21320 7.8 79.2 2 6.41
12751382 thioredoxin peroxidase [Brugia malayi] 18005 9.2 79.2 2 6.28
138532 Vimentin 4 53464 3.5 76.8 2 5.08
138531 Vimentins 1 and 2 52812 3.5 76.8 2 5.16
16945685 disulfide isomerase [Ostertagia ostertagi] 54972 2.8 72.9 3 4.93
202549 iodothyronine 5" monodeiodinase 54033 3.1 69.4 2 4.87
27806501
procollagen-proline, 2- 
oxoglutarate 4-dioxygenase 
[proline 4-hydroxylase], beta 
polypeptide [protei
57230 2.9 69.4 2 4.80
3551774
alpha-glycerophosphate 
oxidase [Streptococcus 
pneumoniae]
66751 2.1 67.2 2 4.98
37362272 2-peptidylprolyl isomerase A [Danio rerio] 17390 9.1 63.5 2 8.87
12230403
Probable proline 
iminopeptidase (PIP) (Prolyl 
aminopeptidase) (PAP)
36452 2.2 53.1 1 5.81
3.4 Analysis o f  Conus venoms by two-dimensional g e l electrophoresis
This paragraph describes the analysis of the following Conus venoms (i) C. arenatus (ii) C. 
nussatella (iii) C. textile. These samples were kindly provided by Dr. Mike Fainzilber from the 
Weizmann Institute o f Science, Rehovot Israel.
3.4.1 Sample solubilisation and labelling of proteins with CyeDye™
Lyophilised Conus venom was dissolved in 2DE sample buffer (8 M, 4% w /v  CHAPS, 
0.5% (v/v) NP-40, 10 mM Tris-HCl). Protein concentration was determined using
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Coomassie Protein Assay Reagent and a BSA standard curve with 3 replicate assays 
performed for each sample. Samples were adjusted to the same protein concentration using 
2D buffer. For protein concentration o f venom stock solutions see Table 3.4.1
Table 3.4.1 Protein concentration of venom solutions.
Lyophilised venom  was weight and dissolved in 2D E sample buffer. Protein concentrations were determined 
against a BSA standard curve (shown in Figure 3.4.1). The accuracy o f the determination is shown by the 
95% prediction interval (PI). CV stands for Crude V enom  and VO for the void volume o f  a size exclusion 
run.
Venom weight
(mg)
concentration 
(m g/m l)
±
(95 % PI)
(1) C.Ar -  CV 9.3 30.8 3.7
(2) C.Nuss -  CV 7.8 19.8 2.7
(3) C.Ar - VO 7.2 40.0 4.6
(4) C.Tex - VO 7.3 20.3 2.8
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Figure 3.4.1 Standard curve for protein determination in Conus venoms.
A regression analysis was perform ed for the protein concentration determination, using an in house Excel 
spreadsheet. The accuracy o f  the measurement is modelled by the prediction intervals (p=0.05).
A sample amount o f 150 pg was aliquoted into tubes for CyDye™ labelling. Equal 
amounts o f protein from each sample were mixed to create an internal standard which was 
labelled with Cy2. Enough material was provided to run the internal standard on every gel. 
Cy3- and Cy5-labelled samples were mixed appropriately (See Table 3.4.2). The samples
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were run in triplicate and labeled both with Cy3 and Cy5. This was to avoid possible dye 
bias was and to enable significant differential analysis could be performed.
T ab le  3.4.2 S am ple labelle ling  schem e for C yD ye™  experim en t.
This table shows scheme used labelling the venom camples. Crude venom  (CV) and the void peak (VO) from 
a sephadex G-50 elution were used.
Gel num ber Cy3 Cy5
1 C. arenatus CV C. nussatella CV
2 C. arenatus CV C. arenatus V0
3 C. textile V0 C. arenatus CV
4 C  nussatella C V C. arenatus V0
5 C. nussatella C V C. textile V0
6 C. aienatus V0 C. textile V0
A suitable amount (150 pg) of the Cy2-labelled pool was added to each gel. Samples were 
reduced by D TT and carrier Ampholines/Pharmalyte (2%) and some bromophenol blue 
was added. The volume was adjusted to 450 pL with lysis buffer, the samples agitated for 2 
min. at room temperature prior to clarifying by centrifugation at 13000 RPM for 10 mins. 
Cy3 and Cy5 were randomly assigned to samples from the 4 venoms under investigation 
and these were run in triplicate. This way significant differential display analysis could be 
performed and dye bias to proteins is ruled out.
Samples were compared in two sets, namely both the crude venoms (CV) and the void 
volume peak samples (V0). The gels of the remaining two samples were analysed, but are 
not included in this work. The individual CyeDye™ images from gel 1 o f the crude 
venoms can be seen in Figure 3.4.2. Conus arenatus was labelled with Cy3 (red, left panel) 
and Conus nussatella with Cy5 (blue, right panel). The protein expression profile of the two 
species is completely different. This is demonstrated in Figure 3.4.3. This figure displays the 
overlay image of the two CyDye images. In a more traditional differential 2DE analysis, for 
instance investigating the influence o f treatment o f a cell line with a compound of interest, 
usually the majority o f spot (proteins) overlap (Hoving et al., 2002).
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Figure 3.4.2 2DE CyeDye images from Conus arenatus and nussatella.
This figure shows the Cy3 (left) and Cy5 (right) image from  gel 1 (see table Table 3.4.2). These were the 
venoms o f Conus arenatus and Conus nussatella respectively.
Identical spots are represented by black spots, indicating no change in protein expression, 
or modification, between the two samples. Some of these unaltered spots can be seen upon 
the comparison o f the two venoms in Figure 3.4.3. The images generated were saturated 
and analysed using DeCyder™ software. Briefly the difference in-gel analysis (DIA) 
module was used to define spot boundaries and to measure normalized spot volumes. The 
biological variation analysis (BVA) mode o f DeCyder™ was used to match all pairwise 
image comparisons from DIA for cross-gel statistical analysis. Spots displaying a > 5 
average fold increase or decrease in abundance (p value < 0.05) were selected for 
identifications. The excised spots were circled in yellow. These were digested in-gel and 
analysed by LC-ESI-MS/MS. Tandem MS data was then searched against the NCBI 
protein database.
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11461104
Figure 3.4.3 2DE overlay image of C onus arenatus and nussatella.
This figure shows the overlay o f  the images from  Figure 3.4.2. Spots that appear in black are com m on on 
bo th  gels in the same am ount. Red spots mean that the particular protein is m ore abundant for the Cy3 
labelled samples, vice versa for the blue spots. Spots circled were excised, digested and analysed by mass 
spectrometry. N um bers starting with ‘m ’ where selected manually to be picked by the picking robot. The 
o ther spot num bers were generated by the DeCyder™  analysis.
Three examples o f spot analyses are given in Figure 3.4.4, Figure 3.4.5 and Figure 3.4.6. In 
each o f these figures, three different panels can be seen. Top left, a zoom-in o f the actual 
gel image. Bottom left a 3D graphical representation o f the spot volume and density. On 
the right hand side a graph with the relative abundance o f  that particular spot across the 
four samples investigated. Venoms 1 through 4 correspond to the numbers in Table 3.4.1.
In Figure 3.4.4 the DeCyder output for spot 1081 is shown. This is a spot, or feature, only 
seen in the crude venom  sample o f Conus arenatus (red Cy3 image from Figure 3.4.2). This 
spot was actually saturated, hence the flattened top o f the densitogram. This protein was 
identified as Arginine Kinase (accession number NCBI 3183057). See also Table 3.4.3 with
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a summary o f the proteins identified from gel 1 (Conus arenatus and Conus nussatelld). This 
protein was also identified during the 1D-PAGE experiments on the crude venoms of 
Conus ventricosus and textile. However, from the spots analysed for the crude venom of Conus 
nussatella, this protein was absent.
F igu re  3.4.4 D eC yder o u tp u t for 2D E  spo t 1081.
This figure displays the spot summary o f the DeCyder output from  spot num ber 1081. The protein was 
identified by homology, as Arginine kinase. In the top two left panels a zoom-in o f  the two emitted 
wavelengths for this particular part o f the gel can be seen. In the bottom  left two panels, a three dimensional 
representation o f  spot volume and optical density from the spot in the zoom-in can be seen. In the right hand 
panel the relative abundance o f this spot across the four examined venoms can be seen. Each point is the 
average measurements from the three gels for each sample.
Figure 3.4.5 is an example o f a spot that has similar spot intensity for the first two venoms 
(black spots from Figure 3.4.3). This spot was identified as Actin (accessions number 
224306). A further three spots in both venoms were identified as Actin.
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F igure  3.4.5 D ecyder o u tp u t for 2D E  spo t m l5 .
This figure shows the spot summary o f the DeCyder output from spot num ber m l 5. The protein was 
identified by homology as Actin. In the top two left panels a zoom-in o f  the two emitted wavelengths for this 
particular part o f the gel can be seen. In the bottom  left two panels, a three dimensional representation o f 
spot volume and optical density from the spot in the zoom-in can be seen. In the right hand panel the relative 
abundance o f this spot across the four examined venoms can be seen. Each point is the average measurement 
from the three gels for each sample.
Figure 3.4.6 is an example of a protein differentially expressed in the venom of Conus 
nussatella. Like the previous figure, also this spot was identified as Actin (Accession number 
32816054).
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Figure 3.4.6 Decyder output for 2DE spot m24
This figure displays the spot summary o f  the DeCyder output from  spot num ber m24. The protein was 
identified by homology, as Actin. In the top two left panels a zoom-in o f  the two emitted wavelengths for this 
particular part o f the gel can be seen. In the bottom  left two panels, a three dimensional representation o f 
spot volume and optical density from  the spot in the zoom-in can be seen. In the right hand panel the relative 
abundance o f this spot across the four examined venoms can be seen. Each point is the average measurement 
from the three gels for each sample.
The overall success rate o f identifying proteins was not very high. O ut o f the 56 spots 
picked for identification, one spot was lost by the picking robot and from the remaining 
samples, 12 spots were identified with four unique proteins. An overview of these results is 
displayed in Table 3.4.3
Table 3.4.3 Summary of identified proteins in Conus venom by 2DE.
The results in this table represent a summary o f  the proteins identified from  the selected 2D E gel spots. 
Besides protein name and accession number, the molecular weight (Mr) and calculated iso-electric point (pi) 
are given. In the last three columns, the num ber o f peptides used for identifying the protein by tandem mass 
spectrometry, the M ascot protein score and sequence coverage are given.
Spot Protein  Name A ccesionN um ber Mr Pi
num ber
of
pep tide
M ascot
Protein
S core
S eq u en ce
coverage
(%)
741 alpha-tubulin 3 [Ciona 
intestinalis]
21667231 44564 5.85 3 124 13
831 enolase 2
[Pycnococcus
provasoliij
15667700 37659 4.58 3 99 4
1075 ARGININE KINASE 
(AK) [Liolophura
3183057 39305 7.12 8 188 14
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japonica]
1081 A R G IN IN E  K INA SE  
(AK) [Liolophura 
japonica]
3183057 39305 7.12 14 218 14
1091 A R G IN IN E  K INA SE  
(AK) [Liolophura 
japonica]
3183057 39305 7.12 18 27 5 14
1221 A R G IN IN E  K IN A SE  
(AK) [Liolophura 
japonica]
3183057 39305 7.12 4 128 7
1289 A R G IN IN E  K IN A SE  
(AK) [Liolophura 
japonica]
3183057 39305 7.12 5 163 13
1371 A R G IN IN E  K INA SE  
(AK) [Liolophura 
japonica]
3183057 39305 7.12 10 27 5 14
m15 Actin
[Strongylocentrotus
purpuratus]
224306 41798 5.30 50 61 6 52
m16 Actin
[Strongylocentrotus
purpuratus]
224306 41798 5.30 25 369 52
m24 actin [Chlamys farreri] 32816054 4 2 11 6 5.29 15 47 5 33
m25 A C TIN  3
[Echinococcus
granulosus]
543768 35027 5.25 17 4 0 5 41
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4 Liquid Chromatography MALDI-MS/MS analysis of 
Conus ventricosus Venom.
Liquid chromatography MALDI tandem mass spectrometry, in short LC-MALDI-MS/MS 
is being used frequently now as a technique to analyse complex biological mixtures (Chen 
et al., 2005; Floyd et al., 1999). Pilot experiments carried out in the UCSF mass 
spectrometry facility, showed that conotoxins can be detected in the crude venom of Conus 
ventricosus. In this particular experiment, Conus ventricosus venom was solubilised in 
ammonium bicarbonate (ABC) and separated in two rounds of reversed phase separation. 
Fractions from the first dimension were re-injected onto the column, only substituting the 
mobile phase acetonitrile with iso-propanol (2-propanol) to generate a semi orthogonal 
separation. This last run was directly spotted onto a MALDI target and analysed by mass 
spectrometry. Results showed motives of a number of so called, contryphans, which are 
single disulfide linked conotoxins (Jacobsen et al., 1998; Jimenez et al., 1996; Massilia et al., 
2001).
4,1 F irst dim ension size separation o f Conus ventricosus venom
Conus ventricosus venom, from a different batch was supplied by Dr. Michael Fainzilber. This 
was solubilised in 25 mM ABC pH 7.8. This buffer was also used as mobile phase for the 
size exclusion separation of the venom. In this way fractions were in the correct medium 
for reduction by dithiothreitol DTT, alkylation by iodoacetamide (LAM) and digestion by 
trypsin.
Figure 4.1.1 shows the scan of a paper trace chromatogram of the size exclusion separation 
from Conus ventricosus venom. For this separation a TSKgel Super SW2000 (Tosoh 
Bioscience) column was used. Fractions were collected manually after each major peak, as 
indicated by the red numbers in the figure.
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Figure 4.1.1 First dimension separation of Conus ventricosus venom.
This figure shows the chrom atogram o f the absorbance at 214 nm  o f size separated Conus ventricosus venom. 
The venom  was solubilised in the mobile phase ABC at a flow rate o f  0.5 m L-m in1. Fractions were taken 
manually, indicated by the red numbers. Proteins and peptides were reduced directly by DTT. Subsequently 
after reduction fractions were alkylated and incubated with trypsin. The resulting peptides were analysed by 
LC-MALDI.
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4.2 LC -M A LD I tandem  m ass spectrom etric analysis o f size  separated 
Conus ventricosus fractions
The speed and sensitivity of MALDI based mass spectrometers are advantageous 
characteristics for high throughput proteomic experiments. With the introduction of 
MALDI tandem mass spectrometers such as the Applied Biosystems 4700 TOF/TOF, LC- 
MALDI is becoming a more widely used tool as the ‘front-end’ part o f the mass 
spectrometric analysis. Besides the aforementioned advantages of MALDI, one major 
advantage of spotting fractions directly onto targets is that the chromatographic runs are 
frozen in time. Using on LC electrospray MS, the amount o f MS/MS spectra that are 
aquired is depending on the sampling time of the MS and the total elution time of the ion 
of interest. Consequently, there is not always enough time to fragment all eluting peptides. 
With LC-MALDI-MS the gradient is fixed onto a target (usually 30 seconds fraction At 350 
nL-min l). Therefore, there is as much time available for fragmentation experiments as 
there is sample in the spot. Also spots /  peptides of interest can be analysed at a later time 
if needed.
The fractions taken from the size separation were reduced and alkylated before being 
treated with the protease trypsin. After digestion, samples were concentrated and injected 
onto an HPLC system as follows. Samples are loaded onto a C l8 peptide trap (i.e. guard 
column) which is on the place of the sample loop. At this point the samples are washed to 
remove salts from the sample itself and those introduced by solubilisation and reducing 
and alkylation. The eluent of the column is directed to waste. After the rinse, the guard 
column is switched online with the analytical column and peptides were eluted onto the 
main column. Peptides are separated in a water /  organic buffer system. Figure 4.2.1 shows 
the UV absorbance at 214 nm of the chromatographic separation o f each size fraction. The 
numbers correspond to the fractions in Figure 4.1.1. Fractions were spotted directly onto a 
stainless steel target. Just before elution onto the target, the eluent is mixed online (t- 
junction) with alpha cyano 4-hydroxy-cinnamic add matrix and an internal standard. The 
internal standard (IS), Adrenocorticotropic Hormone clip 18-38 (ACTH) was at a 
concentration o f approximatdy 4 fmol per spot. The IS functioned as internal calibration 
peptide. The mass spectrum is calibrated on the fly automatically by the controlling 
software of the AB 4700 mass spectrometer.
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Figure 4.2.1 Second dimension reversed phase separation of Conus ventricosus  venom.
This figure shows the UV absorbance chromatogram (214 nm) against the spot numbers (effectively time) of 
the DTT/LA M /trypsin treated fractions from Figure 4.1.1. Concentrated samples were injected onto C18 
peptide trap which was offline from the analytical column and washed subsequently with aqueous buffer. The 
trap was then switched online with the mam capillary C l8 column and peptides were separated using ACN /  
H 2O  /  TFA buffer system. The large peak at the end o f each run is that o f the organic wash (80 % ACN) 
partly due to elution polymers, but mainly due to the refractive index change o f the solvent. The 13 first 
dimension fractions were spotted individually in the second dimension over 100 spots, direcdy onto a 
stainless steel target, corresponding to approximately 30 seconds fractions. TOF-M S spectra were taken from 
each spot and tandem mass spectra for the 8 most abundant ions in the survey scan. Spectra were calibrated 
internally with ACTH (18-39 clip).
4.3 Tandem M S analysis o f  2D -LC separated Conus ventricosus 
venom using M ALDI- T O F /T O F  M S
The mass spectrometric data obtained from the LC-MALDI approach was overwhelming. 
Over 5,500 tandem mass spectra were recorded. Some of this data is captured in Figure
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4.3.1, where we can see all the parent masses that were selected for MS/MS. The masses 
are plotted against the spot number (of course corresponding to the eluting fraction in the 
second dimension). The top panel shows the so called mass map from fraction F03, while 
the bottom panel show all parent masses from all the LC-MALDI runs. Each size fraction 
is colour coded, explained in the legend on the right hand size of the figure.
350C
300C -
250C -
200C -
150C -
100C -
0 20 40 63 80 100
spot number
3500
3000
F01
F02
F03
F04
FUt>
F06
F07
F08
F09
F10
F11
F12
F13
N
^ 2000
15U0
•I*:!.! *1*1 ||*  ;
1000 -
3 20 40 63 CO 100
spot number
Figure 4.3.1 Mass maps generated by LC-MALDI analysis of Conus ventricosus venom.
Peak lists were generated for the LC-MALDI runs o f the size fractions from Conus ventricosus venom. Each 
dot in the figures represents the parent ion mass selected for tandem mass spectrometry. In this figure the
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mass map from fraction F03 (top) is shown and those of all masses from the 13 fractions combined 
(bottom). Fractions were spotted every 30 seconds (spot 1 through 99).
The peak lists generated from all the spectra were searched in batches against NCBI using 
LC-Batch feature o f the in-house version o f ProteinProspector (Clauser et al., 1999). This 
software tool allows for the extraction of data from the onboard Oracle database from the 
ABI 4700. However, the data set was too big to search as a whole. Therefore data was 
searched in batches, with limited results however. In agreement with data presented in 
Chapter 3, the majority of identities were house keeping-protein, identified by homology 
(data not shown). Nevertheless, the vast majority of fragment data remains unidentified. 
The only alternative to automatic database query is de novo sequencing, whereby spectra 
are usually interpreted manually. However, because of the enormous amount of data, this is 
near to impossible on a short time scale. Therefore with the help o f Richard Jacob 
(University College London, Bioanalytical mass spectrometry group in the Ludwig Institute 
for Cancer Research), a software pipeline was constructed for the automatic de novo 
sequencing o f these 5,500 mass spectra.
In visual basic, available in Data Explorer (spectra analysis tool for MALDI instruments 
from Applied biosystems) a macro was written which smoothed, centroided, labelled the 
peaks before extracting the peak list. These peak lists were converted into Lutefisk readable 
files.
Lutifisk is freeware de novo sequencing software, for long the only software that could 
attempt de novo sequencing (Banoub et al., 2004; Johnson and Taylor, 2002; Ma et al., 
2003; Taylor and Johnson, 2001). However, this package was written primarily for fragment 
spectra of peptides generated by electrospray ionization followed by CID. It therefore 
could not cope well with the TOF/TOF data. One of the characteristics of MALDI- 
TOF/TOF mass spectrometers is high abundance of internal fragments. Peptides are 
generally singly charged when ionised by MALDI and therefore more energy is needed to 
fragment. On the contrary electrospray generated ions are multiply charged and tend to 
fragment into b-ions and y-ion.
A Perl script was written to feed all peak lists into the Lutefisk program for de novo 
sequencing. An individual text file with the ten best fit sequences was generated for each 
submitted tandem mass spectrum.
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A beta version o f Mascot Distiller with de novo sequencing tool was kindly provided by Dr. 
David Creasy (Matrix Science). As with the Lutefisk program, de novo output was 
compared with manual annotated spectra. In all the cases, the Matrix Science program 
performed better. However a major drawback of the Matrix Science program is that it 
worked stand alone, only allowing to analyse one user loaded spectrum individually, while 
the Lutefisk program can analyse many spectra in batch mode.
However the data produced by both packages is not shown. The need for user intervention 
or lack of automatic analysis was considered to be not beneficial for the dataset here at 
hand.
A second approach to analyse this huge dataset, was to generate a list o f top spectra. To 
this, a Perl script was written (by Richard Jacob) that gave a list o f average signal to noise 
and peak intensity for each tandem mass spectra. With the assumption that a good MS/MS 
spectrum has a large number o f peaks with good S/N  spectra were sorted according to 
average S /N  value. However, many of the top 100 ‘best’ spectra contained fragment data 
from the same peptide.
The analysis of one interesting fraction is shown in Figure 4.3.2, which shows the survey 
(TOF-MS) spectrum from fraction 3 spot 41. The majority of the peaks visible in this 
figure are the result o f the differential alkylation o f the same peptide. This is shown by the 
inset in the figure, iodoacetamide was used as alkylation reagent, resulting in the 57.0195 
Da difference.
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Figure 4.3.2 MS survey scan of fraction F03 spot 41 from Conus ventricosus.
This figure shows the TOF-M S spectrum o f  spot 41 from fraction F03. The peak labelled with (**) is that o f 
the internal standard ACTH. In the insert, a zoom-in o f  the MS spectrum is displayed. This row o f peaks is 
the result o f  differential alkylation o f  this particular peptide. The tandem  mass spectra o f  the two peaks 
labelled in blue are shown in the next two figures.
From the 8 tandem mass spectra taken from this fraction, two fragment spectra are shown. 
These are labelled blue in Figure 4.3.2.
Figure 4.3.3 shows the fragment spectrum of m /z  1782.738. The primary sequence was 
established as:
E(I/L)NC*GGEVYHEC*C*R m /z  1782.700 [MH]+
The measured mass was within 20 ppm o f the theoretical mass for this peptide. The 
alkylated cysteines are displayed as C* while, by mass, no distinction can be made between 
leucine and iso-leucine (I/L). In the figure immonium ions were labelled in green (the most 
intense fragment in the entire spectrum was that of the immonium ion o f histidine (H)), b 
and a ions in purple, and y-17 are denoted by a red hash (#). The sequence found, was 
searched against NCBI using ProteinProspector. However, no hits were obtained.
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F igu re  4.3.3 M S /M S  spectrum  o f m /z  1782.79 from  F03-spot 41.
This figure shows the tandem mass spectrum o f m /z  1782.790 from F03-spot 41. The spectrum is divided 
into two sections. The y-ions are labelled in blue. The primary sequence was correcdy assigned as 
E(I/L)N C G G EV Y H EC C R. Labelled in purple are a-ions and b-ions. Loss o f amm onium from y-ions is 
indicated with a red hash (#). Immonium ions are labelled in green, note the predom inant immonium ion o f 
Histidine.
As discussed above, M ALDI-TOF/TOF fragmentation generates a high number of 
internal fragments (Harvey et al., 1995; Medzihradszky et al., 2000). The majority of the 
peaks at the low end o f the mass spectra can be assigned to internal fragment ions. All 
peaks that were assigned as internal fragments are listed in Table 4.3.1.
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T ab le  4.3.1 M asses of  in ternal fragm ents.
This table displays the internal fragments that could be assigned from  the spectrum  in Figure 4.3.3.
m / z fragment ion m / z fragment ion
87.069 GG-28 275.141 CGG
115.051 GG 301.187 YH
187.103 GE 321.129 CC
215.182 GGE-28 343.228 GGEV
218.103 CG 404.214 CGGE
229.165 EV 430.251 YHE
235.172 HE-28 431.240 GEVY-18
247.136 NC-28 503.283 CGGEV
247.136 GGC-28 518.280 NCGGE
258.139 GEV-28 529320 EVYH
267.157 H E 590315 YHEC
268.145 GEV-18 613.346 LNCGGE-18
275.141 NC 625325 GGEVYH-18
All the cysteines in this peptide are alkylated. It is therefore surprising to see more delta 57 
adducts. It is know that the N-terminus o f peptides can be alkylated upon favourable 
conditions. However that was not only the case for m /z  1839.716. The tandem mass 
spectrum o f this peptide is shown in Figure 4.3.4. In this figure a mixture o f a peptide 
which was alkylated either on histidine, or at the N-terminal amino group, can be seen.
The y-ion series, as found in Figure 4.3.3, is labelled in blue. However, from the position of 
histidine, the same sequence can be fitted (with extra alkylation). This is shown is red. 
Another strong indication of the alkylation of histidine is the immonium ion. Immonium 
ions o f both alkylated and normal histidine were detected, m /z  167.126 and m /z  110.083 
respectively. This o f course has consequences for database searching, as in general these are 
not interrogated with variable modifications on histidine.
The b13-ion (m /z 1665.903) confirms that the remaining alkylation (of the peptide with 
unmodified histidine) can only occur on the N-terminal glutamic add  (E et al.).
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F igu re  4.3.4 M S /M S  sp ec tru m  o f m /z  1839.77 from  F03-spot 41.
This figure shows the tandem  mass spectrum o f a mixture o f peptides with differential alkylated forms. The 
sequence series labelled in blue is alkylated on the N-terminal Glutamic acid, while the amino acid sequence 
labelled in red is alkylated on the Histidine. In both  case, the ions series were y-ions. Im m onium  ions are 
labelled in green.
The experiments described above were the initial attempt to analyse Conus venom using 
2D-LC and mass spectrometry. Although the actual identification o f putative conotoxins 
was very low it was a very important experience in sample handling. This data set can be 
analysed in the future by adequate automatic de novo sequencing program.
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5 Analysis of Conus venom by multi dimensional liquid 
chromatography and mass spectrometry.
This chapter is concerned with the 2D-LC separation and mass spectrometric analysis of 
Conus venoms. The analysis of Conus textile is described paragraph 5.2, the analysis of Conus 
ventricosus in paragraph 5.3. The essential difference between the two analyses was the 
selection procedure o f fractions from the second chromatographic dimension which were 
taken forward for further analysis, i.e proteolytic cleavage and MS analysis. For the first 
venom sample, two-dimensional fractions were selected according to the UV absorbance in 
the second dimension, while for the second sample fractions were selected for further 
characterization after MS-analysis.
5.1 Introduction
Biological samples can hardly ever be analysed in their original matrix. Not only are the 
matrices often too complex to be analysed in a single mass spectrometric analysis, 
abundant components in the sample will also mask the signals o f low abundant species. 
Furthermore, contaminants such as inorganic salts interfere with ionization processes. For 
these reasons, fractionation and purification o f biological samples are an integral part of 
mass spectrometric methods.
Comprehensive fractionation also provides a platform for future bioassays to identify 
biologically active components in Conus venom. As previously mentioned, toxins isolated 
from Conus venom target selectively specific ion channels. Because conotoxins can 
discriminate between closely related subtypes of ion channels, many of the characterised 
conotoxins are used as pharmacological agents in ion channel research (Moczydlowski et al., 
1986) and several have direct diagnostic and therapeutic potential. The targeting specificity 
derives from the amino add side chains facilitated by compact globular structure of the 
cono toxins peptides (McIntosh et al., 1982), which are typically 20 to 30 amino adds long 
and routinely contain three internal disulfide bridges. The experiments for characterising 
Conus venom have therefore been designed to preserve the conotoxin components in their 
native form. The sample solubilisation and size separation are performed under high salt 
concentration to prevent sample aggregation. No reducing agents, such as DTT or TCEP,
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are used during the solubilisation and chromatographic separation to keep the disulfide 
bridges (cystines) intact.
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Figure 5.1.1 Workflow for 2D-LC separation of C onus venom.
This figure is a workflow o f  the experiments described in this chapter. Venom was solubilised in artificial sea 
water (see Figure 2.4.1) and separated (for instance fractions SI through S10) on a size exclusion column to 
separate the proteins from  the peptides and smaller molecules. Protein fractions were analysed as described in 
chapter 4. Peptide fractions were desalted using a RP C l8 trap column and concentrated under vacuum (for 
instance fraction R1 through RIO from size fraction 4 (S4)). Each o f the size exclusion fractions was 
separated on a preparative RP C18 column and fractions were taken. All fractions were m onitored by 
M A LDI-TO F MS. Fractions from Conus ventricosus where first analysed intact by LC-ESI-M S/M S before 
being treated with a protease.
Figure 5.1.1 Workflow for 2D-LC separation of Conus venom.shows a schematic of the 
workflow adopted for the experiments described in this chapter. Two venom samples were 
used for analysis, Conus ventricosus and Conus textile (lyophilised venoms). In brief, the 
lyophilised venom samples were reconstituted individually in 175 pL artificial sea water 
(ASW; NaCl, 460 mM; KC1,10 mM; CaCl2 11 mM; MgC^; Tris pH 7.2, 20 mM) and mixed 
with shaking for 1.5 hours (750 rpm) at 4°C. The sample was spun down and the 
orange/yellow supernatant was removed. A further 175 pL of ASW was added to the pellet 
and was left shaking for 1 hour (750 rpm) at 4 °C. This process was repeated one more 
time. The supernatants were combined to give approximately 520 pL solubilised venom. 
The solubilised venom was subjected to size exclusion in 5 separate batches of 90 pL each. 
The retention times o f the major peaks of the individual runs were very reproducible. The
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first fractions were analysed using 1D-SDS-PAGE as described in chapter 4. The individual 
peptide fractions from the different elutions were pooled and desalted using a Cl 8 peptide 
trap. Fractions were concentrated under vacuum to approximately 50 pL and separated 
further by reversed phase chromatography. Fractions taken from this second dimension 
separation were analysed both as intact peptides/protein and after digestion with trypsin.
5.2 Tandem  m ass spectrom etric analysis o f 2D -LC  separated Conus 
textile venom .
5.2.1 Size exclusion separation of Conus textile venom.
Orthogonal two-dimensional liquid chromatography is a powerful technique to separate 
peptides from complex biological mixtures (Link et al., 1999). Although the combination of 
cation exchange and reversed phase is frequently used in the proteomics environment 
(Cutillas et al., 2004), the combination of size exclusion and reversed phase has been longer 
used in the studies of conotoxins (Olivera et al., 1990), (Fainzilber et al., 1995b). In most 
cases Sephadex size exclusion resin is used in the first dimension and often only the 
fractions in the conotoxin mass range that also have biological activity have been analysed. 
The size exclusion column used in the experiments described in this chapter has an optimal 
range o f 100 -  7,000 Da. In theory when using denaturating conditions (i.e. prevent 
protein-protein or protein-peptide interaction), proteins co-elute in one fraction while 
peptides and smaller molecules are separated with higher resolution according to the 
optimal size separation range of the column.
Figure 5.2.1 shows the absorbance chromatogram at 214 nrn of the size separation of Conus 
textile. Fractions that where used for further separation and MS analysis were labelled A07 
through B01. Same fractions of consecutive runs were pooled. Individual runs were vary 
reproducible as shown in Figure 5.2.2. The column was characterised with a known protein 
mixture as shown in Figure 3.1.1. Therefore components in the molecular weight range 10 
kDa to approximately 800 Da were further separated. All known conotoxins have a mass 
lower then 4,500 Da (Terlau and Olivera, 2004).
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Figure 5.2.1 Size separation of Conus textile  venom.
The figure shows the absorbance over time for the size separation of Conus textile venom. The blue line is 
the absorbance at 214 nm. Components where separated using an isocratic elution at 0.2 mL-min'1 using 
150 mM NaCl in 20 mM Tris pH 7.2. Fractions where taken every 1.5 mL (magenta). Fraction A06 
through A12 and B01 were further separated by reversed phase chromatography.
Fractions B02, B03 and B04 were cleaned up using the ZipTip protocol and monitored by 
M ALDI-TOF MS, but no components except matrix peaks and chemical noise were 
detected. The UV absorbance can probably attributed to small organic components and 
salts from the venom (Escoubas et al., 2000) as well as the Tris from the artificial sea water.
Figure 5.2.3 shows an overlay o f the absorbance pattern at 214 nm from Figure 5.2.1 with 
the online conductivity measurement. This clearly indicates when salt and small conducting 
organic components eluted. The background conductivity is relatively high at 
approximately 16.5 mS c m 1. This is caused by the eluent which consists of 150 mM 
sodium chloride and 20 mM Tris (pH 7.2)
84
5. Analysis o f Conus venom by multi dimensional LC and mass spectrometry
F igu re  5.2.2 R eproducib ility  o f size exclusion  e lu tion
This figure shows the elution patterns o f consecutive size exclusion runs o f  Conns textile venom.
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F igu re  5.2.3 C onductiv ity  m easu rem en ts  for th e  size exclusion  e lu tion  o f  C onus V enom .
This figure shows the absorbance pattern at 214 nm  (blue line) o f  the size exclusion separation o f  Conus textile 
and the online conductivity measurem ent (brown). The baseline conductivity is caused by the buffer (150 mM 
NaCl in 20 mM Tris pH  7.2) used for the isocratic elution. The conductive com ponents are believed to be the 
salts from  the sample and the solubilisation buffer and Tris, which elute roughly in two peaks.
Figure 5.2.4 shows the absorbance profile of Tris (pH 7.2) with varying wavelengths. The 
absorbance was first scanned on a wider range, namely 200 through 250 nm. Initially the
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absorbance maximum was determined at 209 nm. Figure 5.2.4 shows a more accurate 
zoom-in scan using a narrower range (208.0 — 220.0 nm). The maximum absorbance was at 
wavelength 208.9 nm. The absorbance at 214.0 nm is considerable. This therefore is most 
likely the main contributor of the high absorbance in the size exclusion separation around 
90 minutes.
214 nm
.2 . 0 —,
A = 0 937
F igu re  5.2.4 Z o o m  in  o f abso rbance  sp ec tru m  o f  100 m M  T ris so lu tion .
This figure shows the precision UV absorbance scan from 208 to 220 nm  o f  Tris. The maximum absorbance 
o f  Tris lies at 208.9 nm. A solution o f  approximately 100 mM Tris was put in a quartz cuvet and a baseline 
scan was perform ed on a Cecil Instruments spectrophotom eter (CE 2041). The baseline was corrected 
against dd -fbO . Initially the range from 200 to 250 was scanned where the maximum was determined at 209 
nm. The absorbance o f  Tris at 214.0 nm  was 0.937.
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5.2.2 RP second dimension separation of size separated Conus textile 
fractions
Before submitting the size fraction described above for further separation by a 
chromatographic second dimension, the performance of several reversed phase semi 
preparative analytical columns were evaluated using a trypsin digest of bovine fetuin. 
Samples were prepared according to Medzihradszky et al. (Medzihradszky et al., 1994). 
Fetuin is used as a standard because it is a fair representation o f the elution of peptides 
from biological samples. Peptides resulting from the digest o f fetuin contain both 
hydrophilic and hydrophobic peptides. Also, the peptides span a wide mass range, from 
400 to 7,400 Da.
Figure 5.2.5 shows the chromatographic separation of fetuin digest using three RP columns. 
From top to bottom, Phenomenex Jupiter C18, Agilent Zorbax C8 and Vydac C18. 250 
pmol of fetuin was injected onto the column. The runs of the different columns were 
performed under the same chromatographic parameter (i.e. flow, gradient, buffer system).
Both the first and last columns are 250 mm in length and have the same internal diameter 
(4.6 mm). The Zorbax C8 has shorter aliphatic chains and is 150 mm, but the shorter 
length is compensated for by a smaller particle size. Zorbax has 3 pm particles compared to 
5 pm particles from both the Jupiter C18 and Vydac C18. From the three columns the 
Jupiter had poorest separation performance but retained hydrophilic peptides better in 
comparison to the Zorbax and Vydac columns. This resulted in a overcrowded middle part 
of the chromatogram.
The elution profiles of the Zorbax C8 and Vydac Cl 8 are very comparable. The elution of 
the Vydac C l8 seems to be slightly delayed and over a slightly longer time frame, indicating 
that to some extent this column has a better resolution. The average peak width across the 
elution was approximately 24 seconds, or 0.2 mL. For the second dimension separation the 
Vydac Cl 8 column was used and fractions were taken at fixed time intervals corresponding 
to 600 pi.
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F igu re  5.2.5 E v a lu a tio n  o f  sem i p reparative reversed phase  co lum ns.
This figure shows the absorbance chromatograms (214 nm) o f  250 pmol bovine fetuin digest o f different 
reversed phase columns, namely (from top to bottom) Phenomenex Jupiter C l8 (5pm particle size, 4.6 x 250 
mm); Agilent Zorbax C8 (3 pm  particle size, 4.6 x 150 mm); Vydac C18 (5pm particle size, 4.6 x 250 mm). 
Peptides were eluted with a flow rate o f  0.5mL m in '1 in a 4 step gradient (magenta lines, 4 minutes 5% B; 39 
minutes 50% B; 43 minutes 90% B) using water phase A (0.1% TFA) and organic phase B (0.1% TFA in 
acetonitrile).
In Figure 5.2.6 the eight second dimension RP elutions A07, A08, A09, A10, A l l ,  A12, 
B01 and B02 are overlaid, using alternating green and blue colour. As described above, the 
pooled and concentrated size exclusion fractions (ID) where injected (50 pL). Fractions 
were taken (magenta numbers on the x-axis) at fixed intervals corresponding to 600 pL into 
siliconised tubes. So, each size fraction gave rise to 72 reversed phase fractions. As an 
example, samples were labelled “A09-C11” . This then corresponded to first dimension 
fraction A09 and second dimension fraction C ll . In total 576 fractions were taken in the 
second dimension (8 times 72). A blank, 50 pL of artificial sea water, was run in between 
each analytical run. One o f these runs is shown in magenta, the bottom chromatogram of 
Figure 5.2.6.
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F igure  5.2.6 E lu tio n  profiles o f the second  d im ension  R P sep ara tio n  o f C onus te x tile  size fractions.
This figure shows the UV absorbance at 214 nm  o f the individual chromatograms o f  the reversed phase 
separation from  size fractions (see Figure 5.2.1) from Conus textile. A four step gradient elution was used 
(dashed magenta line). Fractions were taken every 600 pL as indicated by the magenta indentations on the 
time axis. Fraction Are named (A01 A12; B01 - )  B12 .... F01 F12). Displayed in solid magenta (the
bottom  UV trace) is the UV absorbance (214 nm) from a blank run.
In order to get a better idea about how many components there are in Conus venom (in the 
peptide range) and to enhance the detection sensitivity, a mass map was created. All o f the 
approximately 600 fractions were monitored offline by MALDI-TOF MS.
A matrix mixture, consisting o f 1 part 70% methanol and 1 part saturated HCCA (Agilent) 
containing 14 fm ol-pL1 Adrenocorticotropic hormone clip 18-39 (ACTH), was spotted 
every 20 seconds by an automated XY-spotter (Probot, LC-Packing /  Dionex) on a 
stainless steel target plate. To 1 pL matrix, 1 pL analyte (2D fraction) was added manually. 
The analyte/matrix solution was allowed to air dry before analysing with an Applied 
Biosystems 4700. All fractions of the same size exclusion fraction were loaded on one plate. 
Spectra were acquired automatically and calibrated automatically using ACTH (m/z 
2465.1992). Masses were recorded from m /z  800 to m /z  5,000. Peak lists were extracted 
using Teak Spotter’. Peak Spotter (written by Peter Baker) is a module for the in-house 
version o f ProteinProspector (version 4.11.0) (Clauser et al., 1999). This module allows for
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data, such as peak lists and raw data files, to be extracted from the oracle database, onboard 
the 4700 mass spectrometer. A macro was written in Excel to filter the peak list for 
minimum and maximum masses (m/ 2 900 — m/ 2 4,500) and that o f known contaminants, 
introduced by adding the internal standard.
Figure 5.2.7 represents a mass map of ions detected between 900 Da and 4,500 Da with a 
signal to noise higher than 15. To eliminate the internal standard (ACTH 18-39) from this 
figure, the peak lists o f the different spectra were filtered for 2465.1992 ± 1 0  ppm. Fraction 
A 10, represented in the figure by number 1 on the x-axis, through F04 (number 55 on the 
X-axis) are displayed in the figure. A colour code is used to indicate the intensity, as shown 
in the legend o f the figure. None of the earlier fractionsbefore A10 contained detectable 
entries. The absorbance peaks appearing in Figure 5.2.6 around 70 minutes are probably 
mainly due to polyethylene glycol (PEG) contamination. This is an unfortunate but not 
uncommon phenomenon that can arise due to PEG leaching from plastic tubes. The PEG 
is usually detected as an envelope of peaks separated by 44 Da, which corresponds to the 
repeat monomer unit C2H40 .
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Figure  5.2.7 M ass m ap  o f  2D -LC  separa ted  C o n u stex tile  venom .
This figure shows the mass maps of the 2D-LC separation of Conus textile. Each individual panel shows 
the mass to charge ratio measured of each second dimension fraction o f Conus textile. 1088 components 
where detected with S/N > 1 5  for m/z > 900. Intensity is displayed using the colour scheme shown is the
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bottom right hand panel o f the figure. Matrix was spotted automatically using a Probot™ Micro Fraction 
Collector (LC Packings - Dionex). Matrix was made up from 1 part 70% methanol and 1 part CHCA. 
ACTH was added to the matrix (14 fmol p l '1) and used as an internal standard, during the automatic 
acquisition with the 4700 Proteomics Analyzer MALDI-TOF/TOF™. 1 pi analyte was added manually 
before allowing the mixture to air dry.
Initially, from the approximate 600 fractions from 2D LC separation, the ten fractions with 
the largest UV absorbance (Figure 5.2.6) were taken forwards for further characterization 
by MS. Samples were analysed in three states (i) native, (ii) reduced and alkylated (iii) and 
after trypsin digestion. MALDI-TOF MS/MS measurement was performed on all three, 
while LC-ESI-MS/MS measurement was performed on the latter two.
Figure 5.2.8 shows the TOF-MS screen of native, reduced/alkylated and trypsin treated 
fraction A11-C02. MS of the fraction A11-C02 identified a predominant monoisotopic 
singly-charged ion at m /z 1712.4587. After reduction and alkylation and subsequent 
reanalysis, a shift in mass of the predominant ion to m /z 2060.6414 was observed. Both 
peaks were mono-isotopically labelled and singly charged. This corresponded to a mass 
increase of 348.1827 Da indicative of 6 alkylation events with iodoacetamide (CH2CONH2; 
6 x 58.0293) and suggestive of 6 cysteine residues present in the peptide. Despite 
optimisation o f the reduction and alkylation conditions for highly disulfide knotted 
peptides, partial alkylation o f the parent peptide was also detected as minor ions at m /z 
1944.5778 and m /z 2003.6141, corresponding to the ion containing one disulfide and 4 
alkylated cysteines, and one free and 5 alkylated cysteines, respectively. Some of the native 
material remained intact. The reduced and alkylated species remained unaffected after 
trypsin treatment.
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Figure 5.2.8 M ALDI-TOF MS spectra of fraction A11-C02 from Conus textile
This figure shows the MALDI-TOF MS spectra o f fraction A11-C02 from Conus textile. The top spectrum is 
untreated/native sample. The middle panel is reduced (TCEP) and alkylated (LAM) fraction. The bottom 
panel is after trypsin in solution digestion. The spectrum is calibrated internally on ACTH 18-39 
(m/z=2465.1992) which is marked by the blue hash (#). The major ion in the top panel (m /z= 1712.4587) 
shifts 348.1827, indicating 6 alkylations (6 x 58.0293).
In order to elucidate the primary structure, sequence information was collected both from 
the MALDI and ESI experiments. Tandem mass spectra were collected for both the native 
and alkylated peptide (see Figure 5.2.9). Fragmentation by MALDI-TOF/TOF of the 
disulfide linked peptide (top panel) yielded little to no information. Two weak ions where 
detected which, by mass, can be attributed to the internal fragments o f HP and HPS. These 
internal fragments probably originated from the partially unfolded peptide. This will be 
discussed later in this paragraph. When fragmenting the alkylated peptide under the same 
conditions, ions from the b-ion and y-ion series were generated, which can be seen in the 
bottom panel o f the figure.
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Protonation o f ions occurs mainly at the more basic sites. In the case of peptides, the N- 
terminal amino group is basic. During positive mode ionization, the additional protons 
reside on the basic amino acids (R, K, H, P) first and then on the peptide backbone amide 
groups, which are more statistically distributed along the chain. The presence and position 
of a basic amino acid in the peptide sequence influences the fragmentation process 
(Hoffmann and Stroobant). The fragmentation of this singly charged peptide favoured 
fragmentation at the proline and histidine amino adds that were present in this sequence. It 
has been reported that the increase o f collision energy during low energy CID only 
decreases the absolute signal intensities o f the precursor ion and the high mass fragment 
ions (Cramer and Corless, 2001).
Proline favours fragmentation at the N-terminal side of the amino add. This was useful to 
assign the different ion series. Because of this, the b ion which should have been generated 
usually lacked or had a significantly lower intensity. In case o f the y-ion series, the y-ions 
before the proline position are completely missing. Although this spectrum gave 
information about some of the components of the peptide, it was not enough to assign a 
complete sequence.
The fragmentation pattern of peptides depends not only on the type of amino add and its 
location, but also on the experimental fragmentation technique used. In contrast to 
MALDI ionization, dectrospray ionization of peptides (up to 25 amino adds) generally 
produces doubly charged ions.
94
5. Analysis of Conus venom by multi dimensional LC and mass spectrometry
1712.582
HP
IN HPS
in
m
m / z
4 7 5 0
WD VCD C*
1220.375
3 6 0 0  -
C*
2 6 5 0
8
£10c
I
(N1 9 0 0  -
INHP i>-
tiri9 5 0 i*.
coa
a 00CO
2 0 0 4 0 0 6 0 0 8 0 0 1 0 0 0  1 2 0 0  1 4 0 0  1 6 0 0  1 6 0 0  2 0 0 0
m / z
F igure 5.2.9 M A LD I tandem  MS spectra  from  fraction A11-C02.
The top panel shows the tandem mass spectrum o f  m /z  1712.592, from fraction A11-C02 from Conus textile. 
This ion is still disulfide linked. There are two fragment ions which can be assigned as internal fragment ions. 
The bottom  panel shows the MS/MS spectrum of m /z  2060.850 (reduced and alkylated peptide from the top 
panel). This peptide has also been incubated with trypsin, but no cleavage products resulted, indicating the 
lack o f arginine and lysine amino acids or the presence o f RP or KP. The y-ion series are labelled in blue, the 
b-ion series in red. The immonium ion o f histidine is labelled in green and internal fragment ions in purple. 
Loss o f H 2O  is indicated by (@).
Typically the two protons allow for a more even fragmentation along the whole peptide 
backbone. O f course this process is still influenced by sequence specific amino acids. The 
advantages of using a complementary fragmentation technique is demonstrated in Figure 
5.2.10 where the same peptide was dissociated in a CID cell using a quadrupole orthogonal 
acceleration time of flight (Q-TOF) mass spectrometer.
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Figure 5.2.10 ESI Tandem mass spectrum of m /z  1030.828 of fraction A11-C02 from Conus textile  
venom.
This figure shows the MS/MS spectrum o f m /z  1030.828 [M+2H]2+ selected for CID  from fraction A ll-  
C02 from Conus textile. The y-ion series is labelled in blue, while the b-ions are in red. Internal fragments are 
labelled in purple and the cysteine immonium ion in green. The C* indicates an alkylated cysteine residue. 
From this spectrum a complete sequence was assigned (CCSWDVCDHPSCTCCG). N o ions were detectable 
above the noise lever over m /z  1745.
From this tandem mass spectrum the complete primary sequence was assigned, namely: 
CCSWDVCDHPSCTCCG. In comparison to the singly charged MALDI fragment 
spectrum, low mass fragments ions were generated. In this case the extra proton was 
retained by the basic amide groups on the protected cysteine residues (C*), introduced by 
the alkylating reagent. Also internal fragments that contained C* were detected, these were 
labeled purple in the figure and added to the confidence in assigning this sequence.
The sequence was searched against NCBI using ProteinProspector MS-TAG. (Clauser et al., 
1999). The sequence found was the mature toxin part o f a conotoxin precursor which was 
classified in the III/IV  scaffold (accession number: AAG60381 - GI number 12619439). 
The entire precursor predicted by Conticello et al. (Conticello et al., 2001) is shown below 
(70 amino acids).
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1 MLKMGWLFI FLVLFPLATL QLDADQPVER
31 YAENKQLLSP DERREIILHA LGTRCCSWDV CDHPSCTCCG
As mentioned above, most likely some of the native peptide was partially reduced i.e. some 
or one o f the disulfide linkage(s) were not formed. This was clearly seen while looking at 
the isotopic pattern o f the parent peptide. The MS survey scan revealed an unconventional 
isotope pattern for m /z 1712.4587 which could be an indication o f partially unfolded 
peptide. A zoom-in of the survey scan is shown in panel A o f Figure 5.2.11.
The theoretical isotope distribution was calculated using the MS-isotope feature of 
ProteinProspector (Clauser et al., 1999). Panel C shows the theoretical isotope distribution 
for a peptide with sequence CCSWDVCDHPSCTCCG with 3 Cystines. This calculation 
takes into account the 4.29 % natural occurrence of 34S. When this was compared to the 
measured isotope distribution in panel A, a clear difference was observed. The intensity of 
the third isotope was slightly higher, indicating two extra hydrogen at this mass. This was 
never observed previously for conotoxin peptides.
In order to make a rough estimation of the percentage o f unfolded conotoxins, theoretical 
isotope patterns o f mixtures o f partially reduced and native conotoxin were calculated. 
Panel B and D shows the calculated isotope distribution of mixtures of the peptide, with 
both 2 and 3 Cystines. It was estimated that approximately 6 % of the peptide was in the 
partial unfolded state with the hypothesis that all forms have the same ionization efficiency. 
Panel D is 20 % unfolded peptide.
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Figure 5.2.11 T heo re tica l iso tope d is tribu tion  o f m /z  1712.458 from  A11-C02.
This figure shows the measured and theoretical isotope distribution o f m /z  1712.458 from fraction A11-C02 
from Conus textile. Panel A shows a zoom in o f the top spectrum o f Figure 5.2.8. The isotope pattern shows a 
distorted pattern, indicating reduced disulfide bridges. Panel C shows the theoretical isotope distribution of 
triply intra disulfide linked peptide [MH]+ CCSWDVCDHPSCTCCG (elemental composition C65 H 90 N 19 
O 24 S6). Panel B shows a mixture o f native peptide, with native peptide with 1 disulfide bond reduced 
(elemental composition C65 H 92 N 19 O 24 $6)- This is a theoretical mixture with 94 % native peptide. Panel D 
shows, as an example a mixture o f  80 %  native peptide with 20 % 1 reduced disulfide bond. Theoretical 
distributions were calculated using the MS-isotope feature o f ProteinProspector 
(http://prospector.ucsf.edu/ucsfhtm l4-0/m siso.htm ).
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However, not all elucidations were that straight forward. The MALDI-TOF-MS spectra of 
native, reduced/alkylated and trypsin treated fraction A09-B10 are shown in Figure 5.2.12. 
The ion marked with the blue hash (#) is the internal calibrant added to the matrix. Most 
of the peptide was fully alkylated (6 times). The ion with m /z 3099.6016 is the product of 
four alkylations with one disulfide bridge reformed. When this peptide was digested with 
trypsin, one major fragment was generated (m/z 2658.0193).
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Figure 5.2.12 MALDI-TOF MS spectra of fraction A09-B10 from Conus textile
This figure shows the M A L D I-T O F MS spectra o f  fraction A09-B10 from  Conus textile. T he top spectrum  is 
untreated /native sample. T he middle panel is reduced (TCEP) and alkylated (LAM) fraction. T he bottom  
panel is after trypsin in solution digestion. The spectrum  is calibrated internally on A CTH  18-39 
(m /z=2465.1992) w hich is m arked by the blue hash (#). T he m ajor ion in the top panel (m /z  2867.0591) 
shifts 348.1718, indicating 6.000 alkylations (6 x 58.0293).
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The tandem mass spectra of m /z  2658.0193 and that of the reduced /alkylated peptide are 
shown in Figure 5.2.13, top and bottom panel respectively. Both fragment spectra revealed 
partial but unique information. The preferential cleavage in the sequence is at the C- 
terminal side o f aspartate (D), making the indicated sequence part of the y-ions series.
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F igure 5.2.13 M A LD I tan d em  m ass spectra  o f peptides from  C onus te x tile  fraction  A09-B10.
Fraction A09-B10 was reduced and alkylated. The tandem mass spectrum o f  the fully alkylated peptide can be 
seen in the bottom  panel. The MS/MS spectrum of the major proteolytic fragment is shown in the top panel.
The overlapping sequence of both tandem spectra, DCESHCI/LCT, was searched against 
NCBI using the MS-Homology tool from ProteinProspector (Clauser et al., 1999) 
(http://prospector.ucsf.edu/ucshtml4.0/mshomology.htm). MS-Homology allows for a 
user defined number of amino acid substitutions, whereby leucine and isoleucine are 
represented as one amino acid using the wild card [I|L]. The results of this search can be 
found in Table 5.2.1. The sequence determined was unique for Spasmodic peptide tx9a 
precursor (Pi-conotoxin TxIXA). This sequence was first found in Conus textile by Lirazan et 
al (Lirazan et al., 2000). For the search against NCBI two amino acid substitutions were 
allowed. One further conotoxin met the criteria of the sequence, with one amino acid
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substitution. Spasmodic protein tx9a-like protein precursor (Conotoxin gm9a) from Conus 
Gloriamaris (Miles et al., 2002).
The full sequence o f pi-conotoxin TxIXA precursor is displayed below. The mature part of 
the toxin is underlined.
01 MHLSLARSAV LMLLLLFALG NFVWQSGQI TRDVDNGQLT
41 DNRRNLQSKW KPVSLYMSRR GCNNSCQEHS DCESHCICTF
81 RGCGAVN
The theoretical masses o f the mature part o f the toxin and the major tryptic fragment are 
calculated using MS-Product (ProteinProspector: http://prospector.ucsf.edu/ucsfhtm l4.0/ 
msprod.htm). The results are displayed below. The mass error of measured versus 
theoretical is given in ppm.
Native mature toxin:
GCNNSCQEHSDCESHCICTFRGCGAVN-amide [MH]+ = 2867.0271 (11 ppm)
Major tryptic product, where C* is alkylated cysteine:
GC*NNSC*QEHSDC*ESHC*IC*TFR [MH]+ = 2657.9648 (20 ppm)
Table 5.2.1 MS-Homology search from M S/M S data from fraction A09-B10 from Conus textile.
The table shows the top four hits for the homology search from the sequence D CESHCIC sequenced from 
the tandem mass spectra from  A09-B10 from  Conus textile. The homology search was performed with the MS- 
Homology package from  ProteinProspector. For the search two amino acid substitutions were allowed. 
Amino acid substitutions are displayed in bold. The sequence was unique for a precursor conotoxin n-TxIXA 
from  Conus textile.
Matching Sequence Species Protein Name
(S)DCESHCIC(T) Conus textile Spasmodic peptide tx9a precursor (Pi- 
conotoxin TxIXA)
(S)DCASHCIC(T) Conus Gloriamaris Spasmodic protein tx9a-like protein 
precursor (Conotoxin Gm9.1) (Conotoxin 
gm9a)
(A)DCRSNCIC(E et 
al.)
Desulfitobacterium 
hafniense DCB-2
Dinucleotide-utilizing enzymes involved in 
molybdopterin and thiamine biosynthesis 
family 1
(T)DCNSHCHC(E 
et al.)
Anopheles Gambiae 
Str. Pest
ENSANGP00000011827
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The tandem ESI mass spectrum of the tryptic fragment is shown in the top panel of Figure 
5.2.14. Although the ion has a substantial response in MS mode (bottom panel), the 
fragmentation spectrum is poor. The major fragment ion in the spectrum can be 
contributed to the b2 ion (C*G). No fragmentation spectra were recorded for either the 
intact alkylated mature toxin, or lower charged tryptic fragments of this peptide. 
Fragmentation o f peptides during mass spectrometry, and the energy required for 
fragmentation, has some dependency on the peptide sequence, but also has a correlation 
with the peptide mass, where larger peptides require more collision energy.
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Figure 5.2.14 Tandem  ESI m ass spectrum  m /z  665.2350 of Conus textile  fraction A09-B10.
This figure shows the MS scan (bottom ) and M S/M S spectrum  (top) o f  the m ajor tryptic fragm ent from  
fraction A09-B10 ( gc*nnsc*qehsdc*eshc*ic*tfr [M H]+ =  2658.0193 ). T he y-ions are displayed in blue and 
the b-ions in red. A lthough there is a substantial signal in MS m ode, the fragm ent spectrum  is rather poor. 
H ow ever the fragm ents were consistent w ith those o f  the M A LD I-M S/M S spectrum  o f  the same peptide. 
N o  fragm entation w as observed fo r the triply charged ion  o r o f  the intact alkylated peptide before trypsin 
digestion
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To validate the assignment o f pi-conotoxin TxIXA found in this fraction, the theoretical 
fragments that were generated with MS-Product from pi-conotoxin TxIXA of the intact 
alkylated mature toxin are compared with the experimental fragments. The theoretical 
fragments are given in Table 5.2.2 Theoretical y-ion series from native mature toxin from 
A09-B10. The unassigned ions of the MALDI fragment spectrum in the bottom panel of 
Figure 5.2.13 can now be correlated (m /z 1926.78 and 2265.90) An overall sequence 
coverage o f 35 % was achieved (9 out o f 26 y-ion fragments), therefore a confident 
assignment o f the sequence.
Table 5.2.2 Theoretical y-ion series from native mature toxin from A09-B10
T o validate the assignment o f  pi-conotoxin TxIXA to fraction A09-B10, the M ALDI tandem mass spectrum 
is com pared with the theoretical y-ion series for this peptide, seen in the bottom  pannel o f Figure 5.2.13. 
N ine out o f  26 fragment y-ions were detected, yielding 35 %  sequence coverage.
Theoretical y-ion series fragment masses [MH]+
yi 132.08 yw 1140.50 y»9 2265.90
y2 231.15 yu 1253.59 y2o 2394.94
Yi 302.18 yu 1413.62 yzi 2523.00
y4 359.20 yu 1550.68 y22 2683.03
ys 519.23 yM 1637.71 y23 2770.06
y« 576.26 y» 1766.75 y24 2884.11
y7 732.36 y« 1926.78 y25 2998.15
y8 879.43 yn 2041.81 y* 3158.18
y9 980.47 y« 2128.84 Yn 3215.20
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5.3 Com prehensive m ass spectrom etric analysis o f 2D -LC  separated
Conus ventricosus venom .
The basis o f analytical separation was performed in a similar fashion to the separation of 
Conus textile venom in section 5.2. The main difference was that fractions were selected 
according to mass abundance i.e. number of ions detected in a particular fraction after 
MALDI-TOF-MS scanning o f all fraction As opposed to selection of fractions by UV 
absorbance. This resulted in manual interpretation LC-MSMS runs o f 96 fractions selected.
5.3.1 Size exclusion and reversed phase 2D-LC separation of Conus 
ventricosus venom.
Lyophilised Conus ventricosus was solubilised as decribed before and was separated using size 
exclusion chromatography. The UV absorbance (214 nm) chromatogram is shown in 
Figure 5.3.1. In comparison with the elution profile of Conus textile venom, which was run 
under identical condition, the chromatograms have great similarities. As was shown in 
Chapter three, all proteins eluted in fraction A04, A05 and A06. In a similar fashion, a large 
absorbance peak appeared around 85 minutes. Again, not many components were detected 
around this area. As was shown in Figure 5.2.3 all salts and most likely all the small organic 
compounds as well as the solubilisation buffer (ASW) eluted around this time point. The 
conductivity chromatogram for this run is not shown.
The samples from the same second dimension fractions from five consecutive runs were 
pooled and concentrated under vacuum. Peptide samples (fraction A06, A07, A08, A09, 
A10, A l l ,  A12 and B01) were desalted using a C18 peptide trap column. Further 
separation and analysis o f protein fractions in described in chapter 3.
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Figure  5.3.1 Size separa tion  o f C onus ven tricosus venom .
The figure shows the UV absorbance over time o f the size separation o f Conus ventricosus venom. The blue 
line is the absorbance at 214 run. Components were separated using an isocratic elution at 0.2 mL m in ' using 
150 mM NaCl in 20 mM Tris pH 7.2. Fractions were taken every 1.5 mL (magenta). Fraction A06 through 
A12 and B01 were further separated by reversed phase chromatography.
After desalting, the samples were concentrated to approximately 50 pi and injected onto 
semi preparative C l8 column. A detailed chromatogram of one of these fractions (fraction 
A09) can be seen in Figure 5.3.2. A number of parameters were recorded during the run. 
The absorbance was recorded with three wavelengths, of which two are displayed in the 
figure (214 nm light blue and 280 nm dark blue). The pressure (green line) over the column 
remains constant during the run, until the gradient (dashed magenta line) reaches the high 
percentage acetonitrile. The conductivity was decreasing slowly with lower percentage 
aqueous buffer. The fluctuation o f the absorbance indicated by the black arrow was 
apparatus specific. Also in the blank runs, which were run in between the analytical runs, 
this fluctuation was present. It is believed that this is due to less efficient mixing of the 
aqueous and organic buffer during the start o f the gradient. This can be seen also by the 
fluctuation of the absorbance during the start o f the gradient. When the gradient reached 
the critical part o f the separation, both absorbance and conductivity stabilised. It is not 
assumed that this influenced the separation quality.
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Figure 5.3.2 Reversed phase separation of A09 size fraction from Conus ventricosus.
The figure shows the second dimension separation o f size fraction A09 (see Figure 5.3.1). The elution profile 
was recorded at 214 nm  (blue) and 280 nm  (black). A four step gradient elution was used (dashed magenta 
line, right Y-axis) Fraction where taken every 600 pi as indicated by the black indentations on the time axis. 
Fraction Are named (A01 A12; B01 -> B12 .... F01 -> F12). The fluctuation seen in the chromatogram at
214 nm  (see arrow) is attributed to poor mixing of solvents in the beginning o f  the gradient. The pressure 
(green line) remains constant during this part o f the separation, but the conductivity also fluctuates (solid 
magenta line).
The chromatograms of fraction A10, A12 and B01 are shown in Figure 5.3.3. There was a 
clear difference in the abundance of peaks. Fractions were taken (shown in black numbers 
on the x-axis in both figures) at fixed intervals corresponding to 600 pL, into siliconised 
tubes.
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F igure 5.3.3 R eversed phase separa tion  o f A10, A12 and  B01 size fractions from  C onus ven tricosus.
The figure shows the second dimension separation o f size fraction A 10, A12 and B01 (clockwise starting 
from top left). See Figure 5.3.1 for the chromatogram of the size separation. The elution profile was 
recorded at 214 nm (blue). A four step gradient elution was used (dashed magenta line, right Y-axis) 
Fractions were taken every 600 pi as indicated by the black indentations on the time axis.
Fractions were labelled as described before. In a similar fashion to the separation of Conus 
textile a mass map was created. 1 pi of each fraction was added manually to 1 pi matrix 
(spotted automatically) on a stainless steel MALDI target. The matrix consisted of 14 
fmol -pi1 ACTH 18-39 in one part 70 % methanol and 1 part Agilent CHCA. Intensity was 
recorded again mass to charge ratio using the Applied Biosystems 4700 proteome explorer.
The mass to charge ratio with intensity is plotted for each second dimension fractions, 
grouped for each first dimension fraction. The so called mass maps are displayed in Figure 
5.3.4.
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Figure 53.4  Mass maps of the 2D-LC separation of Conus ventricosus.
This figure shows the mass maps of the 2D-LC separation of Conus ventricosus. Each individual panel 
shows the mass to charge ratio measured of each second dimension fraction of Conus ventricosus. 1346 
components were detected with S/N > 15 for m/z > 900. Intensity is displayed using the colour scheme 
shown in the bottom right hand panel of the figure. Matrix was spotted automatically using a Probot™ 
Micro Fraction Collector (LC Packings - Dionex). Matrix was made up from 1 part 70% methanol and 1 
part CHCA. ACTH was added to the matrix (14 fmol-pl'1) and used as an internal standard, during the 
automatic acquisition with the 4700 Proteomics Analyzer MALDI-TOF/TOF™. 1 pi analyte was added 
manually before allowing the mixture to air dry. Based on the results displayed in this figure, 96 fractions 
were taken for further analysis.
The peak lists that were recorded were first filtered before being plotted. An Excel macro 
was written which filtered the peak list for ions with m /z greater then 900 and signal to 
noise ratio over 15, identical to the mass maps shown for Conus textile (Figure 5.2.7). This 
resulted in the detection of 1346 ions, compared to the 1088 from Conus textile. This had no 
significant meaning as different amounts of venom were used. Also as can be seen in 
Figure 5.2.1 and Figure 5.3.1, the overall response (intensity) for the size exclusion 
chromatogram was higher for Conus ventricosus under identical conditions. However, the 
peptides from the venom of Conus ventricosus seem to cluster around fraction A09 and A10 
while the overall elution from Conus textile seems to be more equally spread.
Based on the number of ions that were detected per fraction, 96 were selected for further 
analysis. Each fraction was buffered to 50 mM ABC. To 40 pi sample, 2 pi 20 mM TCEP 
was added. The solution was covered with argon and the reduction took place at 70 °C for 
30 minutes. After a brief spin and cool down, 2 pi 200 mM LAM were added. The solution 
was left in the dark for one hour.
After reduction and alkylation, the solution was concentrated under vacuum to 
approximately 20 pi. The sample was cleaned up using ZipTips. This gave an end volume 
of 10 pi, which was analysed both by MALDI and ESI tandem MS.
Using scripts available in the Analyst analysis software, peak lists were generated. These 
peak lists were searched against NCBI using Mascot-Deamon. This is an automated search 
tool to query databases with the Mascot search engine. However no positive hits for this 
species was returned. To date 50 entries exists in the NCBI database for Conus ventricosus. 
Therefore all 96 LC-ESI-MS/MS runs were analysed manually. Figure 5.3.5 shows the ESI 
tandem mass spectrum from m /z 1156.922 [M+2H]2+ from fraction A09-B11. From the
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overlapping b-ion and y-ion series and internal fragment ions, 29 diagnostic ions were used 
to determine the sequence:
TVGDPERNYC PETCPTPCC m /z  2312.836 [MH]+
The predominant ion in the spectrum was the unfragmented doubly charged parent ion. 
Some of the doubly charged b ions were also detected, these are labelled in purple in the 
figure. This sequence was searched against NCBI, using MS-Homology 
(PropeinProspector). The results from these searches revealed that this sequence was 
unique up to the point o f 10 amino acid substitutions, which was over half o f the peptide. 
This sequence at present could not be classified into a known superfamily (Terlau, 
2004}(Cruz et al., 1985; Gray et al., 1988). The cysteine framework found for this sequence 
can be represented by -C-C-CC, putatively a new cysteine scaffold, or part o f a degraded 
larger conotoxin. No further conotoxin like sequences were found in fraction A09-B11. 
The presence o f arginine (R) in the sequence was a strong indication that the peptide was 
not subjected to the protease trypsin.
1158.822
2 0 0 0 -
TVG C*
1500-
</>
c3
8
.2 > 1000 -  
C/>
C
q 04
0)
c
5 0 0 -
co
ID
inn
200 400 600 800 1000 1200 1400 1600 1800
m/ z
110
5. Analysis of Conus venom by multi dimensional LC and mass spectrometry 
Figure 53.5 T andem  mass spectrum of m /z  1156.922 from fraction A09-B11 from Conus ventricosus.
This figure shows the annotated tandem mass spectrum o f the doubly charged parent ion m /z 1156.922. This 
peptide (TVGDPERNYCPETCPTPCC) is found in fraction A09-B11. The near complete y-ion and b-ion 
series are annotated blue (top), and red (bottom) respectively. The most intense peak is unfragmented parent 
ion (m /z 1156.922). Also some doubly charged fragment ions are used to assign this sequence. Two o f  these 
are high lighted in dashed purple (bis and bis).
As is well documented, fragmentation after collision induced dissociation benefits greatly 
from the very basic guanidine group of arginine in the peptide backbone (Burlet et al., 
1992; Csonka et al., 2004; Summerfield and Gaskell, 1997; Zhang, 2004). The tandem mass 
spectrum shown for fraction A09-B11 was a good example. Interpreting the fragmentation 
mass spectra o f remaining fractions was a challenge. Often, the quality of fragmentation 
data, combined with the lack o f an extensive Conus protein/peptide database gave only 
partial only sequence information. Figure 5.3.6 shows the tandem mass spectrum of m /z 
934.404 [M+2H]2+ from fraction A09-B06. The b-ion (red) and y-ion (blue) overlap at 
position b3 /  y14 .
SNVCA’aa’CYN GGQC’z i’ m /z 1867.800 [MH]+
Where ‘xx’ can be replaced by a number of dipeptide combinations, namely FH, QR or KR 
and ‘zz’ with dipeptide PP or GH. The combination ‘KR’ /  ‘PP’ results in the best mass 
accuracy fit (m/z 1867.8002) i.e. is the theoretical mass closest to the measured mass, but 
this remains far from ideal for a positive assignment of a novel sequence.
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Figure  5 3 .6  E SI tan d em  m ass spectrum  of m /z  934.404 from  fraction  A09-B06.
This figure shows the MS/MS spectrum o f peptide SNVCAxxCYNGGQCxx (parent ion 934.399 [M2H]2+). 
The y-ion series is displayed in blue. The b-ion series is displayed in red. The internal ion AKRCYNG -  N H 3 
is shown in purple. Multiple options are given when no positive assignment could be made.
The sequence SNVCAKRCYNGGQCPP was searched against NCBI using MS- 
Homology from ProteinProspector. For the query 8 amino acid substitutions were allowed. 
The ‘top’ hits are summarised in Table 5.3.1.
T ab le  53 .1  H om ology  search  results.
This table shows the top hit results o f a homology search (MS-Homlogy from ProteinProspector) using the 
sequence SNVCA’xx’C Y N G G Q C ’zz’. This peptide was searched against the NCBI database allowing for 8  
substitutions.
Matching Sequence Species Protein Name
(K)IPLCAKSCVDDGQCPD(T) Cyprinus Carpio ovarian fibroin-like substance-2
(E et
al.)TM VCNRHCENGGQCLT(E 
et al.)
Homo Sapiens unnamed protein product
(E et
al.) VN HCSNY CQN G G T CIP(S)
Mus Musculus unnamed protein product
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For 16 amino acids there are over 1 x 1024 possible sequence, taking only the 20 common 
amino acids into account. It is therefore not surprising that the partial sequence found is 
unique. In total 8 amino acids (50 %) were replaced for the ‘top’ hit in the homology search.
A representative example of fragmentation data of a potentially interesting spectrum is 
given in Figure 5.3.7. The tandem mass spectrum is from fraction A09-C11 m /z 726.315 
[M+2H]2+. However the amount of information that could be derived from the spectrum is 
minimal. The double cysteine C-terminus is a common feature in conopeptides. The 
presence of several possible cysteines reinforces the possibility of a conotoxin. But except 
for the two y-ions (blue), it was impossible to derive accurate information about the 
primary sequence o f this peptide.
The two cysteines labelled in purple appeared to be b-ions as all ions had a -28 satellite 
peak (a-ions), but also internal fragment ions were a possibility. Often seen in this data set, 
cysteines alkylated by iodoacetamide give predominant internal fragment ions and the 
intensity o f the immonium ion o f alkylated cysteine was an indicator (not qualitative) of the 
number o f cysteines present.
The ions labelled in black were not complementary ions of both the y-ions, b-ions or the 
expected internal fragment ions. The sum of the masses of the y-ion and its complementary 
b ion, with the same charge, equals that of the mass of the parent ion plus one proton. This 
is represented by the following equation:
y + b = p + H +
y = y-ion [MH]+ b = b-ion (MH]+ p = parent ion [MH]+
The survey scan revealed that a single ion was detected around the parent ion (m/z 726.3) 
(data not shown), minimising the possibility of a mixture of two peptide fragmentations 
spectra.
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F igure  5.3.7 E SI tan d em  m ass spectrum  of m /z  726.315 from  fraction  A09-C11 from  C onus 
ven tricosus.
This figure is a representative example of a mass spectrum encountered during this analysis. The double 
cysteine in blue are y-ions. The double cysteine in purple appear to be b-ions as well as they all have -28 
satellite peaks (indicated by red @ ) indicating loss of CO, indicative of b-ions. Labels in green are 
immonium ions.
As mentioned, the success rate of assigning unambiguous sequence was very low. The 
comprehensive analysis4 of all 96 fractions is summarised in Table 5.3.2. for fractions 
which contained sequencable data, the precursor mass of the peptide in question is given. 
From the charge state the monoisotopic mass was calculated and where possible, a 
theoretical mass was generated using MS-Product (ProteinProspector). Complete and 
incomplete sequences are given, some of which contain gaps. In the last column the 
number o f ions used to assign a specific sequence is given. Fractions which contained 
peptides with evidence of multiple cysteines, highlighted in grey, were selected for trypsin 
digestion. The results are shown in the next paragraph.
4 Due to the overwhelming am ount o f  data, some o f de novo sequencing was performed by Dr. Craig 
Bnnkworth (Mass Spectrometry Facility UCSF, California, USA)
114
5. Analysis of Conus venom by multi dimensional LC and mass spectrometry
T a b le  5 3 .2  C on us ven trico su s  sequence  results o f u n d ig es ted  2D LC  fractions.
This table show the summary o f results of the manual de novo analysis o f 96 2D-LC fractions from 
Conus ventricosus. Only fraction Are show which had sequencable data. Fractions with evidence of 
containing multiple cysteines, highlighted in grey where taken for further analysis. The second column 
shows the measured precursor ion (m/z). The calculated monoisotopic ([MH]+) mass from the parent ion 
is given in the third column. Where possible the theoretical monoisotopic mass was calculated, displayed 
in the fourth colmn. The last column shows the number o f ions used to assign a specific sequence. Some 
spectra also contain an ion at m/z 133.0, indicative o f a carbamidomethylated cysteine.’NH2’ is used to 
show possible amidation of C terminus.
Fraction Precursor(m /z)
Cal­
culated
(MH]+
Theo­
retical
[MH]+
Assigned sequence
number 
o f  ions 
used
A07-B09 776.95 2328.83 2328.97 (PQ V FN H V G EPC Y yG I/L TPC C 15
A07-B12 413.20 825.39 825.34 (GE)P(NSS)VH-NH2 6
A07-C01 398.24 795.39 795.47 I/L I/L A P P (Y oon  et al)P(Y oon et al.)R 7
A07-C01 702.67 2105.99 E E q q /K D V E
A07-C01 974.10 2920.28 GLD D???K IV ICCEG IV CTG LG R 26
A07-C06 826.73 2478.17 2478.13 G TEA A V PG D (M T)D TV EEQ K D V ETR 22
A07-C07 429.75 858.49 858.46 (G A )I/L E Q V I/L E 9
A07-C07 567.28 1133.55 1133.45 (GA)PCSSNCN (PA)-NH2 11
A07-C10 421.76 842.51 842.50 (G I/L)TV SI/LV (G P)
A07-C10 437.75 874.49 (G P)PP(146)PKH -N H2 8
A07-C10 481.27 961.53 (GP)PSP(146)PKH-NH2 8
A07-D02 648.71 1296.41 1296.47 G LCO W KPBC-NH 2 7
A07-D02 700.87 1400.73 Q PA PPI/LSV SA P
A07-D02 911.42 1821.83 EVA AIVD NG S 17
A07-D02 765.72 2295.14 2295.09 EED (130.04)N ELEEV K LESY PTIK 21
A07-D10 421.75 842.06 842.49 (G I/L )T W T V P G 11
A07-D10 737.95 1474.90 T P I/L V G Q P I/L S T P 13
A07-D11 421.76 842.06 842.49 (G I/L )T W T V P G 13
A07-D11 929.80 2787.38 2787.39 (F D )G SD IITID IPD ID PE N E IIV ST R 35
A07-D12 719.70 2157.08 2157.02 A I/L (371.11)TTV A FG I/LTSED W FK 18
A07-E01 1068.89 2136.77 (I/LC)CP????(I/LQ CV(PS)
A09-B04 752.34 1503.67 D A G D (K G )A K PR
A09-B06 549.78 1098.55 (GL)C?C?........G D T
A09-B06 650.31 1299.61 1299.65 I/LD (T A )Q R A D R I/L(EA ) 15
A09-B06 934.39 1867.77 1867.80 SN VCAK RCY NG G QCPP 18
A09-B08 345.16 689.31 689.33 (D Q I/L P G K 5
A09-B08 413.22 825.43 825.37 W T SSSM D 11
A09-B08 519.23 1037.45 1037.45 SSKN E FD pE T -N  H2 9
A09-B08 599.77 1198.53 1198.56 DS YV G D E A K SK 12
A09-B08 642.30 1283.59 1283.62 (PM )or(NN)or(DL)TAQPW RPEA 12
A09-B08 653.33 1305.65 1305.69 (D P )I/L I/L E (84)IH E K
A09-B08 691.78 1382.55 (CA)IIICK 5
A09-B11 357.21 713.41 713.36 WVPSAPG 5
A09-B11 413.74 826.46 826.46 (E V )PIPSG K /Q 7
A09-B11 486.74 972.46 D PE(G T )N K V L  or PEK Q M K K V L 10
A09-B11 508.26 1015.51 1015.54 K P E D A N I/L T K 8
A09-B11 515.28 1029.56 1029.56 A PA V N TTEV K 23
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A09-B11 606.29 1211.57 1211.58 PD EPPIN ETV T 12
A09-B11 680.82 1360.62 1360.62 A H (G T)EN ED G K FR 20
A09-B11 790.34 1579.66 1579.63 (M YN)PSAENEDGPQQ 16
A09-B11 1156.90 2312.83 2312.90 TVGDPERNYCPETCPTPCC 35
A09-C01 398.24 795.47 795.47 IIAPPER /  IIN M ... 10
A09-C01 417.72 834.43 834.48 (VP)ADII(HA)-NH2 9
A09-C01 427.78 854.55 KPKAPAAAGP?
A09-C01 503.25 1005.49 1005.49 SSVDEAIER 12
A09-C01 547.25 1093.49 1093.49 PSAEN E D G FK 18
A09-C01 611.28 1221.55 K G D E N T
A09-C01 627.84 1254.67 TTANIApEAI
A09-C02 462.29 923.57 Q /K I/L I/L A
A09-C02 489.20 977.39 (DP)D??PDL
A09-C02 625.82 1250.63 1250.62 ISWPVDYTNR 9
A09-C06 509.71 1018.41 TPE(NG)A???L
A09-C06 515.77 1030.53 1030.52 ADGDVEGVLR 12
A09-C06 518.80 1036.59 1036.58 V ETGEPAPPR 13
A09-C06 545.24 1089.47 (PD)G(179.1)AGPFHL 11
A09-C06 582.30 1163.59 1163.60 (Q I)IIA ED M (0)SK 10
A09-C06 594.31 1187.61 1187.60 EESAIQNAVAR 15
A09-C06 661.86 1322.71 V EV SAAI/LGTI/LPPR 12
A09-C06 442.59 1325.75 (D N )I/L Q /K G I/L T K ??S-N H 2 10
A09-C06 666.37 1331.73 1331.72 TTIEEEK IN V R 16
A09-C06 689.33 1377.65 1377.68 RDFEK IDD SPR 21
A09-C06 691.82 1382.63 1382.62 E D SG I/L I/L E Y D W R 14
A09-C06 722.37 1443.73 M Q I/LEN I/LQ APPR 10
A09-C06 482.60 1445.78 1445.72 (S I/L )Q T D A G E D E /L I/L Q R 18
A09-C06 741.84 1482.67 1482.72 N FQ PSA Q V EQ A Q TQ 17
A09-C09 434.77 868.53 868.53 A P V ID W R 15
A09-C09 440.76 880.51 880.52 TPIPD IPK 15
A09-C09 466.25 931.49 931.51 ATAAAEITAL 12
A09-C09 491.82 982.63 982.60 APVIDRAIK 14
A09-C09 624.34 1247.67 1247.66 (QV)APVYSEVAGK 17
A09-C09 635.30 1269.59 D Y G SD V SW R
A09-C09 636.33 1271.65 1271.65 (ID )E P T W D E V R 11
A09-C09 661.34 1321.67 1321.64 SFDSVNPDALTR 20
A09-C09 668.81 1336.61 FPFSDISA(139)PES 9
A09-C09 710.90 1420.79 IP A V W D T G T 14
A09-C09 735.35 1469.69 ESYTT 5
A09-C09 782.33 1563.65 N D FSG D FEEA A 10
A09-C11 513.80 1026.59 (I/LW ) or (Q )V I/LSD 10
A09-C11 563.30 1125.59 E ^ T I/L R R 9
A09-C11 717.80 1434.59 CPPPCC 5
A09-C11 726.30 1451.59 I/LPPCPCPCC 14
A09-C11 739.40 1477.59 NFES 6
A09-C11 760.80 1520.59 NFPPI/LGNFES 16
A09-C11 774.40 1547.79 YAAEEFDGSF 15
A09-D01 818.40 1635.90 I /L N E I/L I /L E N 19
A09-D02 552.30 1103.59 PV I/LM 8
A09-D02 886.40 1771.79 (NH2-GN)QS(ETS) ????? D S I/L G 12
A09-D02 530.80 2120.08 SSSGSAV 11
A09-D03 439.22 877.43 877.43 E V T I/L D I/L (M G ) 8
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A09-D03 443.75 886.49 886.50 I/L E N V I/L I/L W 7
A09-D03 452.26 903.51 I/LEN V I/LPW 9
A09-D03 454.74 908.47 I/L E A  VN
A09-D03 472.26 943.51 943.53 (EG)IVNLLW  or (AD)IVNLLW 8
A09-D03 478.31 955.61 955.56 GSPEIAIIR contains 133 peak 9
A09-D03 559.34 1117.67 (T V )G S I/L (130)I/L S I/L W
A09-D03 756.39 1511.77 1511.75 G Y A T G Q FW D E V A R 20
A09-D03 805.40 1609.80 1609.79 LGLD PIEEG V N Y G PLH 17
A09-D03 886.39 1771.77 1771.79 (H A)AG I/LSD G SD FPSK D D G P-N H 2 31
A09-D05 501.80 1002.59 PPVI/LVRA-NH2 8
A09-D05 513.30 1025.59 N H 2-(G I/L )G I/L S V T G I/L G G 16
A09-D05 518.80 1036.59 G I/LPA (N N ) 11
A09-D05 640.80 1280.59 I/L E D Q 7
A09-D05 686.40 1371.79 SD I/L V G N 17
A09-D05 694.30 1387.59 FS??(F)PFSGD 14
A09-D06 646.40 1291.79 NH2-A G  VPPAEVWN (N) 13
A09-D07 614.30 1227.71 NH2-W PRDW 5
A09-D07 717.80 1434.49 ECC 4
A09-D07 496.50 1487.45 YGPC 4
A09-D07 774.40 1547.80 YAAEEFDGSF 13
A09-D09 722.90 1444.79 STY G I/LA N I/LSA 15
A09-D09 771.90 1542.81 I/LI/LVKPPYN 7
A09-D10 696.40 1391.79 ??W F T F-oh 6
A09-D10 819.90 1638.79 P I/U /V A V E ? 9
A09-D12 444.60 1332.79 PPI/LQEEE? 9
A09-D12 492.00 1474.99 ??(MN)I/L??SE
A09-E01 453.20 905.39 G FA G D D A PR 9
A09-E01 771.60 2312.78 TPCC 4
A09-E01 1156.90 2312.78 TEPPNRPPT (PCC) 10
A09-E01 777.30 2329.88 TPCC 4
A09-E01 789.20 2365.58 TPCC 4
A09-E01 592.20 2365.78 TPCC 4
A09-E01 866.70 2597.80 PCC 3
A10-B09 347.15 693.29 693.36 AAA GEFK 12
A10-B09 357.18 713.35 713.35 ADVPSGAP 10
A10-B09 359.18 717.35 717.34 I/LA SEG G SP 13
A10-B09 362.13 723.25 723.29 DCCIR 9
A10-B09 362.21 723.41 723.45 P P P W R 13
A10-B09 364.66 728.31 728.33 Y FGV QD 12
A10-B09 420.20 839.39 839.45 I/LV TSY EK 13
A10-B09 462.70 924.39 VSYAAEPST
A10-B09 469.17 937.33 937.39 P F N D E (C 02)G SK 16
A10-B09 470.69 940.37 940.43 Y G D EE ISK 15
A10-B09 340.16 1018.46 1068.52 V G SD I /  LSTSPR 20
A10-B09 525.72 1050.43 1050.49 DAPVDYTNR 15
A10-B10 771.60 2312.78 TPCC 4
A10-C01 699.00 2094.87 many Cysteines multiply charged
A10-C02 447.70 894.39 R PI/L N V 11
A10-C04 787.90 2361.68 TPCC 4
A10-C12 534.80 1068.59 V Q D FI/LD fl851 8
A10-C12 504.20 1510.58 I/LST F 4
A10-C12 822.28 2464.85 CC 3
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A10-D01 550.20 1099.45 G D S I/L G N E T
A10-D03 530.80 1060.59 E T I/L W 7
A10-D03 576.80 1152.59 I/L D A T 5
A11-C02 827.90 2481.68 (E et al.)Y?????SSCCY 11
A11-D01 822.60 2465.78 CSYESCCY ??? YPYA 17
A11-D01 1241.40 2481.79 CSY 4
5.3.2 Protease treatment of reduced and alkylated 2D-LC fractions of Conus 
ventricosus.
Peptide tandem mass spectra generated from low energy CID processes are often used for 
protein and peptide identification and characterisation (Medzihradszky et al., 2001; 
Wysocki et al., 2000). In a proteomic study, proteins are often digested with an enzyme to 
generate mass spectrometry amenable peptides. Trypsin is a highly specific serine protease 
which cleaves the amide bond on the C-terminus side o f arginine (R) and lysine (K), except 
when followed by proline. The added advantage from the point of view of mass 
spectrometry is that tryptic fragments contain a basic amino acid at their C-terminus (R or 
K).
The fractions highlighted in grey in Table 5.3.2 were reduced, alkylated and digested with 
trypsin as described before. Briefly, a 250 pi fraction was concentrated to 100 pi, reduced 
with TCEP and alkylated with LAM. To approximately 70 pi, 20 ng o f trypsin was added.
MALDI-TOF-MS spectra were recorded for (i) native (ii) reduced /  alkylated (iii) and 
trypsin digested fractions, as shown in Figure 5.3.8. The native peptide (m /z 2116.6487 
[M+H]4) was alkylated six times by iodoacetamide. The mass increase by alkylation was 
348.1562 Da, which indicated three disulfide bonds. When analysing the reduced /  
alkylated peptide, insource prompt fragmentation occurred. This is indicated by the red 
arrow in the figure and will be discussed in paragraph 5.3.3.
The peptide was hydrolysed by trypsin (bottom panel). The two proteolytic products were 
m /z  1014.3254 and m /z  1469.5177. The digestion reaction was incubated at 37°C for 
approximately 4 hours, however not all o f the starting product was digested. Here also 
prom pt fragmentation from the starting product was detected. All other labelled peaks 
were the result o f  deficient alkylation and the subsequent digestion of partially alkylated 
products.
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Figure  5.3.8 T O F-M S spectra  o f fraction  A11-D01 from  C onus ven tricosus
This figure shows the MALDI-TOF-MS spectra o f  fraction A11-D01 from the 2D-LC separated Conus 
ventricosus venom. The top panel is the mass spectrum o f the untreated fraction. The middle panel is the mass 
spectrum o f  the same fraction, but reduced (TCEP) and alkylated (IAM). The bottom  panel shows the mass 
spectrum after trypsin digestion o f the reduced and alkylated fraction. A theoretical digest shows that m /z  
1014.3254 and m /z  1469.5177 result from a single cleavage by trypsin from 2464.8113. The ion indicated by 
the red arrow is the result o f insource prom pt fragmentation o f the parent ion between aspartic acid and 
proline. See Figure 5.3.16 and Figure 5.3.17 for the zoom  MS spectra and the M /M S spectra respectively.
Tandem mass spectra were recorded for the fully alkylated peptide, and for both the 
proteolytic products. This was done by LC-ESI-MS/MS and MALDI-TOF/TOF tandem 
MS. The next two figures (Figure 5.3.9 and Figure 5.3.10) show the MALDI tandem mass 
spectra from m /z  1469.6089 and m /z  1014.3666 (both singly charged) respectively. In the 
first spectrum an unambiguous sequence was assigned, namely
qCCDPCAYPCR m /z  1469.5070 [MH] +
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F igu re  5.3.9 M A L D I-T O F /T O F  tandem  m ass spec trum  o f m /z  1469.6089 from  fraction A11-D01
This figure shows the MS/MS spectrum o f  m /z  1469.6089 [MH]+. Fraction A11-D01 from Conus ventricosus 
were reduced and alkylated before being digested with trypsin. The sequence assigned from this spectrum is 
qCCDPCAYPCR where q is pyroglutamic acid. The y-ion series is displayed in blue, the b-ion series in red. 
Loss o f N H 3 from y-ions is indicated with a red hash (#). The carbamidomethylated cysteine immonium ion 
is shown in green. Internal fragment ions are displayed in purple.
Where ‘q’ is pyroglutamic acid (pyroGlu), the b, ion is detected at m /z  112.0887. PyroGlu 
is a natural amino acid and is, for instance, an important neurotransmitter in the vertebrate 
central nervous system. But PyroGlu acid can also be introduced by the experimental 
circumstances of the digestion, where the N-terminal Glu can cyclise to pyroGlu, resulting 
in the net loss o f H20 .  However, this is not the case for this peptide, as the mass 
determined for the native peptide includes the pyroGlu modification. The major fragment 
ion resulted from the cleavage of the peptide backbone in between aspartic acid and 
proline. The charge was retained at the C-terminal side (y7-ion). The fragmentation at this 
site is also the source of the prompt fragmentation seen in the MALDI-TOF-MS scans in 
Figure 5.3.8. Furthermore, some proline initiated internal fragments were detected, 
confirming parts o f the sequence.
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The M ALDI-TOF/TOF fragmentation spectrum of the remaining protease product (m/z 
1014.3668) in shown in Figure 5.3.10. Also from this spectrum the primary sequence could 
be fully determined, namely:
FDYSCCS m /z  1014.3337 [MH] +
J2c3oo
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Figure  5.3.10 M A L D I-T O F /T O F  tandem  m ass spec trum  o f m /z  1014.3668
This figure displays the M S/M S spectrum o f m /z  1014.3666 [MH]+. Fraction A11-D01 from Conus ventricosus 
were reduced and alkylated before being digested with trypsin. The sequence assigned from this spectrum is 
FDYSCCS. The y-ion series is displayed in blue, the b-ion series in red.
These two sequences were verified by the analysis of the trypsin treated fraction by LC- 
ESI-MS/MS. The MS/MS spectrum of intact alkylated peptide is shown in Figure 5.3.11. 
The parent ion (m /z 1232.906) was doubly charged. With the knowledge of the previously 
determined sequences, many of the peaks can be assigned in this spectrum. As often, large 
peptides hardly ever lead to full assignment o f the primary structure.
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Figure 53.11 ESI-CID tandem mass spectrum of m /z  1232.906 from fraction A11-D01
This figure shows the M S/M S spectrum o f  m /z  2464.8042 [MH]+. Fraction A11-D01 from Conus ventricosus 
were reduced and alkylated and subjected to LC-MSMS. The carbamidomethylated cysteine immonium ion is 
shown in green. Internal fragment ions are displayed in purple (numerals). The doubly charged ion is y u .
In Figure 5.3.12 the ESI-MS/MS spectrum of the largest o f the two proteolytic fragments 
(m /z 1469.5892 [M+H]+) is displayed. This spectrum confirms the sequence already 
determined in Figure 5.3.9. The additional information that was retrieved from this 
spectrum was the confirmation o f the amino acid sequence CDPC. In the MALDI 
fragment spectra the b5-ion was not detected, unlike in the ESI fragment spectrum.
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F igu re  5.3.12 E S I-C ID  spec trum  o f m /z  735.7540 from  A ll-D l
This figure shows the tandem mass spectrum o f m /z  1469.5892 [MH]+ from fraction A11-D01 from Conus 
ventricosus venom. The sample was reduced and alkylated before being treated with trypsin. The assigned 
sequence is qCCDPCAYCPR where q is pyroglutamic acid. The y-ion series is shown in blue (top) and the b- 
ion series in red (bottom). Internal fragment ions are displayed in purple and immonium ions in green. Losses 
o f  N H 3 from  y-ions are indicated with a red hash (#).
The opposite can be said about the next spectrum. In Figure 5.3.13, as in the previous 
spectrum, the sequence from the MALDI fragment spectrum was confirmed. But in this 
case, the assignment o f FD would have been impossible without the MALDI tandem mass 
spectrum. Here the b,-ion was not detected. The added advantage of ESI spectra is, that 
quite often, at least in the experience of the author, the immonium ions are an indication 
on the quantity o f their accompanying amino acid. The predominant 136 and 133 
immonium ions of tyrosine and carbamidomethylated cysteine respectively are good 
indicators when de novo sequencing an unknown peptide.
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Figure 5.3.13 ESI-CID tandem mass spectrum of m /z  1014.373 of fraction A ll-D l.
This figure shows the tandem mass spectrum o f m /z  1014.373 [MH]+ from fraction A11-D01 from Conus 
ventncosus venom. The sample was reduced and alkylated before being treated with trypsin. The assigned 
sequence is [FD]YSCCY. The y-ion series is shown in blue (top) and the b-ion series in red (bottom). Internal 
fragment ions are displayed in purple and immonium ions in green. Losses o f  H 2O from b-ions are indicated 
with a red hash (#).
The last five tandem mass spectra can be summarised by the next sequence, which prior to 
this writing has not been reported:
qCCDPCAYPCRFDYSCCY m /z  2464.8224 [M H ]+ (7 ppm)
This sequence is found in the NCBI database only when allowing for 8 substitution in an 
homology search (MS-Homology, ProteinProspector). A few examples are given in Table 
5.3.3
Table 5.3.3 M S-Homology search results from Conus ventrscosus fraction A11-D01
Matching Sequence Species Protein Name
(I) VRCDHCAFPLRFDNACQY (H) Drosophila
pseaudoobscure 
(I) VKCEHCSFPLRFDTSCQY (H) Drosphila
melanogaster
GA22022-PA
RE38137p
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(S)SCCQPCCRPSCCQSSCCK(E et Mus musculus unnamed protein product 
al.) . ' V.
Other good quality fragmentation spectra were obtained, however no complete new 
putative conotoxins could be identified. An example o f this is in fraction A09-C11. The de 
novo sequencing generated the two sequences:
CI/LASGETCDAR m /z 1239.5102 [MH]+ (0.3 ppm)
I/LTCCDI/LPSQTDDC-NH2 m /z 1583.6642 [MH]+ (32 ppm)
The respective tandem mass spectra are shown in Figure 5.3.14 and Figure 5.3.15. 
However the masses could not be correlated to the MS-survey scan (data not shown). 
Unfortunately there was no data in the MS survey spectra o f the alkylated fraction. It is 
believed that this particular fraction was misplaced on the sample target. One major peak 
was detected in the MS-survey scan o f the native fraction. When these two sequences are 
combined and the masses are corrected for the amount o f alkylation and the net gain o f  
H 20  after the trypsin digestion, these cannot possibly be part o f the same peptide.
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F igu re  5.3.14 T a n d e m  m ass sp ec tru m  o f m /z  620.259 o f fraction  A09-C11 from  C onus ventricosus.
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This figure shows the MS/MS spectrum o f m /z  1239.5102 [MH]+. C I/LA SGETCD A R is assigned as the 
correct sequence. The y-ion series is displayed in blue, the b-ion series in red. Immonium ions and y-N fb  
ions are displayed in green.
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Figure 53.15 Tandem  mass spectrum of parent ion m /z  792.336 from fraction A9-C11.
This figure shows the M S/M S spectrum o f  m /z  1583.6642 [MH]+ The sequence that can be derived from 
this spectrum  is I/L T C C D I/L PSQ T D D C -N H 2. The y-ion series is displayed in blue (bottom) and the b-ion 
series in red (top). The immonium ion o f carbamidomethylated cysteine (m /z 133.055) is shown in green, as 
is the doubly charged yn ion. There are a number o f internal fragments present in the spectrum, shown in 
purple.
All LC-MS/MS data acquired from trypsin digested fractions from both Conus textile and 
Conus ventricosus were searched against NCBI using Mascot search engine. Data was 
imported in a test version of Mascot Integra (a laboratory information management system, 
LIMS). All significant protein hits, with a Mascot proteins score higher than 50 and at least 
one significant peptide were retrieved from the LIMS. The full list of proteins identified are 
listed in appendix 4.
5.3.3 Tandem  m ass spectrometric analysis o f prompt fragmentation ions.
An interesting observation was made whilst analysing the M ALDI-TOF/TOF spectra. As 
mentioned before, the MALDI desorption/ionization process of the alkylated peptide
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from fraction A ll-D O l created prompt fragmentation. This form of in-source 
fragmentation occurs in the ionization chamber simultaneously with or immediately after 
ionization. The prompt fragment was selected for MS/MS by the automatic acquisition 
software. In Figure 5.3.16 a zoom-in of the MS scan o f the alkylated peptide is shown. 
Besides the very well resolved prompt fragment (m/z 1918.6737) some metastable decay 
was detected.
Metastable decay is a process long associated with mass spectrometry as one of the first 
reports is from 1945 (Hippie et al., 1945). The actual process of metastable decay was 
detected as early as 1902 (Wien, 1902) although it was at that time not attributed to 
metastable decay.
Prompt fragmentation is not uncommon, it has for instance been used to demonstrate that 
singly disulfide linked peptide can be specifically fragmented at the S-S bond, by increasing 
the laser fluence in MALDI-MS (Patterson and Katta, 1994). Talbo and co-workers used 
prompt fragmentation to remove sialic acids at high laser irradiance in positive-ion mode to 
elucidate carbohydrates and oligonucleotides by MALDI post-source decay (PSD) MS 
(Talbo and Mann, 1996).
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F igu re  53 .16  P ro m p t frag m en ta tio n  o f pep tides betw een  A spartic  acid  and  Proline.
This figure shows a zoom-in o f  the MS survey scan from the alkylated peptide from fraction A ll-D O l. Two 
o f  the in source fragmentation processes are visible, besides well resolved prom pt fragmentation, metastable 
decay was detected. The prom pt fragmentation occurred between the aspartic acid (D) and proline (E et al.).
The tandem mass spectrum is shown in Figure 5.3.17. Although the intensity of most of 
the fragments was low, 5 b-ions and 1 y-ion could be assigned as well as an internal 
fragment ion. Even though it is unlikely that an entire primary sequence can be determined, 
the information was used to confirm sequences determined from fragmentation of ordinary 
parent ions. The fragmentation of this prompt fragment also follows the pattern of 
preferable cleavage o f aspartic acid on the C-terminal side of the amino acid. In Figure 
5.3.18 the fragments that were detected are represented in a schematic.
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F igu re  5.3.17 M A L D I-T O F /T O F  tan d em  m ass spec trum  o f p ro m p t fragm en ta tion  ions.
The tandem  mass spectrum  o f  the prom pt fragment PCAYCPRFDYSCCY is shown in this figure. The 
prom pt fragment was created after the laser desorption/ionization process o f the alkylated peptide 
qCCDPCAYPCRFDYSCCY.
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F igu re  5.3.18 F ra g m e n ta tio n  sch em e  o f m /z  1918.6061.
The detected ions in Figure 5.3.17 are represented in this figure by a fragmentation scheme. The b-ions are 
labelled in red, the y-ion in blue. The part o f  the peptide backbone that was detected as internal fragment is 
displayed in purple.
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6 Analysis o f Conus ventricosus venom: Identification of 
contryphans.
Contryphans are single disulfide linked members of the conotoxin family (Terlau and 
Olivera, 2004) and were first discovered in the venom of the piscivorous snail Conus radiatus 
(Jimenez et al., 1996). Contryphans are highly post-translationally modified small peptides. 
Typically only 8 to 12 amino acids long, these peptides incorporate modifications like 4- 
trans-hydroxy-proline (Stone and Gray, 1982), leucine (Jacobsen et al., 1999) and 
Tryptophan (Jacobsen et al., 1998; Jimenez et al., 1996) isomerisation, C-terminus 
amidation (Nakamura et al., 1996) and bromination of tryptophan (Craig et al., 1997; 
Jimenez et al., 1997). The post-translational modification of L- to D-amino acid is catalyzed 
by an enzyme and has been found in several biological systems (Kreil).
In this chapter, data is presented of the data analysis of pre-fractionated Conus ventricosus 
venom. The data presented resulted in the identification of several contryphans with 
numerous modifications. The venom fractionation was carried out at the University of 
California San Francisco, Mass Spectrometry facility (Prof. Dr. Alma L. Burlingame) by Dr. 
Kirk C. Hansen.
6.1 Venom  preparation and separation
Conus ventricosus venom was solubilised in ddHaO and injected onto a semi-preparative C l8 
column (Vydac). Venom components were separated using iso-propanol (2-propanol) as 
the organic phase. Figure 6.1.1 shows a scan of the paper trace from the absorbance 
chromatogram (214 nm). Fractions were collected as indicated by the red numbers and 
were reduced (TCEP) and alkylated (LAM). Fractions were concentrated under vacuum, in 
order to remove organic and acid content and to concentrate the sample.
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The resulting samples were re-injected onto a capillary C l8 column as in previous chapters. 
In order to create a semi orthogonal separation, acetonitrile (instead of iso-propanol in the 
first dimension) was used as the organic phase in this second dimension.
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Figure 6.1.1 Reversed phase chromatogram of Conus ventricosus venom.
This figure shows the UV absorbance (214 nm) o f  the separation o f  Conus ventricosus venom. Venom was 
solubilised in ddl-bO  and separated on a semi-preparative C18 reversed phase column, using iso-propanol as 
the organic phase. Fractions were taken as indicated in red. A number o f these fractions were further analysed 
by LC-ESI-M S/M S with ACN  as the organic phase.
6.2 2D  L C  analysis o f  Conus ventricosus venom.
Figure 6.2.1 shows the ESI MS-survey scan of two co-eluting peptides. As the isotope 
distribution is clearly remarkable, the third and following isotopes are clearly out of 
proportion when compared to a standard “averagine” peptide. Averagine is used to 
calculate isotope ratios, using an average amino acid (Johnson and Muddiman, 2004). Such 
isotope distributions were seen in case of partially reduced peptides, where for each 
disulfide formed or broken a 2.0156 Dalton differential peptide is formed. However, when 
analysing the tandem mass spectra, a complete different picture unfolded.
131
6. Analysis of Conus ventricosus venom: Identification of contryphans.
120
649.7045
100 -
648.70468 0 -
tn
c
o
O 6 0 -
&
C/>
^  4 0 -
640.7107 641.7161
   ^ uI H iL l^
2 0 -
635 640 645 650 660 665655
m  /  Z
F igu re  6.2.1 Z o o m -in  o f  ESI M S survey scan, d e tec ting  iso tope  pa tte rn s  o f brom ine.
In this figure, a zoom -in o f  a MS survey scan can be seen o f  the second dimension run from Conus ventricosus 
venom. The peak envelopes o f  two peptides are present. The more abundant third isotope from each peak is 
caused by selective brom ination o f  tryptophan.
The tandem mass spectrum from the more intense ion (m /z 648.7046) from Figure 6.2.1 is 
shown is Figure 6.2.2. The rather exotic sequence determined by tandem MS from this 
fragment spectrum is:
G(I/L)COWKPWBrC-NH2 m /z  1296.4014 [MH]+ (49 ppm)
Where “O ” is hydroxy-proline and “WBr” is bromo-tryptophan. Cysteines (E et al.) are 
modified by acetamide. The C-terminus is amidated (NH^. The measured parent mass is 
within 50 ppm  o f the theoretical mass.
Hydroxy-proline (QHyNO-j) is a rare post-translational modification. Because its mass is 
near to that o f (iso)leucine (C6H nNO) with a difference o f 0.03636 Da, it is easily mistaken 
during de novo sequencing for the latter. However, hydroxy-proline behaves in a similar
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way as proline regarding its fragmentation characteristics. Both give rise to prominent 
internal fragments (the backbone is cleaved in two places and the internal fragment retain 
the charge). These internal fragments are indicated in purple in Figure 6.2.2. Three internal 
fragments, which included hydroxy-proline were detected, namely (decreasing mass) OWK, 
OW and OW-28. The loss o f the ketone group (C=0) from the peptide backbone results 
in a mass ‘loss’ o f 28 Da. The other proline present in the peptide gave rise to two 
(detectable) internal fragments, PWBr and PW^C. Another post-translational modification, 
besides the disulfide bond, is the amidation of the C-terminal hydroxyl group. As said 
before, this is common for conotoxins.
As could be seen in the MS-survey scan and confirmed by the fragmentation data, this 
peptide contained one brominated tryptophan. This PTM has been reported before in 
Conus venom peptides (Craig et al., 1997; Jimenez et al., 1997; Steen and Mann, 2002). The 
elemental composition o f bromo-tryptophan is CnH9N 2OBr and it has a mono-isotopic 
mass o f 263.9898 Da. Remarkably only one of the tryptophans has this PTM. No evidence 
was found o f bromination on either the other or both o f the tryptophans, ruling out 
experimentally introduced modifications.
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Figure 6.2.2 Tandem mass spectrum of bromo-contryphan m /z  648.7046
This figure shows the M S/M S mass spectrum o f m /z  1296.4014 [MH]+. The y-ions series is shown in blue, 
while the b-ion series is shown in red. Internal fragment ions are displayed in purple. For y ions 2,3 and 4 also 
the third isotope mass is labelled. The distorted isotope pattern is caused by the incorporation o f bromine on 
Tryptophan.
The unusual isotope distribution was also detected in the tandem mass spectrum of the 
fragments containing the modified tryptophan (y2, y} and y4). A zoom in of the raw 
spectrum for the y3 fragment ion (m /z 539.126) is shown in Figure 6.2.3. the intense third 
isotope (m /z 541.1314) is clearly visible.
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Figure 6.2.3 Zoom-in o f tandem mass spectrum, y3-ion.
This figure shows a zoom  in o f the tandem mass spectrum from Figure 6.2.2. The y3 -  fragment ion contains 
brom ine which is responsible for the unusual isotope distribution.
The theoretical isotope distribution of the y3 fragment ion was calculated with MS-Isotope, 
the software package o f ProteinProstector (Clauser et al., 1999).The calculated masses of 
the y3 ion, with the elemental composition C21H28N 60 4BrS and the graphical representation 
are displayed in Figure 6.2.4. The experimental data matches the calculated values. This was 
also the case for the other y-ions that incorporated bromine (data not shown).
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isotope
num ber m /z
percent
total
percent
maximum
1 539.1076 36.8 94.3
2 540.1104 10.0 25.5
3 541.1058 39.0 100.0
4 542.1084 10.3 26.4
5 543.1062 3.2 8.3
6 544.1070 0.6 1.6
Figure 6.2.4 Theoretical isotope distribution of bromo-tryptophan containing y3 -ion.
The panel on  the left hand side shows the graphical representation o f  the theoretical isotope distribution of 
the y3 fragment ion extracted from  the table on the right hand side o f  the figure. The theoretical isotope 
distribution was calculated with the M S-Isotope feature o f  ProteinProspector using the elemental 
com position C 2iH 2sN 6 0 4 BrS.
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The tandem mass spectrum o f the second peptide (m /z 640.7107) visible in the MS-survey 
scan (Figure 6.2.1) is shown in Figure 6.2.5. The primary sequence determined is:
G(I/L)CPWKPWBrC-NH2 m /z 1280.4136 [MH] +
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Figure 6.2.5 Bromo-contryphan, E S I tandem mass spectrum of m /z  640.7107
This figure shows the M S/M S spectrum o f  m /z  1280.4136 [MH]+. The b-ion series is labelled in red. The y- 
ion series is labelled in blue. Internal fragment ions are shown in purple, immonium ions in green and the loss 
o f  water from  b-ions with a red hash (#). For y-ions containing the brominated tryptophan, both the first and 
third isotope o f  the ion were labelled. The same for internal fragment ions.
The mass difference in the MS spectrum, 7.99 Da (15.9878 for singly charged), indicated 
oxidation o f  the peptide. The oxidation site is on Proline in position 4. Hydroxy-proline is 
a relatively common PTM in conotoxins (Cruz et al., 1985; Fainzilber et al., 1995a; Hill et 
al., 1996; Pallaghy et al., 1999; Stone and Gray, 1982). In a similar fashion to bromo- 
tryptophan, evidence was found that supported the oxidation o f this particular hydroxy- 
proline only. The internal fragments (purple labels) detected in this fragment data 
originated from both prolines present in the peptide.
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Compared with the previous tandem mass spectra, more ions were detected in the high 
mass range (truncated for clarity in Figure 6.2.2). The b-ion series overlaps the y-ion series 
for this particular peptide.
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F igu re  6 2 .6  E S I tan d em  m ass sp ec tru m  o f con tryphan  o f m /z  602.7784
This figure shows the M S/M S spectrum o f  m /z  1204.5496. The b-ions series is shown in red, the y-ion series 
in blue. T he C-terminus is amidated. Internal fragment ions with their sequence are shown in purple. The 
losses o f  am m onium  from  y-ions are indicated with a red hash (#). The immonium ion is labelled in green.
Another two contryphans were found in the remaining second dimension fractions. The 
contryphan with sequence
CDGPWKPWC-NH2 m /z  1204.5496 [MH]+ (38 ppm)
Is shown in Figure 6.2.6. And the contryphan with sequence:
CPWNAWC-NH2 m /z  992.1922 [MH]+ (31 ppm)
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Is shown in Figure 6.2.7. None o f the contryphans shown in this chapter have been, to 
date, reported in the literature.
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F ig u re  6.2.7 E S I ta n d e m  m ass sp ec tru m  o f con tryphan  w ith  m /z  496.6001.
This figure shows the M S/M S spectrum o f m /z  992.1922. The b-ions series is shown in red, the y-ion in 
blue. The C-terminus is amidated. Internal fragment ions with their sequence are shown in purple.
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7 Concluding remarks and Oudook
The purpose o f the studies presented in this thesis was the exploration of Conus venom 
using polypeptide separation methods and mass spectrometry. As previously mentioned, 
venom samples were supplied as crude venom in several batches. Unfortunately I had no 
access to large amounts of sample. The data are presented in four chapters. Chapter three 
explores the protein content o f Conus venoms using several gel based separation techniques. 
Chapter four describes a LC-MALDI MS approach of the identification of peptides from 
Conus ventricosus venom. Chapter five is concerned with the comprehensive analysis of Conus 
ventricosus and Textile venom using a two-dimensional LC system, followed by mass 
spectrometry. Chapter 6 describes the identification of novel contryphans (a type of 
conotoxins) from the venom of Conus ventricosus.
Chapter three can be roughly divided into two parts, namely based on the gel 
electrophoresis method used prior to mass spectrometric analysis, one and two- 
dimensional GE.
One o f the interesting findings for the IDE in both Conus textile and Conus ventricosus was 
Vitamin K-dependent gamma-glutamyl. Conotoxins were known to have gamma- 
carboxyglutamate residues (Fainzilber et al., 1991). The gamma-gutamylcarboxylase 
responsible for this post-translational modification was found to be strictly dependent on 
vitamin K (Stanley et al., 1997). This carboxylase was originally found in Conus textile but 
was never reported for Conus ventricosus venom. Vitamin K-dependent gamma-glutamyl 
carboxylase has been predicted by conceptual translation in the following Conus species: 
omaria, imperalis and episcopatus. Therefore it is likely to assume that proteins like Vitamin K- 
dependent gamma-glutamyl carboxylase are well preserved in Conus species.
Among other interesting proteins identified was Protein Disulfide Isomerase (PDI), a 
chaperone known to facilitate the correct formation o f disulfide bridges, obviously 
extremely important in the disulfide rich conotoxins. Further identified was Peptidyl-Prolyl 
cis-trans isomerase B. Conotxins are known to include L- D- conformational change of 
amino adds as post translational modifications.
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The various methods used for identifying proteins in Conus venom yielded mainly so called 
housekeeping proteins. Actin was the most abundant protein found throughout all the 
tandem MS runs. For instance in case of Conus textile venom a total number of 26 peptides 
were sequenced resulting in 44.7% sequence coverage for actin with accession number 
3182894. Other household proteins that were identified are vimentins. Vimentins belong to 
the group o f intermediate filaments to which also proteins such as keratin, lamins and 
neurofilaments belong. Vimentins provide mechanical strength to muscle (and other) cells 
(Evans, 1998).
Amongst the proteins identified were also a number of inhibitors of biological processes. 
Examples were Protein kinase C inhibitor and trypsin inhibitor. Besides neurotoxic 
components, venoms from snakes, bees and spiders are known to contain protease 
inhibitors (Shkenderov, 1973; Zhou et al., 2004).
The overall identification rate for the 2DE analysis of the proteins in the venoms of Conus 
arenatuSy textile and nussatella was not very high. From the 56 spots picked for in-gel 
digestion and subsequent MS analysis, only 12 spots resulted in an identification of four 
unique proteins. One interesting find is Arginine kinase (AK). AK belongs to a class of 
kinases that play a role in the maintenance o f ATP levels by the phosphorylation of the so 
called "phosphagens" which then serve as a high energy source from which ATP can be 
rapidly replenished. In a wide variety o f invertebrates, phosphoarginine is the most 
important phosphagen, whereas in vertebrates this is phosphocreatine. Some AKs contain 
an alpha-actinin like actin binding region (Pereira et al., 2000), and it has been shown that 
AK from mollusc muscle (Scallop, Pecten maximus) binds actin with reasonable affinity 
(Reddy et al., 1992). This protein was also identified in the ID  experiment with Conus textile.
Some o f the proteins identified from the Conus venoms are normally found in the cytosol. 
It was therefore very likely that during the extraction procedure o f the venom, cells from 
the actual venom duct were damaged and that their cytosolic components leaked into the 
venom. It is therefore difficult to establish whether the proteins identified originate from 
the venom. One possibility to possibly prevent the rupture of cells is to milk the snails 
rather than dissect the venom duct. In this process a snail is forced to inject its venom into 
a tube. Unfortunately we were dependent on the samples supplied.
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The experiments described in chapter four were an initial attempt to analyse Conus venom 
using 2D-LC and mass spectrometry. The underlying thought o f this experiment was to 
identify conotoxin peptides by digestion from size exclusion fractions. It is postulated in 
many previous papers, that Conus venom contains many conotoxins, up to 200 peptides 
were predicted. However, the actual identification, by database searching or de novo 
sequencing o f putative conotoxins was very low. But it was a very important experience in 
sample handling. An added disadvantage is that manual de novo sequencing proved to be 
more difficult for TOF/TOF generated fragmentation data, compared to electrospray CID. 
TOF/TOF type fragmentation results in more internal fragments. One could argue that 
therefore this is also less sensitive as the sample is ‘diluted’. O f course in the future this 
data set needs to be analysed by an adequate automatic de novo sequencing program. 
However batch searches performed on this data set were consistent with the findings of 
Chapter three. Many o f the peptides originated from housekeeping proteins, primarily 
Actin.
An implication however o f this experiment was the discovery of alkylated histidine. 
Alkylation o f histidine has been sporadically reported in the early 60s (Fruchter and 
Crestfield, 1967; Szewczuk and Connell, 1965). Iodoacetamide is one of the established 
alkylating reagent in proteomic experiments. However, in some cases this modifies other 
amino acids besides the free sulfhydril groups of cysteine. This has a significant implication 
on database searching. Therefore, as a result of this pilot experiment, this user modification 
was added to some o f the searches in protein prospector. However no other modified 
histidines were found. It was out o f the scope o f this work to further characterize this 
specific modification.
From the experiments described in Chapter five a novel conotoxin was described with the 
following sequence: qCCDPCAYPCRFDYSCCY
This conotoxin has not been reported before. The N-terminal amino acid is a pyroglutamic 
acid. This is a post-translational modification that occurs naturally but also quite often is 
user induced. However, the intact mass o f the native peptide indicated a pyroglutamic acid.
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The cysteine scaffold was conform with that of the M superfamily (framework III) of 
conotoxins (Terlau and Olivera, 2004). This framework is represented by:
- c c - c - c - c c -
To date 38 conotoxins have been reported that are classified in framework III. Amongst 
these toxins are for instance the p-conotoxins which target to muscle voltage-sensitive 
sodium channels. The disulfide bonds between the conserved cysteines uphold the 
structural framework o f surface loops of these toxins. However, the inter loop amino acids 
are hypervariable (Conticello et al., 2000; Woodward et al., 1990). Duda and coworkers 
reported an accelerated evolution strategy for Conus snail to assemble a combinatorial type 
library, maximising the effect to capture and kill prey (Duda and Palumbi, 1999). This work 
was later repeated with a larger dataset by Conticello et al. (Conticello et al., 2001).
One other interesting find is the confirmation of a putative conotoxin sequence found by 
Conticello et a l (Conticello et al., 2001) : CCSWDVCDHPSCTCCG.
In that study an EST-generated assemblage o f 170 distinct conopeptides from five 
different Conus species was described. The EST library was translated from the cDNA 
library created from isolated mRNA from venom ducts from the different species. The 
preparation o f Conus Textile venom duct cDNA library was described by Sasaki et al (Sasaki 
et al., 1999). The mRNA needed for the creation of this library was prepared from venom 
ducts o f 20-30 specimens each. The putative conotoxin sequences could be categorised 
into three cysteine frameworks, namely scaffold V I/V II, scaffold IX and scaffold III/IV  
(Terlau and Olivera, 2004).
In both studies it was reported that the mature toxin contained two gamma-carboxy- 
glutamic acid (Gla) sites at positions 68 and 73 of the precursor, however no evidence was 
found o f this post-translational modification for our sample. Carboxy-glutamate adds 
43.9898 Da to glutamic add (E et al.). Peak lists from both electrospray and MALDI 
datasets were screened for masses that corresponded to one and two Gla residues (+ /- 50 
ppm). Gamma-carboxy glutamic acid is a post-translational modification, mainly found on 
proteins and peptides assodated with blood coagulation or bone metabolism (Stanley et al., 
1997). Gamma-carboxyglutamyl residues are good chelators o f caldum ions (Sunnerhagen
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et al., 1996). Blood coagulation is a process that changes circulating circumstances within 
the blood into an insoluble gel. The gel plugs leak in blood vessels and stops the loss of 
blood. This process requires coagulation factors, calcium and phospholipids. By chelating 
the calcium from the blood, the coagulation process is disrupted, maximising the 
envenomination o f the prey.
The experiments described in Chapter six permitted the identification of two novel 
contryphans, namely:
G(I/L)COWKPWBr C-NH2 
G(I/L)CPWKPWBr C-NH2
Neither Contryphan found has been reported before. Contryphans, single disulfide linked 
conopeptides, are know to be heavily modified. This particular peptide, a so called bromo- 
Contryphan was a good example. Besides one disulfide, it contained a brominated 
tryptophan, a C-terminal amidation and an hydroxyproline. Bromination of tryptophan is a 
known post-translational modification for these types of peptides. Surprisingly the same 
peptide revealed a differential modification of hydroxyl proline. It is o f course likely that 
this is a ‘side product’ o f the incomplete PTM formation.
Two more contryphans were identified, namely:
c d g p w k p w c - n h 2 
c p w n a w c - n h 2
The contryphans found in this Conus ventricosus sample were not detected in the venom 
batch that was analysed in chapters four and five. The different venom batches that were 
analysed troughout the experiments described here were taken from different locations and 
at different time points. It has been postulated that there is a huge variation between 
different Conus populations. Also, the toxin expression in venom might be dependent on 
season and feeding. It is known that snails go without food for months. It is therefore 
plausible that a snail does not produce high amounts o f toxins after feeding.
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In conclusion, the work presented in this thesis has revealed several new conotoxins /  
contryphans and verified some predicted conotoxin sequences. However, the expected 
multitude o f conotoxins that supposedly are present in Conus venom were not detected. 
The proteome o f an organism, in this case Conust is defined as the complete set of proteins 
(peptides) that can be expressed by the genetic material. Based on the number of conotoxin 
sequences found in the extensive separation and analysis shown by this work, the number 
o f expressed conotoxins might well be lower than the postulated numbers in the literature.
The novel conotoxin qCCDPCAYPCRFDYSCCY that was found in the venom of Conus 
ventricosus is o f course a candidate to be tested for biological activity.
To further improve the chance of finding conotoxins in complex venoms, a number of 
parameters could be improved. On the sample preparation side by using the milked venom 
rather then dissected venom ducts, to prevent the ‘contamination’ of the venom with 
materials other than that o f the content of venom ducts. However in the case of Conus 
ventricosus this would be rather difficult, as these specimens only grow a few centimeters 
large and the amount o f sample would become a considerate challenge. A pulldown and 
enrichment o f cysteine containing peptides could be an option to circumvent the 
complexity o f the venom. Although a good alternative for sample complexity reduction, 
size exclusion is a rather crude method, and into a certain extend is strong cation exchange. 
A good alternative for the first dimension separation would be to use free flow 
electrophoresis (FFE). With this separation technique, peptides and proteins are separated 
according to their iso-electric point. This will result in better resolved fractions which will 
increase the sensitivety of the overall method.
In order to increase analyse complex venom mixture in a high-throughput manner, 
automation is o f the essence. However, to automatically search data, large and well 
annotated databased have to be in place. The alternative to database searching is de novo 
sequencing. Automating accurate de novo sequencing remains a challenge. However, with 
the advent o f high accuracy mass spectrometers, particularly ICR-FT-MS, automated de 
novo sequencing seems to become more realistic, as with the increase of mass accuracy the 
number o f false positives can be dramatically decreased.
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8 Appendices
8.1 A ppendix 1: Am ino acid  m asses and m ore
Name residue Symbols
Mass
Monoisotopic Average Immonium ion y l  - ion bl - ion
Glycine Gly G 57.02146 57.0520 30.03439 76.03984 58.02929
Alanine Ala A 71.03711 71.0788 44.05004 90.05549 72.04494
Serine Ser S 87.03203 87.0782 60.04496 106.05041 88.03986
Proline Pro P 97.05276 97.1167 70.06569 116.07114 98.06059
Valine Val V 99.06841 99.1326 72.08134 118.08679 100.07624
Threonine Thr T 101.04768 101.1051 74.06061 120.06606 102.05551
Cysteine Cys C 103.00919 103.1448 76.02212 122.02757 104.01702
Leucine Leu L 113.08406 113.1595 86.09699 132.10244 114.09189
Isoleucine lie I 113.08406 113.1595 86.09699 132.10244 114.09189
Asparagine Asn N 114.04293 114.1039 87.05586 133.06131 115.05076
Aspartic acid Asp D 115.02694 115.0886 88.03987 134.04532 116.03477
Glutamine Gin Q 128.05858 128.1308 101.07151 147.07696 129.06641
Lysine Lys K. 128.09496 128.1742 101.10789 147.11334 129.10279
Glutamic acid Giu E 129.04259 129.1155 102.05552 148.06097 130.05042
Methionine Met M 131.04049 131.1986 104.05342 150.05887 132.04832
Histidine His H 137.05891 137.1412 110.07184 156.07729 138.06674
Phenylalanine Phe F 147.06841 147.1766 120.08134 166.08679 148.07624
Arginine Arg R 156.10111 156.1876 129.11404 175.11949 157.10894
Tyrosine Tyr Y 163.06333 163.1760 136.07626 182.08171 164.07116
Tryptophan -  TrP W 186.07931 186.2133 159.09224 205.09769 187.08714
Hydroxy Proline Hyp 0 113.04770 113.1168 86.06063 132.06608 114.05553
Bromo - Tryptophan — 263.98980 265.1103 237.00273 283.00818 264.99763
The molecular mass of a normally terminated and unmodified peptide or protein 
may be calculated by summing the masses of the appropriate amino acid residues from the 
table and adding the masses o f H (1.00782 for monoisotopic, 1.0079 for average mass) and 
O H  (17.00274 for monoisotopic and 17.0073 for average mass) for the N- and C-termini 
respectively. Also the symbols and masses o f two post-translationally modified amino acids, 
relevant to this thesis, are given.
145
8. Appendices
8.2 A ppendix 2: Search results Conus ventricosus in -gel
Ac­
cession
Number
Protein Description
Mass
p a )
Sequence
Coverage
Mascot
Protein
Score
Number
of
Peptides
P1
3182894 Actin 41683 44.7 564.0 26 5.30
39591775 Hypothetical protein CBG18256 [Caenorhabditis briggsae] 41889 39.5 534.9 23 5.43
33346945 ubiquidn/actin fusion protein [Gymnochlora stellata] 49352 28.1 405.9 20 5.03
8895765 alpha actin [Ictalurus punctatus] 41986 33.4 364.4 24 5.30
7546413
Chain A, The Yeast Actin Val 159 Asn Mutant Complex With 
Human Gelsolin Segment 1 41678 16.5 286.6 9 5.44
14318479
Structural protein involved in cell polarization, endocytosis, and 
other cytoskeletal functions; Ac 41663 16.5 286.6 9 5.44
294852 alpha-muscle actin 41511 16.9 266.8 10 5.47
2598562 BiP [Mu* musculus] 72433 8.2 265.4 6 5.10
109893 dnaK-type molecular chaperone grp78 precursor - mouse 72377 8.2 265.4 6 5.12
31981722
heat shock 70kD protein 5 (glucose-regulated protein); glucose 
regulated protein, 78 kDa; heat shoe 72378 8.2 265.4 6 5.01
25742763 heat shock 70kD protein 5 [Rattus norvegicus] 72302 8.3 263.7 6 5.07
45382769
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) 
[Gallus gallus] 71974 8.3 263.7 6 5.12
16507237
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa); 
BiP; heat shock 70kD protein 5 (glue 72288 8.3 263.7 6 5.07
45544521 heat shock protein [Numida meleagtis] 72004 8.3 263.7 6 5.12
46359618 78kDa glucose regulated protein [Crassostrea gigas] 73030 9.8 262.6 6 5.02
21064361 RE 12057p [Drosophila melanogaster] 37816 22.0 244.8 8 5.36
6693629 B-actin [Pagrus major] 41813 20.0 243.1 8 5.30
17647135 CG 10067-PA [Drosophila melanogaster] 41808 19.9 243.1 8 5.23
576368 Chain A, Beta-Actin-Profilin Complex 41801 19.9 243.1 8 5.21
7387473 Cyl actin [Tripneustes gradlla] 41836 19.9 243.1 8 5.29
809561 gamma-actin [Mu* musculus] 40992 20.4 243.1 8 5.56
19528317 LD04994p [Drosophila melanogaster] 40232 20.8 243.1 8 5.56
28336 mutant beta-actin (beta"-actin) [Homo sapiens] 41786 20.0 243.1 8 5.22
45872608 Unknown (protein for MGC:76228) [Xenopus tropicalis] 41726 20.0 243.1 8 5.29
39794594 Bactinl protein (Danio rerio] 41740 20.0 241.4 8 5.30
9049272 beta actin [Carassius auratus] 41752 20.0 241.4 8 5.30
3386376 cytoskeletal actin 1 [Molgula oculata] 41680 20.0 241.4 8 5.29
45361511 hypothetical protein MGC75587 [Xenopus tropicalis] 41738 20.0 241.4 8 5.30
3421457 cytoplasmic actin [Dreissena polymorpha] 41826 19.9 240.4 8 5.30
7245500
Chain A, Crystal Structure O f  1:1 Complex Between Gelsolin 
Segment 1 And A DictyosteliumTETRAHYMENA 41619 20.0 239.7 8 5.38
7245526
Chain A, Crystal Structure O f A 
DictyosteliumTETRAHYMENA CHIMERA Actin (Mutant 
646: Q228kT229AA230Y 41718 20.0 239.7 8 5.39
7245498
Chain A, Crystal Structure O f  Dictyostelium Caatp-Actin In 
Complex With Gelsolin Segment 1 40846 20.4 239.7 8 5.17
2624850
Chain A, Structure O f  Bovine Beta-Acdn-Profilin Complex 
With Actin Bound Atp Phosphates Solvent Ac 41664 20.0 239.7 8 5.15
41393660 pupal-specific flight muscle actin [Aedes aegypd] 41572 20.7 235.2 8 5.29
3913786 Luminal binding protein precursor (BiP) (78 kDa gjucose- 73547 6.0 231.9 5 5.03
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regulated protein homolog) (GRP 78)
309090 A-X actin 41667 22.1 229.7 7 5.21
2724046 beta-actin [Mustela putorius furo] 35814 26.2 229.7 7 5.65
17568549 heat shock protein (73.0 kD) (hsp-3) [Caenorhabditis elegans] 72979 8.0 224.4 5 4.95
797290 muscle actin 41629 23.9 209.8 7 5.31
407521 chaperone [Saccharomyces cerevisiae] 68503 9.6 206.5 6 5.21
6319396
heat-inducible cytosolic member o f the 70 kDa heat shock 
protein family; Ssa3p [Saccharomyces cerev 70504 9.2 206.5 6 5.05
49868 put. beta-actin (aa 27-375) [Mus musculus] 39161 21.2 200.2 8 5.78
45198632 AFR114Wp [Eremothecium gossypii] 69498 7.0 190.9 4 5.00
31212573 ENSANGP00000022307 [Anopheles gambiae] 30160 23.1 183.7 8 5.13
3550539 K15 intermediate filament type I keratin [Ovis aries] 48740 8.8 181.1 4 4.73
27525276 putative cytoskeletal actin [Ciona intestinalis] 41726 15.7 168.9 7 5.29
17061835 stress protein HSP70-1 [Xiphophorus maculatus] 70235 7.1 163.1 4 5.38
1620388 70kD heat shock protein [Takifugu rubtipes] 70033 7.0 161.4 4 5.28
1170372 HEA T SHOCK PROTEIN 70 Al 70208 5.8 143.3 4 5.55
1170376 HEA T SHOCK PROTEIN 70 A2 70194 5.8 143.3 4 5.54
33591249 heat shock protein 68 [Drosophila erecta] 68292 6.0 142.6 4 5.85
123633 HEA T SHOCK 70 KD PROTEIN 4 (HSP70) 71391 7.0 142.4 4 5.25
3287859 Heat shock protein 70 (HSP70) 70025 5.8 141.6 4 5.62
38325842 heat shock protein Hsp70a [Drosophila virilis] 70132 5.8 140.9 4 5.67
38325846 heat shock protein Hsp70c [Drosophila virilis] 70090 5.8 140.9 4 5.67
38325856 heat shock protein Hsp70d [Drosophila lummei] 69895 5.8 140.9 4 5.75
38325840 heat shock protein Hsp70g [Drosophila virilis] 70131 5.8 140.9 4 5.74
1170377 HEA T SHOCK PROTEIN 70 B2 70110 5.8 139.9 4 5.68
46391140
putative Luminal binding protein [Oryza sativa (japonica 
cultivar-group)] 74267 4.9 136.5 3 5.09
46095698
ARF.CRYNE ADP-RIBOSYLATION FACTOR [Ustilago 
maydis 521] 20593 14.9 135.1 4 6.85
38104058 hypothetical protein MG04438.4 [Magnaporthe grisea 70-15] 20931 14.8 135.1 4 6.32
29789317
keradnocyte associated protein 1; cytokeradn KRT2-6HF [Mus 
musculus] 59704 6.4 134.5 4 8.46
18858335 bacdnl; beta-acdn [Danio rerio] 41726 10.4 132.7 4 5.30
14278147
Chain A, Crystal Structure O f Caenorhabditis Elegans Mg-Atp 
Actin Complexed With Human Gelsolin Seg 41638 10.4 132.7 4 5.30
3036959 CsCAl [Ciona savignyi] 41698 10.4 132.7 4 5.29
39595059 Hypothetical protein CBG17727 [Caenorhabditis briggsae] 20549 15.0 131.5 4 6.43
15419605 masticatory epithelia keratin 2p [Canis familiaris] 66782 4.3 130.1 3 8.47
3891470
Chain A, Crystal Structure O f  Human Galectin-7 In Complex 
With Galactosamine 14935 24.4 128.2 3 7.00
4504985 galecdn 7; lecdn galactoside-binding soluble 7 [Homo sapiens] 15066 24.3 128.2 3 7.03
46228393 A RF1/2 like small GTpase [Cryptosporidium parvum] 21443 13.2 128.1 4 5.94
30425250 RIKEN cDNA 4732495G21 gene [Mus musculus] 41977 13.8 127.6 5.30
4757756
annexin A2; annexin II; annexin II (lipocordn II); calpacdn I, 
heavy polypeptide (p36); lipocord 38580 12.4 126.0 3 7.57
18645167 ANXA2 protein [Homo sapiens] 38552 12.4 126.0 3 7.57
309215 EndoA" cytokeradn (5" end put.); putadve 53210 2.5 124.2 5.42
18202174 14-3-3 protein sigma (Stradfin) 27832 18.1 123.1 4 4.65
631131 epithelial cell marker protein 1 - human 27759 18.1 123.1 4 4.72
16306737 SFN protein [Homo sapiens] 24321 20.8 123.1 4 4.77
5454052 stradfin [Homo sapiens] 27757 18.1 123.1 4 4.68
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9055338
strati fin; 14-3-3 protein sigma; tyrosine 3- 
monooxygenase/tryptophan 5-monooxygenase activation pro 27696 18.1 123.1 4 4.75
229552 albumin 66088 6.0 120.6 4 5.76
123592 Heat shock 70 kDa protein 56500 6.6 118.3 3 6.45
27503439 ArQ-prov protein [Xenopus laevis] 20626 13.3 116.8 4 6.32
30749336
Chain A, Crystal Structure O f  Ggal Gat N-Terminal Region In 
Complex With Arfl Gtp Form 18918 14.5 116.8 4 5.64
1065361
Chain A, Human Adp-Ribosylation Factor 1 Complexed With 
Gdp, Full Length Non-Myristoylated 20553 13.3 116.8 4 6.36
40889633
Chain A, Structure O f A rfl-G dp Bound To Sec7 Domain 
Complexed With Brefeldin A 18789 14.6 116.8 4 5.63
39584902 Hypothetical protein CBG09004 [Caenorhabditis bnggsae] 20481 13.3 116.8 4 6.15
45360689 hypothetical protein MGC76046 [Xenopus tropicalis] 20679 13.3 116.8 4 6.43
34909214
putative ADP-ribosylation factor [Oryza sahva (japonica 
culdvar-group)] 42184 6.4 116.8 4
10.3
1
17512384 BC031593 protein [Mus musculus] 59144 5.7 116.2 3 7.10
22164776 cDNA sequence BC031593 (Mus musculus] 57517 5.8 116.2 3 7.55
29028256 ARFI-like GTP-binding protein [Gossypium hirsutum] 20650 13.3 115.1 4 7.85
6573751 F20B24.7 [Arabidopsis thaliana] 21221 12.9 115.1 4 6.92
25294174 F508.5  protein - Arabidopsis thaliana 21553 12.8 115.1 4 6.97
25404268
probable ADP-ribolylation factor F8A5.3 [imported) - 
Arabidopsis thaliana 12683 21.2 115.1 4 8.76
8778579 F28C 11.12 [Arabidopsis thaliana] 28379 9.8 113.4 4 9.03
23463261 vitamin K-dependent carboxylase [Ghms text,ik\ 93905 3.5 113.1 3 5.37
18652793 vitamin K-dependent gamma-g)utamyl carboxylase [Cttuts textile] 93858 3.5 113.1 3 5.37
27805925
heat shock 70 kDa protein 8; heat shock cognate 71 kD protein; 
heat shock 70kd protein 10 (HSC71) [ 71195 5.7 111.4 5 5.49
5729877
heat shock 70kDa protein 8 isoform 1; heat shock cognate 
protein, 71-kDa; heat shock 70kd protein 1 70854 5.7 111.4 5 5.37
24234686
heat shock 70kDa protein 8 isoform 2; heat shock cognate 
protein, 71-kDa; heat shock 70kd protein 1 53484 7.5 111.4 5 5.62
45384370 heat shock cognate 70 [Gallus gallus] 70783 5.7 111.4 5 5.47
123647 Heat shock cognate 71 kDa protein 70761 5.7 111.4 5 5.24
45544523 heat shock protein [Numida meleagris] 70827 5.7 111.4 5 5.37
42542422 Heat shock protein 8 [Mus musculus] 70828 5.7 111.4 5 5.28
13242237
heat shock protein 8; Heat shock cognate protein 70; heat shock 
70kD protein 8 [Rattus norvegicus] 70827 5.7 111.4 5 5.37
16041102 hypothetical protein [Macaca fascicularis] 62378 6.5 111.4 5 5.53
17545950
PROBABLE TRANSALDOLASE PROTEIN [Ralstonia 
solanacearum GMI1000] 34822 6.3 104.9 3 5.50
20903595 RIKEN cDNA 2310001L23 [Mus musculus] 62806 4.7 104.6 3 8.68
22985792 COG0176: Transaldolase [Burkholderia fungorum] 38760 5.7 103.2 3 7.64
28564918 TALI [Saccharomyces castellii] 36911 6.0 103.2 3 6.99
202549 iodothyronine 5' monodeiodinase 54033 4.1 101.9 4 4.87
27806501
ptocollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4- 
hydroxylase], beta polypeptide [protein disulfide isomerase; 
thyroid hormone] [Bos taurus] 57230 3.9 101.9 4 4.80
6981324
prolyl 4-hydroxylase, beta polypeptide; Protein disulfide 
isomerase (Prolyl 4-hydroxylase, beta polypeptide); protein 
disulfide isomerase [Rattus norvegicus] 56829 3.9 101.9 4 4.82
42415475 prolyl 4-hydroxylase, beta polypeptide; protein disulfide 57023 3.9 101.9 4 4.77
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isomerase [Mus musculus]
19880309 protein disulfide-isomerase 56975 3.9 101.9 4 4.78
339647 thyroid hormone binding protein precursor 57069 3.9 101.9 4 4.82
21703694
cognin/prolyl-4-hydroxylase/protein disulfide isomerase 
[Gallus gallus] 58497 3.8 100.6 5 4.75
40741908 conserved hypothetical protein [Aspergillus nidulans FGSC A4] 20600 12.4 100.1 3 9.00
27368649 112 (Haliods tuberculata] 380301 0.9 98.9 3 5.37
24158633 Chain A, Cyclophilin_5 From C. Elegans 19848 4.9 98.2 2 9.22
227879 cyclop hilin 18995 5.0 98.2 2 8.65
17506307 CYcloPhilin (21.9 kD) (cyp-5) [Caenorhabditis elegans] 21913 4.4 98.2 2 8.98
13592067 ribosomal protein S9 [Rattus norvegicus] 22492 13.9 94.3 4
10.4
8
40787691 LOC395048 protein [Xenopus tropicalis] 56745 2.6 93.8 2 4.73
28436918 P4hb protein [Xenopus laevis] 57980 2.5 93.8 2 4.81
462328
H EA T SHOCK 70 KDA PROTEIN 6 (HEAT SHOCK 70 
KDA PROTEIN B*) 71065 3.4 93.0 2 5.77
34419635
heat shock 70kDa protein 6 (HSP70B'); heat shock 70kD 
protein 6 (HSP70B1) [Homo sapiens] 70984 3.4 93.0 2 5.81
7672737
hsp-70-reiated intracellular vitamin D  binding protein [Saguinus 
oedipus] 71112 3.4 93.0 2 6.06
38103539 hypothetical protein MG03982.4 [Magnaporthe grisea 70-15] 39700 9.3 92.6 3 5.62
34853536 similar to peroxiredoxin 1 [Rattus norvegicus] 21861 10.6 89.4 4 8.29
19912722 platyfish HSP70-1 with S-tag [Cloning vector pSTHl-GFP] 72151 4.1 88.7 5.43
41393662 pupal-specific flight muscle acdn [Aedes aegypd] 41556 7.4 87.2 3 5.29
6980088 inner-ear cytokeradn [Rana catesbeiana] 56584 4.5 84.3 5.81
33598988 constitutive heat shock protein HSC70-1 (Cyprinus carpio] 70545 4.0 82.3 3 5.19
32394421 muscle-specific heat shock protein Hsc70-1 [Cyprinus carpio] 70318 4.1 82.3 3 5.19
191765 alpha- fetoprotein 47195 3.1 82.3 5.47
38093961 similar to protease [Mus musculus] 38658 2.3 81.9 4 9.63
112696
14-3-3 protein zeta/delta (Protein kinase C inhibitor protein-1) 
(KCIP-1) 27839 13.1 81.1 4 4.77
7435027 14-3-3 zeta protein - mouse 27740 13.1 81.1 4 4.72
4507953
tyrosine 3/tryptophan 5 -monooxygenase acdvadon protein, 
zeta polypeptide; protein kinase C inhib 27728 13.1 81.1 4 4.73
41054687 coated vesicle membrane protein [Danio redo] 22915 7.0 79.7 2 5.08
1352660 Cop-coated vesicle membrane protein p24 precursor 22175 7.1 79.7 2 5.07
28277266 Rnp24-prov protein [Xenopus laevis] 22826 7.0 79.7 2 4.99
39545706 L-lactate dehydrogenase A [Macroclemys temminckii] 36662 5.4 79.4 2 6.95
440306 enhancer protein 22113 8.5 77.4 2 8.16
7963723 natural killer cell enhancement factor [Oncorhynchus mykiss] 22001 8.5 77.4 2 6.51
2914482
Chain A, Complex O f  The Second Kunitz Domain O f Tissue 
Factor Pathway Inhibitor With Porcine Trypsi 23460 12.6 76.5 2 8.26
1942351
Chain A, Crystal Structure O f  The First Acdve Autolysate Form 
O f The Porcine Alpha Trypsin 13284 22.4 76.5 2 7.83
494360
Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor 
From Bitter Gourd 23458 12.6 76.5 2 8.60
999627 Chain B, Porcine E-Trypsin (E.C.3.4.21.4) 8814 34.1 76.5 2 6.67
3318722
Chain E, Leech-Derived Tryptase InhibitorTRYPSIN 
COM PLEX 23457 12.6 76.5 2 8.26
136429 Trypsin precursor 24394 12.1 76.5 2 7.00
22086550 heat shock protein Hsp90 [Achlya ambisexualis] 80120 2.7 75.8 5 5.00
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22086553 heat shock protein Hsp90 [Achlya ambisexualis] 80134 2.7 75.8 5 5.01
1314736 Der f  3 mite allergen 24938 3.9 74.5 3 5.57
2507248 Mite allergen Der f 3 precursor (Der f III) 27657 3.5 74.5 3 5.36
729315 Mite allergen Der p 3 precursor (Der p III) 28042 3.4 74.5 3 8.08
14423685 Mite allergen Eur m 3 precursor 28020 3.4 74.5 3 5.80
32527715 Ac2-048 (Rattus norvegicus] 33643 6.0 73.9 2 9.72
38372905 cell line NK14 derived transforming oncogene (Mus musculus] 23653 8.7 73.9 2 9.15
5669640
ethylene-responsive small GTP-binding protein [Lycopersicon 
esculentum] 23755 8.3 73.9 2 8.37
23463313 GTPase Rab8b [Rattus norvegicus] 23588 8.7 73.9 2 9.15
24306110 GlV-binding protein [Pichia angusta] 22561 8.9 73.9 2 5.48
1362065 G  l'P-binding protein G TP11 - garden pea 23687 8.4 73.9 2 7.66
1362067 G  IV-binding protein GTP13 - garden pea 23791 8.4 73.9 2 7.66
1362066 G lV-binding protein GTP6 - garden pea 23924 8.3 73.9 2 7.63
103720 G lV-binding protein o-rabl - electric ray (Discopyge ommata) 22218 9.0 73.9 2 5.54
92339 GlV-binding protein rablB  - rat 22176 9.0 73.9 2 5.55
466171 GlV-binding protein yptl 22462 8.9 73.9 2 5.47
32418088 G TP-BIN D IN G  PROTEIN YPTl [Neurospora crassa] 26693 7.4 73.9 2 6.82
4886443 hypothetical protein [Homo sapiens] 13894 14.0 73.9 2 5.44
7498104 hypothetical protein D 1037.4 - Caenorhabdids elegans 25664 8.0 73.9 2 5.26
46123663 hypothetical protein FG06209.1 [Gibberella zeae PH-1] 22694 8.9 73.9 2 5.95
38106736 hypothetical protein MG06135.4 [Magnaporthe grisea 70-15] 22719 8.7 73.9 2 6.60
38109427 hypothetical protein MG06962.4 [Magnaporthe grisea 70-15] 22448 8.9 73.9 2 5.27
46099538 hypothetical protein UM03865.1 [Ustilago maydis 521] 22860 8.6 73.9 2 5.69
37360618 mKIAA3012 protein [Mus musculus] 27317 7.1 73.9 2 7.68
33146687
putative ethylene-responsive small GTP-binding protein [Oryza 
sativa (japonica cultivar-group)] 23978 8.4 73.9 2 7.63
14475537 putative Rab/G TPase [Colletotrichum lindemuthianum] 22533 8.9 73.9 2 6.60
25150215 RAB family member (24.0 ItD) (rab-8) [Caenorhabdids elegans] 24007 8.5 73.9 2 7.64
4758988
RAB1A, member RAS oncogene family; RAB1, member RAS 
oncogene family (Homo sapiens] 22663 8.8 73.9 2 5.93
13569962
RAB IB, member RAS oncogene family; small GTP-binding 
protein [Homo sapiens] 22157 9.0 73.9 2 5.55
1619841 rabl-like [Caenorhabdids elegans] 7735 26.1 73.9 2 4.57
27924279 Rabl-prov protein [Xenopus laevis] 22647 8.8 73.9 2 5.93
1370190 RAB8A [Lotus comiculatus var. japonicus] 23761 8.3 73.9 2 6.60
7706563
RAB8B, member RAS oncogene family; RAB-8b protein 
[Homo sapiens] 23569 8.7 73.9 2 9.15
1370194 RAB8C [Lotus comiculatus var. japonicus] 23520 8.5 73.9 2 7.64
1370196 RAB8D [Lotus comiculatus var. japonicus] 23613 8.4 73.9 2 6.74
1370198 RAB8E [Lotus comiculatus var. japonicus] 23700 8.4 73.9 2 6.74
1619851 rab8-like [Caenorhabdids elegans] 14194 14.6 73.9 2 7.74
2500076 Ras-like GTP-binding protein YPTl 22278 9.0 73.9 2 7.60
15238542 Ras-related GTP-binding family protein [Arabidopsis thaliana] 23819 8.3 73.9 2 8.35
15231847
Ras-related GTP-binding protein, putadve [Arabidopsis 
thaliana] 23924 8.3 73.9 2 8.35
15231322
Ras-related protein (ARA-3) /  small GTP-binding protein, 
putadve [Arabidopsis thaliana] 23820 8.3 73.9 2 7.66
131785 Ras-related protein ORAB-1 22319 8.9 73.9 2 5.54
131787 Ras-related protein Rab-IA 22748 8.8 73.9 2 5.95
464524 Ras-related protein Rab-IA 22745 8.8 73.9 2 5.52
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131803 Ras-related protein Rab-IB 22149 9.0 73.9 2 5.55
3024527 Ras-related protein RAB1BV 23772 8.4 73.9 2 7.66
32411557 RAS-RELATED PROTEIN RAB1BV (Neurospora crassa] 22541 8.8 73.9 2 5.58
1710002 Ras-related protein Rab-8 (Oncogene c-mel) 23542 8.7 73.9 2 9.26
21313162 RIKEN cDNA 1110011F09 [Mus musculus] 22173 9.0 73.9 2 5.55
11558649 secretion related GTPase (StgB) [Aspergillus niger] 22289 9.0 73.9 2 5.14
27817324
SI:zC101N13.3 (novel protein similar to human RAS oncogene 
family member RAB1B) [Danio rerio] 22274 9.0 73.9 2 5.56
41055496 similar to RAB1, member RAS oncogene family [Danio rerio] 22370 9.0 73.9 2 5.55
27709432 similar to Ras-related protein Rab-IB [Rattus norvegicus] 22163 9.0 73.9 2 5.55
7438394 small GTP-binding protein rab-1 - turnip 25005 8.1 73.9 2 6.17
11558500 small GTP-binding protein YPTI [Hypocrea jecorina] 22407 8.9 73.9 2 5.47
40739629
YPT1_NEUCR GTP-binding protein yptl [Aspergillus 
nidulans FGSC A4] 22204 9.0 73.9 2 5.53
46138717
YPT1_NEUCR GTP-binding protein yptl [Gibberella zeae 
PH-1] 22411 8.9 73.9 2 5.28
19115492 yptl-related protein 2 [Schizosaccharomyces pombe] 22741 9.0 73.9 2 5.59
7533034 YptA [Aspergillus awamori] 22321 9.0 73.9 2 5.14
39579623 Hypothetical protein CBG22322 [Caenorhabditis briggsae] 41252 5.6 73.5 3 5.88
27357027 alpha tubulin [Oncorhynchus mykiss] 21399 14.6 72.8 3 5.85
340019 alpha-tubulin 38102 8.2 72.8 3 4.92
37779014 CralO alpha tubulin [Pagrus major] 24124 12.9 72.8 3 5.33
22595342 serine protease [Dermatophagoides pteronyssinus] 26311 3.7 72.8 3 6.82
46016010
Chain C, Crystal Structure Analysis O f  The Site Specific Mutant 
(Q253c) O f  Bovine Carbonic Anhydras 29199 7.3 72.5 2 6.63
6006601 beta-mannanase [Thermotoga neapolitana] 91483 1.6 72.4 3 6.17
2429092 beta- xylosidase [Thermotoga neapolitana] 86819 1.7 72.4 3 5.73
39588485 Hypothetical protein CBG01077 [Caenorhabditis briggsae] 22561 8.8 122 2 5.52
39586275 Hypothetical protein CBG12025 [Caenorhabditis briggsae] 23980 8.5 72.2 2 7.64
16933567
mel transforming oncogene; mel transforming oncogene 
(derived from cell line NK14)- RAB8 homolog; r 23653 8.7 72.2 2 9.15
17558550 RAB family member (22.5 IcD) (rab-1) [Caenorhabditis elegans] 22531 8.8 72.2 2 5.52
234746 RAS-related protein MEL [Homo sapiens] 23582 8.7 122 2 9.35
18447913 ras-related protein RAB8-1 [Nicotiana tabacum] 23959 8.3 122 2 7.66
15077428 small GTP-binding protein Y ptlp  [Candida albicans] 23005 8.7 122 2 5.27
11277107
heat-shock protein 70 [imported] - Petrosia ficiformis 
(fragment) 51549 4.7 72.1 3 5.95
28277305 Vim4 protein [Xenopus laevis] 53507 4.1 71.9 3 5.12
138532 Vimentin 4 53464 4.1 71.9 3 5.08
138531 Vimentins 1 and 2 52812 4.1 71.9 3 5.16
33591156 thioredoxin peroxidase [Ixodes ricinus] 19134 10.7 71.3 4 6.93
27735456 Alphatub84b-prov protein [Xenopus laevis] 50147 6.2 71.1 3 4.94
15988311
Chain A, Refined Structure O f  Alpha-Beta Tubulin From Zinc- 
Induced Sheets Stabilized With Taxol 50022 6 2 71.1 3 4.91
3745821 Chain A, Tubulin Alpha-Beta Dimer, Electron Diffraction 48785 6.4 71.1 3 5.18
68288
carbonate dehydratase (EC 4.2.1.1) II - bovine (tentative 
sequence) 28963 7.3 70.8 2 7.93
30466252 carbonic anhydrase II [Bos taurus] 29096 7.3 70.8 2 6.41
46016008
Chain A, Crystal Structure Analysis O f Bovine Carbonic 
Anhydrase Ii 28965 7.3 70.8 2 6.40
12214171 putative small GTP-binding protein (rablb) [Homo sapiens] 18648 11.0 70.5 2 9.87
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13537192 SCCAlb (Homo sapiens] 38495 5.9 70.0 2 6.28
5902072
serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), 
member 3; squamous cell carcinoma a 44537 5.1 70.0 2 6.35
897844 squamous cell carcinoma antigen 13407 17.1 70.0 2 9.16
10121745 AAG13352.11 skeletal alpha-actin [Gillichthys mirabilis] 13956 19.4 69.6 4 8.49
42525543
glycosyi hydrolase, family 3 [Treponema denticola ATCC 
35405] 61795 2.2 69.6 3 6.59
44829400 peroxiredoxin 1 [Ixodes ricinus] 18977 10.6 69.6 4
11.8
0
2143554 14-3-3 protein isoform zeta - rat (fragment) 21471 15.4 69.0 3 4.67
42523784
thiosulfate sulfurtransferase [Bdellovibrio bacteriovorus 
H D  100] 31343 4.3 68.6 1 9.45
2118384 leupin precursor - human 44873 5.1 68.4 5.86
13537194 SCCA2b [Homo sapiens] 42260 5.4 68.4 5.74
131774 20 kDa protein in rubredoxin operon (ORF Q 20023 8.4 68.1 3 4.96
22208480 putative stripe rust resistance protein YrlO [Sorghum bicolor] 99421 3.7 68.0 8.68
44917135 14-3-3 a-1 protein [Nicodana tabacum] 28747 9.4 67.8 3 4.70
44917143 14-3-3 c-2 protein [Nicodana tabacum] 29362 9.2 67.8 3 4.78
44917151 14-3-3 e-1 protein [Nicodana tabacum] 29365 9.2 67.8 3 4.72
44917153 14-3-3 e-2 protein [Nicodana tabacum] 29337 9.2 67.8 3 4.72
44917155 14-3-3 f-1 protein [Nicodana tabacum] 29078 9.3 67.8 3 4.76
45476403 14-3-3 f-2 protein [Nicodana tabacum] 27419 9.9 67.8 3 4.80
44917163 14-3-3 i-1 protein [Nicodana tabacum] 29368 9.2 67.8 3 4.79
44917165 14-3-3 i-2 protein [Nicodana tabacum] 29454 9.2 67.8 3 4.77
7435015 14-3-3 protein - barley 29924 9.1 67.8 3 4.73
26454607 14-3-3 protein 2 28861 9.4 67.8 3 4.72
3041662 14-3-3 protein 3 (PBLT3) 29287 9.2 67.8 3 4.74
1168191 14-3-3 protein 4 (PBLT4) 29281 9.2 67.8 3 4.69
3023182 14-3-3 protein 5 28736 9.4 67.8 3 4.68
26454608 14-3-3 protein 6 28949 9.3 67.8 3 4.70
2895518 14-3-3 protein epsilon [Xenopus laevis] 29168 9.4 67.8 3 4.68
18396217 14-3-3 protein GF14 nu (GRF7) [Arabidopsis thaliana] 29806 9.1 67.8 3 4.74
466334 14-3-3 protein homologue 25776 10.5 67.8 3 4.88
41056815 14-3-3 protein isoform 20R [Solanum tuberosum] 28748 9.4 67.8 3 4.72
7435010 14-3-3 protein tft2 - tomato 28804 9.4 67.8 3 4.63
6321025
14-3-3 protein, major isoform; binds proteins and DNA, 
involved in regulation o f many processes inc 30073 9.0 67.8 3 4.82
46096636 1433_CANAL 14-3-3 protein homolog [Usdlago maydis 521] 29263 9.2 67.8 3 4.76
40741654
1433_TRIHA 14-3-3 PROTEIN HOM OLOG (TH1433) 
[Aspergillus nidulans FGSC A4] 29098 9.2 67.8 3 4.75
34452069 14-3-3E1 protein [Oncorhynchus mykiss] 29298 9.3 67.8 3 4.67
34452071 14-3-3E2 protein [Oncorhynchus mykiss] 28988 9.4 67.8 3 4.70
1702985 14-3-3-like protein 28716 9.5 67.8 3 4.82
3023190 14-3-3-LIKE PROTEIN 16R 28918 9.3 67.8 3 4.74
38569374 14-3-3-like protein 2 [Paracoccidioides brasiliensis] 29624 9.1 67.8 3 4.68
3023194 14-3-3-LIKE PROTEIN A (SGF14A) 29031 9.3 67.8 3 4.72
1168189 14-3-3-LIKE PROTEIN A (VFA-1433A) 29402 9 2 67.8 3 4.71
3912948 14-3-3-LIKE PROTEIN B 28809 9.4 67.8 3 4.70
2492487 14-3-3-LIKE PROTEIN B (14-3-3B) 29673 9.2 67.8 3 4.67
3023189 14-3-3-like protein C (14-3-3-like protein B) 29346 9 2 67.8 3 4.78
3912950 14-3-3-LIKE PROTEIN E 30551 8.8 67.8 3 4.98
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3912951 14-3-3-LIKE PROTEIN F 29207 9.3 67.8 3 4.76
1702986 14-3-3-like protein GF14 chi (General regulatory factor 1) 29883 9.0 67.8 3 4.68
18413181
14-3-3-like protein GF14 chi /  general regulatory factor 1 
(GRF1) [Arabidopsis thaliana] 29913 9.0 67.8 3 4.68
1168200
14-3-3-like protein GF14 psi (General regulatory factor 3) (14- 
3-3-like protein RCI1) 28589 9.4 67.8 3 4.68
1345587 14-3-3-LIKE PROTEIN GF14-6 29644 9.2 67.8 3 4.76
2492489 14-3-3-LIKE PROTEIN RA215 28577 9.4 67.8 3 4.78
543711 14-3-3-LIKE PROTEIN S94 29112 9.2 67.8 3 4.77
45201203 AGR107Cp [Eremothecium gossypii] 28389 9.6 67.8 3 4.87
13430385 ARTA [Emericella nidulans] 29097 9.2 67.8 3 4.83
14532442 Atlg35160/T32G9_30 [Arabidopsis thaliana] 30160 9.0 67.8 3 4.79
671634 BMH1 [Saccharomyces cerevisiae] 30158 9.0 67.8 3 4.87
683696 BMH2 [Saccharomyces cerevisiae] 31148 8.8 67.8 3 4.82
13447104 GF14 omega [Brassica napus] 29108 9.2 67.8 3 4.68
38110176 hypothetical protein MG01588.4 [Magnaporthe grisea 70-15] 30075 8.8 67.8 3 4.93
13702816 putative 14-3-3 protein [Oryza sadva] 29160 9.2 67.8 3 4.81
28279518
Similar to tyrosine 3-monooxygenase/tryptophan 5- 
monooxygenase acdvadon protein, epsilon polypept 29054 9.4 67.8 3 4.65
9798603 TaW IN l [Tribcum aesdvum] 29377 9.0 67.8 3 4.75
9798605 TaW IN2 [Tridcum aesdvum] 28680 9.3 67.8 3 4.80
6688554 tft3 14-3-3 protein [Lycopersicon esculentum] 25977 10.4 67.8 3 4.94
29367361 WIN2-like protein [Oryza sadva (japonica culdvar-group)] 28982 9.1 67.8 3 4.85
23613323 hypothetical protein [Plasmodium falciparum 3D7] 214645 1.2 67.6 3 8.65
27497749 elongation factor-1 alpha [Chrysolina coerulans] 15539 14.3 66.4 2 7.77
15986653 14-3-3 epsilon 2 [Schistosoma mansoni] 28414 9.6 66.1 3 5.20
530049 14-3-3 protein 26279 10.4 66.1 3 4.80
112684 14-3-3-LIKE PROTEIN A (14-3-3A) 29334 9.2 66.1 3 4.83
11262432
DNA damage checkpoint protein rad24 - fission yeast 
(Schizosaccharomyces pom be) 30357 8.9 66.1 3 4.84
19115079
dna damage checkpoint protein Rad24p [Schizosaccharomyces 
pombe] 30064 8.9 66.1 3 4.66
17542208 endoplasmin (87.1 kD) (4L887) ((Caenorhabditis elegans] 87058 2.4 65.8 5 4.97
39593714 Hypothetical protein CBG06014 [Caenorhabditis briggsae] 87138 2.4 65.8 5 5.03
16596797 hemocyanin [Octopus dofleini] 334668 0.7 65.5 2 5.61
6685487 Hemocyanin G-type, units Oda to Odg 331711 0.7 65.5 2 5.58
32266201
Inosinic acid dehydrogenase GuaB [Helicobacter hepadcus 
ATCC 51449] 52001 2.9 65.3 2 6.77
38077190 expressed sequence A1507495 [Mus musculus] 56715 3.7 65.1 2 7.08
6492278
coatomer complex COPI delta-COP subunit [Drosophila 
melanogaster] 54198 2.4 65.0 1 5.56
3256111 EG:63B12.10 [Drosophila melanogaster] 57782 2.3 65.0 1 5.85
38146975 DN A  polymerase I [Caldicellulosiruptor saccharolyticus] 97778 1.9 64.9 4 5.99
23619253 helicase, putadve [Plasmodium falciparum 3D7] 136547 1.0 64.8 3 8.21
33872678 YW HAZ protein [Homo sapiens] 31711 7.9 64.5 3 4.94
123615 Heat shock 70 kDa protein, mitochondrial precursor 71102 2.9 64.1 2 7.49
25553516 mitochondrial HSP70 [Trypanosoma congoleme] 71625 2.9 64.1 2 5.70
38104826 hypothetical protein MG09353.4 [Magnaporthe grisea 70-15] 77045 1.4 63.7 3 5.99
19114004 atp-dependent dna helicase hus2 [Schizosaccharomyces pombe] 149553 0.7 63.7 2 6.73
17561130
em p24/gp25L/p24 family (23.7 kD) (5L804) [Caenorhabdids 
elegans] 23665 7.4 63.3 2 7.06
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39592002 Hypothetical protein CBG23171 [Caenorhabditis briggsae] 23618 7.4 63.3 2 7.02
3087752 S31 protein [Cyprinus carpio] 14867 11.7 63.3 2 4.91
33241320
Molecular chaperone, DnaK [Prochlorococcus marinus subsp. 
marinus str. CCMP1375] 68186 2.7 63.2 1 4.78
9909982 putative XIRG protein [Xenopus laevis] 54675 3.2 63.2 2 6.34
17433174 Transaldolase 37452 4 2 63.1 2 6.57
236793
13 kDa calgizzarin-like protein [rabbits, lung. Peptide Partial, 35 
aa] 3923 45.7 62.9 1 4.83
115499 Calgizzann (S100C protein) 11422 15.7 62.9 1 6.73
34811429
Chain A, Solution Structure O f  Rabbit Apo-SlOOall (19 
Models) 11291 15.8 62.9 1 6.69
7388240 Putative S100 calcium-binding protein A ll  pseudogene 11280 15.7 62.9 1 7.77
20874201 S100 calcium binding protein A ll  (calizzarin) [Mus musculus] 11075 16.3 62.9 1 5.28
25023967
similar to endothelial monocyte-activating polypeptide [Mus 
musculus] 11002 16.3 62.9 1 5.73
19113132 cell division control protein 7 [Schizosaccharomyces pombe] 119216 1.6 62.5 5 7.54
86248
dolichyl-diphosphooligosaccharide-protein glycotransferase 
(EC 2.4.1.119) giycosylation site-binding chain precursor - 
chicken 56929 2.6 62.3 2 4.84
45382295 giycosylation site-binding protein [Gallus gallus] 56856 2.6 62.3 2 4.84
27370850 Hspa5-prov protein [Xenopus laevis] 72375 2.7 62.1 2 5.03
860916 60C beta tubulin [Drosophila melanogaster] 48805 4.4 62.0 2 4.69
30088884 beta tubulin [Aplysia califomica] 50286 4.2 62.0 2 4.73
1066143 beta-tublin [Haliotis discus] 38269 5.6 62.0 2 5.85
27227551 class II beta tubulin isotype [Homo sapiens] 49884 4.3 62.0 2 4.82
4884102 hypothetical protein [Homo sapiens] 36792 5.8 62.0 2 4.85
45361395 hypothetical protein MGC75628 [Xenopus tropicalis] 49889 4.3 62.0 2 4.78
13097483 Tubb2 protein (Mus musculus] 33979 6.4 62.0 2 4.81
4105827 nuclear alpha-tubulin [Guillardia theta] 42355 4 2 61.8 2 6.14
13879585 1110014C03Rik protein [Mus musculus] 11327 16.0 61.7 2 7.82
16758214 integral membrane protein Tmp21-I (p23) [Rattus norvegicus] 24842 6.8 61.7 2 6.02
3915137
Transmembrane protein Tmp21 precursor (21 kDa 
Transmembrane trafficking protein) 23262 7.4 61.7 2 6.03
40555903 Transmembrane trafficking protein [Mus musculus] 24955 6.8 61.7 2 6.25
37748485 Wu:fe06g04 protein [Danio rerio] 24426 12 61.7 2 6.37
39595426 Hypothetical protein CBG04075 [Caenorhabditis briggsae] 49948 3.1 61.6 2 5.08
39596178 Hypothetical protein CBG16131 [Caenorhabditis briggsae] 49947 3.1 61.6 2 5.01
38109071 hypothetical protein MG06650.4 [Magnaporthe grisea 70-15] 51390 3.0 61.6 2 5.33
46107512 TBA_SORMA Tubulin alpha chain [Gibberella zeae PH-1] 49939 3.1 61.6 2 4.98
40746566
TBA1_EM ENI TUBULIN ALPHA-1 CHAIN [Aspergillus 
nidulans FGSC A4] 50327 3.1 61.6 2 4.92
28261777 ycfl protein [Atropa belladonna] 223728 0.8 61.5 3 9.70
16945685 disulfide isomerase [Ostertagia ostertagi] 54972 2.8 61.5 3 4.93
18086539 reverse transcriptase [Human immunodeficiency virus type 1] 26147 7.9 61.0 4 9.32
6689664 p24 deltal putative cargo receptor [Xenopus laevis] 23930 12 60.7 2 6.92
46318644 Enolase [Burk hoideria cepacia R1808] 45642 2.6 60.5 2 4.77
23612644
integral membrane protein, putative [Plasmodium falciparum 
3D7] 224933 0.9 60.3 3 8.74
23491117 235 kDa rhoptry protein [Plasmodium yoelii yoelii] 264686 1.1 60.3 6 6.35
2981970
Chain A, An Avian Class-Mu Glutathione S-Transferase, 
C gstm l-l At 1.94 Angstrom Resolution 25745 4.1 60.1 1 7.00
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10120620
Chain A, T yrll5 , Glnl65 And Trp209 Contribute To The 1,2- 
Epoxy-3-(P- Nitrophenoxy)propane Conjugating Activities O f 
Glutathione S-Transferase Cgstml-1 25730 4.1 60.1 1 7.00
5822511
Chain B, Ligand-Free Heterodimeric Human Glutathione S- 
Transferase M2-3 (Ec 2.5.1.18), Monodinic C 26411 4.0 60.1 1 5.37
8489487 class mu glutathione S-transferase [Capra hircua] 22332 4.8 60.1 1 8.57
255725
glutathione S-tranaferaae, GST=isoenzyme M4 [Syrian golden 
hamsters, Peptide Partial, 21 aa, aegmen 2439 42.9 60.1 1
10.4
5
204499 glutathione S-tranaferaae Y-b aubunit (EC 2.5.1.18) 21871 4.8 60.1 1 7.82
423912 mu-class glutathione S-tranaferaae hGSTYBX - hamster 25551 4.1 60.1 1 6.90
28494710 RIKEN cDNA 0610005A07 [Mus musculus] 25693 4.1 60.1 1 6.34
15897104 Hypothetical protein [Sulfolobus aolfataricus] 69157 2.7 60.1 5 8.62
13473927
DNA-directed DNA polymerase [Mesorhizobium loti 
MAFF303099] 106058 1.8 59.9 3 6.80
18311435 probable lysine decarboxylase [Clostridium perfringens] 54681 3 2 59.7 4 5.93
347527 riboaomal protein S3 10679 18.9 59.6 2 9.69
231660 Hypothetical 226 kDa protein ycfl (ORF 1901) 225999 0.6 59.4 2 9.74
46121903 hypothetical protein FG05329.1 [Gibberella zeae PH-1] 111987 12 58.9 2 5.68
18312252 conserved hypothetical protein [Pyrobaculum aerophilum] 49023 2.1 58.9 2 5.04
23488517 hypothetical protein [Plasmodium yoelii yoelii] 457509 0.5 58.7 6 5.36
45190352 AEL255Wp [Eremothedum goaaypii] 21400 8.5 58.6 2
10.2
7
4557966
Chain A, Ligand-Free Human Glutathione S-Transferaae M2-2 
(E.C.2.5.1.18), Monodinic Crystal Form 25597 4.1 58.4 1 6.02
21743012 OSJNBbOOl3003.2 [Oryza sadva (japonica culdvar-group)] 132160 1.2 58.4 3 8.86
1752728
alpha-aminoadipyl-cysteinyl-valine synthetase [Lysobacter 
lactamgenus] 411361 0.5 58.2 4 5.47
15922299
422aa long hypothetical interferon-gamma inducible protein 
[Sulfolobus tokodaii] 49426 3.3 58.1 3 6.66
45184912 AAR089Cp (Eremothedum gossypii] 186517 1.1 58.1 5 7.54
19698783 thiredoxin peroxidase [Acanthocheikmema viteae] 27703 6.1 58.1 2 5.10
17565948
predicted CDS, putadve protein family member (5S783) 
[Caenorhabdids elegans] 74114 1.4 58.0 3 4.61
19111953 putadve RNA binding protein [Schizosaccharomyces pombe] 31418 4.4 57.9 3 7.27
42519216 signal peptidase I [Lactobacillus johnsonii NCC 533] 21926 5.3 57.7 3 9.74
46323625
COG1012: NAD-dependent aldehyde dehydrogenases 
[Burkholderia cepacia R1808] 50608 2.7 57.6 2 5.74
32484222 Gstm2-prov protein [Xenopus laevis] 25375 4.1 57.4 1 7.64
46097256 hypothetical protein UM01791.1 [Usdlago maydis 521] 122733 0.9 57.4 2 7.92
12733945 40S ribosomal protein SI5a [Pladchthys flesus] 9145 21.3 57.3 2
10.4
3
36142 ribosomal protein homologous to yeast S24 [Homo sapiens] 14707 13.2 57.3 2
102
3
18000277 ribosomal protein S15 isoform [Lapemis hardwickii] 14846 13.1 57.3 2
10.0
7
14165469
ribosomal protein SI 5a; 40S ribosomal protein SI 5a [Homo 
sapiens] 14830 13.1 57.3 2
10.1
4
30109302 R psl5a protein [Mus musculus] 15610 12.3 57.3 2
10.0
1
45534427 hypothetical protein Mflo061301 [Mesoplasma florum LI] 68947 2.4 56.9 4 5.40
46129441 RS9_PODAN 40S ribosomal protein S9 (S7) [Gibberella zeae 21947 8.4 56.9 2 10.5
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PH-1] 3
14701840 MB2 [Plasmodium falciparum] 106077 2.2 56.7 5 6.85
23473347
Signal transduction histidine kinase (Desulfovibrio desulfuricans 
G20] 51082 3.3 56.6 2 5.76
38105537 hypothetical protein MG03548.4 [Magnaporthe grisea 70-15] 189263 0.9 56.5 4 5.51
30313543
mitochondrial malate dehydrogenase precursor [Plicopurpura 
patula] 24405 6.1 56.5 2 6.84
11493210 CAC17476.11 alpha tubulin [Usdlago maydis] 49072 5.4 56.4 3 4.92
28302252 Calr-prov protein [Xenopus laevis] 48491 4.1 56.4 2 4.42
28277246 Crc-prov protein [Xenopus laevis] 48998 4.1 56.4 2 4.41
20896331 RIKEN cDNA 4921538N17 [Mus musculus] 148522 2.1 56.3 5 6.36
11138320 vfl4-3-3c protein [Vida faba] 29664 6.8 56.2 2 4.79
15678305
bactenochlorophyll synthase 43 kDa subunit 
[Methanothermobacter thermautotrophicus] 42199 5.0 56.0 2 4.75
2895520 14-3-3 protein zeta [Xenopus laevis] 27712 9.0 56.0 2 4.73
34783865 MGC64423 protein [Xenopus laevis] 27741 9.0 56.0 2 4.70
27370992 Ywhaz-prov protein [Xenopus laevis] 27740 9.0 56.0 2 4.72
32398830 rhoptry protein, possible [Cryptosporidium parvum] 161902 1.6 55.9 4 6.01
31982284 UV radiation resistance associated [Mus musculus] 77514 1.0 55.8 1 8.20
6635207 Uvrag [Mus musculus] 38868 2.1 55.8 1 8.81
6319146 H2A protein (Oryza sadva] 14485 6.5 55.7 1
10.1
8
15224957 histone H2A, putadve [Arabidopsis thaliana] 14361 6.6 55.7 1
10.4
8
15232536 histone H 2A .P /Z  [Arabidopsis thaliana] 14532 6.6 55.7 1
10.3
2
37534390 putadve histone H2A [Oryza sadva (japonica culrivar-group)] 14603 6.5 55.7 1
10.3
9
198578 ribosomal protein 17730 5.9 55.6 1
11.1
2
28626512 ribosomal protein S18 [Danio rerio] 17721 5.9 55.6 1
10.9
9
41150652 similar to ribosomal protein [Homo sapiens] 17628 5.9 55.6 1
10.3
4
32469491 opdneurin; TFIIIA-INTP [Mus musculus] 66976 2.9 55.6 2 5.21
23598413 hemocyanin [Euprymna scolopes] 14367 8.0 55.4 2 6.57
6685493 Hemocyanin, beta-C chain unit G 46182 2.5 55.4 2 5.48
419976 calredculin (done 8) - African clawed frog (fragment) 45246 4.4 55.4 2 4.40
15384299 variable surface lipoprotein Vsp422-10 [Mycoplasma bo vis] 29812 2.8 55.2 1 8.37
21224465 putadve sensor kinase [Streptomyces coelicolor A3(2)] 41405 3.1 55.2 2 8.81
3426021 heat shock 70 kD protein cognate [Bombyx mori] 73052 2.7 55.1 2 5.13
27260894 heat shock cognate 70 protein [Spodoptera frugiperda] 73064 2.7 55.1 2 5.20
6681668 sea urchin Arp2 (SUArp2) [Hemicentrotus pulcherrimus] 44145 4.6 55.1 3 6.73
15791804
succinate dehydrogenase flavoprotein subunit [Campylobacter 
jejuni subsp. jejuni NCTC 11168] 66330 3.6 55.0 3 6.43
21230675
hypothetical protein [Xanthomona* campestris pv. campestns 
str. ATCC 33913] 31201 2.4 54.9 1 6.24
29375773 conserved hypothetical protein [Enterococcus faecalis V583] 33825 2.3 54.6 1 8.56
29346075 hypothetical protein [Bacteroides the taiotaomicron VPI-5482] 25484 3.3 54.6 1 8.87
10338322 14-3-3 epsilon (Schistosoma japonicum] 28529 8.0 54.6 3 5.64
42560899 D N A  polymerase III alpha chain (Mycoplasma mycoides subsp. 170741 0.6 54.5 2 6.10
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mycoides SC]
17559380 acyltransferase (82.0 kD) (5F913) [Caenorhabditis elegans] 82019 1.7 54.5 3 8.53
153462 sporulation protein 1422 49522 5.7 54.3 3 6.74
28630917 ADP-ribosylation factor [Gossypium hirsutum] 5426 22.4 54.2 1
10.1
2
29245482 GLP_334_11456_12031 [Giardia lamblia ATCC 50803] 21751 5.8 54.2 1 8.48
28436853 LOC398551 protein [Xenopus laevis] 20350 6.2 54.2 1 6.81
4102193 Tcarf [Trypanosoma cruzi] 7402 16.7 54.2 1 9.45
23017275 Leucyl-tRNA synthetase [Thermobifida fusca] 92582 3.9 54.1 3 5.23
40745738
GR78_NEUCR 78 KDA GLUCOSE-REGULATED 
PROTEIN HOM OLOG PRECURSOR (GRP 78) 
(IMMUNOGLOBULIN HEAVY CHAIN 73652 3.3 54.1 2 4.84
38081072 similar to myosin heavy chain [Mus musculus] 270321 1.1 53.9 6 6.51
41393050 polyprotein [Soybean mosaic virus] 354371 0.6 53.9 4 8.55
15895958 IMP dehydrogenase [Clostridium acetobutylicum] 52155 2.5 53.9 3 7.05
212997 keratin 49148 4.1 53.9 3 5.60
45198425 AFL096Cp [Eremothecium gossypii] 36577 1.9 53.8 1 6.90
15891262 AGR_L_2309p [Agrobacterium tumefaciens str. C58] 283038 0.2 53.8 1 5.22
22325705 hypothetical protein [Arabidopsis thaliana] 12857 5.4 53.8 1 9.95
34763159
hypothetical protein [Fusobacterium nudeatum subsp. vincendi 
ATCC 49256] 42809 1.6 53.8 1 5.20
29142237
membrane protein, suppressor for copper-sensidvity B 
precursor [Salmonella enterica subsp. enterica serovar Typhi 
Ty2] 68552 1.0 53.8 1 8.59
16759992
membrane protein, suppressor for copper-sensidvity B 
precursor [Salmonella enterica subsp. enterica serovar Typhi] 68580 1.0 53.8 1 8.59
15641108
oligopeptide ABC transporter, ATP-binding protein [Vibrio 
cholerae O l biovar eltor str. N16961] 37061 1.8 53.8 1 8.95
17937390 pepdde synthetase [Agrobacterium tumefaciens str. C58] 237031 0.3 53.8 1 5.18
16764472
suppression o f  copper sensidvity protein [Salmonella 
typhimurium LT2] 68623 1.0 53.8 1 8.75
16041069 glycogen branching enzyme [Aspergillus oryzae] 78701 1.9 53.8 3 5.62
29248824 GLP_22_45903_36058 [Giardia lamblia ATCC 50803] 370869 0.4 53.8 4 7.68
34540392 cell division protein FtsA [Porphyromonas gingivalis W83] 53875 3.1 53.7 3 5.55
2209034 FtsA [Porphyromonas gingivalis] 51193 3.3 53.7 3 5.54
15609566 ahpD  [Mycobacterium tuberculosis H37Rv] 18769 9.0 53.7 3 6.51
24159058
Chain A, Crystal Structure O f  Mycobacterium Tuberculosis 
Alkylperoxidase Ahpd H132q Mutant 18760 9.0 53.7 3 6.41
22219311
Chain A, Crystal Structure O f  Mycobacterium Tuberculosis 
Alkylperoxidase Ahpd H137f Mutant 18779 9.0 53.7 3 6.41
23509685
chloroquine resistance marker protein [Plasmodium falciparum 
3D7] 442796 0.4 53.6 4 8.64
46112098
COG1131: ABC-type mulddrug transport system, ATPase 
component [Moorella thermoacedca ATCC 39073] 26087 4.3 53.5 2 621
15626070 vitellogenin [Larus argentatus] 201549 0.8 53.5 4 9.18
7441379 hypothetical protein C44B11.3 - Caenorhabditis elegans 50866 4.6 53.5 2 5.05
39580244 Hypothetical protein CBG20310 [Caenorhabditis briggsae] 50060 4.7 53.5 2 5.00
17554312
MEChanosensory abnormality MEC-12, TuBulin, Alpha, 
specific o f 15 protofilament microtubules found in 
mechanosensory neurons (50.1 kD) (mec-12) [Caenorhabditis 
elegans] 50081 4.7 53.5 2 5.00
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21064813 RH71862p [Drosophila melanogaster] 50034 4.7 53.5 2 5.10
39996908 cell division protein FtsH [Geobacter sulfurreducens PCA] 67516 1.5 53.4 2 5.91
46364347
COG0673: Predicted dehydrogenases and related proteins 
[Kineococcus radiotolerans SRS30216] 35510 2.4 53.4 1 5.00
29346817
activator o f (R)-2-hydroxyglutaryl-CoA dehydratase 
[Bacteroides thetaiotaomicron VPI-5482] 156145 0.8 53.3 3 5.71
13358122 unique hypothetical [Ureaplasma urealydcum] 216587 0.8 53.1 4 8.70
27378001
phenyiacetic add degradation operon negative regulatory 
protein [Bradyrhizobium japonicum] 31669 2.4 53.1 1 6.62
7434407 S-receptor kinase (EC 2.7.1.-) - turnip 95772 1.3 53.1 3 822
1402512 S-receptor kinase SRK9 [Brassica rapa] 95513 1.3 53.1 3 8.11
23050378
Glycosyl transferases, related to UDP-glucuronosyl transferase 
[Methanosarcina barken] 42294 3.2 53.0 4 9.29
3334157
Peptide-prolyl ds-trans isomerase (PPIase) (Rotamase) 
(Cyclophilin) (Cyclosporin A-binding protein) 18273 8.7 53.0 2 8.36
29349208
two-component system sensor histidine kinase/response 
regulator, hybrid ( one-component system1) [Bacteroides 
thetaiotaomicron VPI-5482] 151234 1.6 52.9 5 6.03
40746570 hypothetical protein AN0320.2 [Aspergillus ntdulans FGSC A4] 165883 0.9 52.9 3 8.85
34912926
carboxypepddase precursor-like protein [Oryza sativa (japonica 
cultivar-group)] 48047 1.5 52.8 1 6.62
34541249
lipoprotein signal peptidase, putative [Porphyromonas gingivalis 
W83] 25121 3.1 52.8 1 6.59
17551432
putative protein, with a transmembrane domain (XO70) 
[Caenorhabditis elegans] 23336 3.5 52.8 1 5.54
38503269 30S ribosomal protein SI 63801 3.0 52.7 4 6.52
32413959 hypothetical protein [Neutospora crassa] 20834 9.2 52.5 2 8.94
11465738 NP_053882.11 ORF199 [Porphyra purpurea] 22268 7.5 52.5 2 4.68
44829140 TPA: ADP-ribosylahon factor 1; ARF1 [Trypanosoma brucd] 20611 6.0 52.5 1 8.80
15595887 hypothetical protein [Pseudomonas aeruginosa PA01] 429760 0.3 52.4 2 4.72
15027208 hypothetical protein [Erwinia chrysanthemi] 112491 1.4 52.3 4 8.65
13021648 peptidyi-prolyl ds-trans isomerase B [Xenopus laevis] 11343 10.6 52.3 3 9.36
32484306 Ppib-prov protein [Xenopus laevis] 23845 5.1 52.3 3 9.30
39996920
N-acetylmuramoyl-Dalanine amidase, family 3 [Geobacter 
sulfurreducens PCA] 45687 1.4 52.2 1 9.00
28317324 AT04875p [Drosophila melanogaster] 141444 0.6 52.1 1 8.20
46318277
COG0827: Adenine-specific DNA me thy Use [Burkholderia 
cepacia R1808] 145858 1.0 52.0 3 5.12
37287387 neural alfa2 tubulin [Paracentrotus livid us] 50161 4.6 51.8 2 4.90
32400736 putative alpha-tubulin [Oikopleura dioica] 39662 5.9 51.8 2 5.00
39588311 Hypothetical p ro tdn  CBG19875 [Caenorhabditis briggsae] 50009 4.8 51.8 2 5.03
23037696
ABC-type metal ion transport system, ATPase component 
[Oenococcus oeni MCW] 38957 4.5 51.8 2 9.07
42523406 cell division protdn [Bdellovibrio bactenovorus H D  100] 70941 1.4 51.7 2 6.26
19924051
cytokine-induced neutrophil chemoattractant-2 [Rattus 
norvegicus] 10982 10.0 51.7 3 9.43
38090277 RIKEN cDNA 1110008114 [Mus musculus] 196393 0.6 51.7 3 6.61
15594512 outer membrane protein (tpn50) [Borrelia burgdorferi] 45861 3.1 51.6 3 9.16
10179990 AAG13968.11 cyclophilin (Magnaporthe grisea] 23538 4 2 51.6 1 9.86
10179991 AAG13969.11 cyclophilin [Magnaporthe grisea] 17834 5.5 51.6 1 8.67
41615186 NEQ399 [Nanoarchaeum equitans Kin4-M] 32302 3.5 51.5 2 6.27
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31615504
Chain A, Structure O f Deoxygenated Hemocyanin Prom 
Rapana Thomasiana 46707 2.7 51.5 1 5.02
31076723 Hemocyanin type 2 unit e (RtH2-e) 47933 2.7 51.5 1 5.17
38345704 OSJNBb0085C12.6 [Oryza sativa (japonica cultivar-group)] 128580 1.5 51.5 3 5.60
15922739 195aa long hypothetical protein [Sulfolobus tokodaii] 22818 5.1 51.4 3 8.67
39584414 Hypothetical protein CBG19736 [Caenorhabditis briggsae] 22088 4.4 51.4 1 8.85
16943775 putative cyclophilin [Pieurotus ostreatus] 17604 5.5 51.4 1 9.37
2497858 Malate dehydrogenase, mitochondrial precursor 38485 2.9 51.2 1 8.76
45768386 D230019K20Rik protein [Mus musculus] 163109 0.6 51.1 3 6.39
14779065 KIAA1093 protein [Homo sapiens] 182703 0.5 51.1 3 6.57
9629470 IVa2 protein [Duck adenovirus A] 45730 2.5 51.0 2 8.95
23482828 dynein beta chain, ciliary [Plasmodium yoelii yoelii] 604279 0.4 51.0 6 5.47
4138173 allergen [Malassezia sympodialis] 17202 5.6 49.7 1 8.79
547682 Heat shock cognate protein (Aginactin) 70456 2.2 49.0 2 5.40
13537429 small GTPase Rabl [Entamoeba histolytica] 22882 7.3 49.0 2 5.95
45358795 conserved hypothetical protein [Methanococcus maripaludis S2] 34403 3.0 47.8 2 9.05
1708308 H EA T SHOCK PROTEIN 70 2 70030 2.2 45.7 2 4.95
124212 Type III intermediate filament 52787 3.3 44.3 3 5.06
40737034 putative Integrase [Oryza sativa (japonica cultivar-group)] 171484 0.8 40.8 3 7.37
281428 genome polyprotein - soybean mosaic virus (strain G7) 349484 0.6 40.0 4 7.75
15807795 aldehyde dehydrogenase (Deinococcus radiodurans] 52254 2.2 38.4 2 4.86
41147635
protein phosphatase 1, regulatory (inhibitor) subunit 9 A [Homo 
sapiens] 148111 0.8 37.5 3 5.30
38347275 OSJNBa0056L23.20 [Oryza sativa (japonica cultivar-group)] 72341 1.9 37.0 3 8.88
37534234 hypothetical protein [Oryza sativa (japonica cultivar-group)] 160432 0.8 36.5 3 7.53
46114676 hypothetical protein FG03180.1 [Gibberella zeae PH-1] 22746 5.4 35.9 2 4.94
17224953 tryparedoxin peroxidase [Trypanosoma cruzi] 22246 5.5 35.9 2 5.96
16798799 putative tape-measure protein [Bacteriophage A118] 186141 0.6 35.8 3 9.75
11131581 60 kDa chaperonin 1 (Protein Cpn60 1) (groELI protein) 57274 1.7 32.5 3 4.90
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8.3 A ppendix 3: Search result Conus textile in -gel
Ac­
cession
Number
Protein Description
Mass
(Da)
Sequence
Coverage
Mascot
Protein
Score
Number
of
Peptides
P1
27817324
SI:zC101N13.3 (novel protein similar to human RAS oncogene 
family member RAB IB) (Danio rerio] 22274 38.8 340.8 11 5.56
15277503 ACTB protein [Homo sapiens] 40194 22.5 337.7 10 5.55
2829750 ACTIN 41297 21.8 337.7 10 5.46
17647135 CG10067-PA [Drosophila melanogaster] 41808 21.5 337.7 10 5.23
17137090 CG18290-PA [Drosophila melanogaster] 41775 21.5 337.7 10 5.30
17975545 CG5178-PA [Drosophila melanogaster] 41673 21.5 337.7 10 5.29
576368 Chain A, Beta-Actin-Profilin Complex 41801 21.5 337.7 10 5.21
14278147
Chain A, Crystal Structure O f Caenorhabditis Elegans Mg-Atp 
Actin Complexed With Human Gelsolin Seg 41638 21.6 337.7 10 5.30
31196067 ENSANGP00000016398 [Anopheles gambiae] 41986 21.4 337.7 10 5.38
31210881 ENSANGP00000015027 [Anopheles gambiae] 42369 21.1 337.7 10 5.47
31210009 ENSANGP00000009996 [Anopheles gambiae] 42696 21.0 337.7 10 5.48
31210879 ENSANGP00000015039 [Anopheles gambiae] 43637 20.5 337.7 10 5.47
31212569 ENSANGP00000022308 [Anopheles gambiae] 43653 20.5 337.7 10 5.47
31204457 ENSANGP00000019055 [Anopheles gambiae] 45438 19.8 337.7 10 5.46
809561 gamma-actin (Mus musculus] 40992 22.0 337.7 10 5.56
19528317 LD04994p [Drosophila melanogaster] 40232 22.5 337.7 10 5.56
45361511 hypothetical protein MGC75587 [Xenopus tropicalis] 41738 21.6 336.0 10 5.30
231498 ACTIN 2 41792 21.5 335.0 10 5.30
17530805 CG4027-PB [Drosophila melanogaster] 41795 21.5 335.0 10 5.30
3421457 cytoplasmic actin (Dreissena polymorpha] 41826 21.5 335.0 10 5.30
2624850
Chain A, Structure O f  Bovine Beta-Actin-Profilin Complex With 
Actin Bound Atp Phosphates Solvent Ac 41664 21.6 334.3 10 5.15
6680602 keratin complex 1, acidic, gene 15; keratin 15 [Mus musculus] 49129 11.7 329.4 9 4.78
34784398 K rtl-15 protein [Mus musculus] 49463 11.6 329.4 9 4.79
8895859 actin [Cranchia scabra] 28519 35.2 312.7 10 5.14
13111394 larval keratin XLK [Xenopus laevis] 59904 8.6 302.3 7 5.82
6754488 keratin complex 2, basic, gene 6b [Mus musculus] 60285 9.6 292.3 7 8.51
3219772 ACTIN 51 37151 22.0 292.0 8 5.28
6678643 keratin complex 2, basic, gene 1 [Mus musculus] 65183 5.3 289.3 6 8.97
6754480 keratin complex 1, acidic, gene 13; keratin 13 [Mus musculus] 47724 10.8 284.8 9 4.79
23463261 vitamin K-dependent carboxylase [Conus textile] 93905 7.8 272.6 6 5.37
309215 EndoA" cytokeratin (5" end put.); putative 53210 6.3 252.8 5 5.42
13624315
keratin complex 2, basic, gene 8; cytokeratin 8; cytokeradn8; 
cytokeratin-8 [Mus musculus] 54220 6 2 252.8 5 5.40
19112997 yptl-related protein 1 [Schizosaccharomyces pombe] 22802 32.0 242.9 8 5.31
32398899
small G TP binding protein rabla, probable [Cryptosporidium 
parvum] 22790 24.1 228.5 7 7.63
1168322 ACTIN 71 41755 19.4 228.4 7 5.38
46275808
keratin complex 2, basic, gene 17; keratin complex 2, gene 17 [Mus 
musculus] 70934 1 2 220.5 6 8.23
38114739 KRT13 protein [Homo sapiens] 51029 9.3 217.2 7 4.95
49868 p u t beta-actin (aa 27-375) [Mus musculus] 39161 17.8 216.2 7 5.78
38077190 expressed sequence A1507495 [Mus musculus] 56715 6.9 215.4 6 7.08
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9910294
keratin complex 2, banc, gene 6g; keratin complex 2, gene 6g; 
caracul (Mus musculus] 57347 6.9 200.2 5 6.60
421942 GTP-binding protein, ras-related - common tobacco 22407 24.1 199.4 6 5.26
40786432 keratin complex 2, basic, gene 8; keratin 8 [Rattus norvegicus] 53985 7.0 194.0 5 5.83
349484 GTP-binding protein homologue 22210 19.5 193.8 5 5.55
3036959 CsCAl [Ciona savignyi] 41698 14.1 193.8 7 529
27764565 TPA: keratin 5c [Homo sapiens] 59333 6.6 192.4 5 7.55
741022 keratin 15 49086 7.1 183.9 5 4.75
183817 beta-globin 18919 36.6 181.3 6 6.28
3660434
Chain B, Crystal Structure O f Deoxy-Human Hemoglobin Beta6 
Glu->trp 15914 43.8 181.3 6 7.26
46014946
Chain B, Crystal Structure O f Human Hemoglobin E  At 1.73 A 
Resolution 15856 43.8 181.3 6 7.98
3660145
Chain B, Crystal Structure O f S-Nitroso-Nitrosyl Human 
Hemoglobin A 15865 43.8 181.3 6 6.81
5822282
Chain B, Deoxygenated Structure O f A Distal Pocket Hemoglobin 
Mutant 15930 43.8 181.3 6 6.70
442854
Chain B, Hemoglobin (Deoxy) Mutant With Val 1 Replaced By 
Ala In The Beta Chains (Beta Via) 15829 43.8 181.3 6 6.82
27065154
Chain B, Structure O f Mutant Human Carbonmonoxyhemoglobin 
C (Beta E6k) At 2.0 Angstrom Resolution I 15856 43.8 181.3 6 7.98
113226 ACTIN 15A 41800 10.9 181.1 6 5.29
71622 actin Cyl - sea urchin (Strongylocentrotus purpuratus) 41804 10.9 181.1 6 5.29
7387473 Cyl actin (Tripneustes gradlla] 41836 10.9 181.1 6 5.29
27525276 putative cytoskeletal actin [Ciona intestinalis] 41726 10.9 181.1 6 5.29
41018458 Substrate-specific endoprotease Tex31 precursor 33350 13.3 166.6 4 5.30
41393660 pupal-specific flight muscle actin [Aedes aegypd] 41572 8.8 165.3 5 5.29
114131 ADP-ribosyladon factor 21751 14.1 163.1 5 8.48
29245482 GLP_334_11456.12031 [Giardia lamblia ATCC 50803] 21751 14.1 163.1 5 8.48
229149 hemoglobin beta 15866 32.9 160.6 5 5.23
3318722 Chain E, Leech-Derived Tryptase InhibitorTRYPSIN COMPLEX 23457 13.5 158.2 5 8.26
71626 actin 7 - fruit fly (Drosophila melanogaster) 41778 14.1 153.5 5 5.30
17975540 CG7478-PA [Drosophila melanogaster] 41760 14.1 153.5 5 5.30
21064361 RE12057p [Drosophila melanogaster] 37816 15.5 153.5 5 5.36
1703124 ACTIN 6 41497 14.2 151.8 5 5.31
85358 actin - sea urchin (Strongylocentrotus purpura tus) 41025 14.3 150.2 5 5.97
1703122 ACTIN 5 41157 14.3 150.2 5 5.56
31212573 ENSANGP00000022307 [Anopheles gambiae] 30160 19.4 150.2 5 5.13
728798 ACTIN 11 41762 14.1 147.5 5 5.24
17647133 CG12051-PA [Drosophila melanogaster] 41797 14.1 147.5 5 5.30
31212571 ENSANGP00000022306 [Anopheles gambiae] 41990 11.1 144.9 5 5.52
31241979 ENSANGP00000022175 [Anopheles gambiae] 42640 10.9 144.9 5 5.58
41393662 pupal-specific flight muscle actin [Aedes aegypd] 41556 11.2 144.9 5 5.29
5669640
ethylene-responsive small GTP-binding protein [Lycopersicon 
esc ulen turn] 23755 13.9 144.3 4 8.37
1362065 GTP-binding protein GTP11 - garden pea 23687 14.0 144.3 4 7.66
1362067 GTP-binding protein GTP13 - garden pea 23791 14.0 144.3 4 7.66
1362066 GTP-binding protein GTP6 - garden pea 23924 13.9 144.3 4 7.63
479442 GTP-binding protein ypt2 - tomato 23896 13.9 144.3 4 7.64
33146687
putadve ethylene-responsive small GTP-binding protein [Oryza 
sadva (japonica cultivar-group)] 23978 14.0 144.3 4 7.63
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18447913 ras-related protein RAB8-1 [Nicodana tabacum] 23959 13.9 144.3 4 7.66
7438394 small GTP-binding protein rab-1 - turnip 25005 13.5 144.3 4 6.17
31210883 ENSANGP00000015031 [Anopheles gambiae] 42932 10.9 141.6 5 5.32
18656777 ras-like protein [Pythium spinosum] 9731 31.0 136.1 5 6.92
20911031
keratin complex 2, basic, gene 5; tuftelin interacting protein 8; 
keratin 5 [Mus musculus] 61729 5.0 135.2 3 7.59
31559819
keratin 25(2; type I inner root sheath specific keratin 25 irs3 
[Homo sapiens] 49793 5.9 134.2 4 5.06
20520618 Keratin 12 [Oncorhynchus mykiss] 51904 4.8 134.0 4 5.15
20520616 Keratin 13 [Oncorhynchus mykiss] 51938 4.9 134.0 4 5.17
12214171 putadve small GTP-binding protein (rablb) (Homo sapiens] 18648 19.6 128.7 4 9.87
32527715 Ac2-048 (Rattus norvegicus] 33643 9.6 123.1 4 9.72
103720 GTP-binding protein o-rabl - electric ray (Discopyge ommata) 22218 14.4 123.1 4 5.54
4585808 putadve RablA protein [Plasmodium falciparum] 23814 11.1 121.4 3 7.60
37360618 mKIAA3012 protein [Mus musculus] 27317 11.5 121.4 4 7.68
7546413
Chain A, The Yeast Acdn Val 159 Asn Mutant Complex With 
Human G dsolin Segment 1 41678 6.4 120.4 4 5.44
14318479
Structural protein involved in cell polarization, endocytosis, and 
other cytoskeletal functions; Ac 41663 6.4 120.4 4 5.44
37928140
Chain A, Crystal Structure O f Oxy-Human Hemoglobin Bassett 
At 2.15 Angstrom 15073 28.4 119.2 4 9.07
3114508
Chain A, R State Human Hemoglobin [alpha V96w], 
Carbonmonoxy 15204 28.4 119.2 4 8.73
27574247 Chain A, Dcoxy Hemoglobin (A,C:vlm,V621; BJD:v1m,V671) 15163 28.4 117.5 4 8.72
3891367 Chain A, Hemoglobin (Alpha Vim) Mutant 15149 28.4 117.5 4 8.72
996122
Chain A, Hemoglobin A (Deoxy) Mutant With Arg A 141 And 
Arg C 141 Deleted (Del R(A 141), R(C 141)) 14961 28.6 117.5 4 8.07
493850
Chain A, Hemoglobin Thionville Alpha Chain Mutant With Val 1 
Replaced By Glu And An Acetylated Met 15389 28.0 116.5 4 7.82
2982013 Chain A, Cyanomet R hbl.l (Recombinant Hemoglobin) 30305 14.1 112.4 4 8.91
9256890 Chain A, Deoxy Rhbl.2 (Recombinant Hemoglobin) 30362 14.1 112.4 4 8.91
122359 Hemoglobin alpha-I and alpha-II chains 14999 28.4 109.0 4 8.91
42523784 thiosulfate sulfurtransferase [Bdellovibrio bacteriovorus H D  100] 31343 4.3 103.6 1 9.45
440306 enhancer protein 22113 8.5 102.5 2 8.16
7963723 natural killer cell enhancement factor [Oncorhynchus mykiss] 22001 8.5 102.5 2 6.51
27806081 peroxiredoxin 1 [Bos taurus] 22151 8.5 102.5 2 8.81
45185452 ABR220Wp [Eremothecium gossypii] 22737 13.7 100.9 3 5.04
16974365 AT4gl7530/dl4800c [Arabidopsis thaliana] 22272 13.9 100.9 3 521
24648682 CG3320-PA [Drosophila melanogaster] 22748 13.7 100.9 3 5.31
28572143 CG3320-PB [Drosophila melanogaster] 16604 19.2 100.9 3 5.39
31208125 ENSANGP00000011746 [Anopheles gambiae] 23571 13.2 100.9 3 5.32
7438375 GTP-binding protein - Arabidopsis thaliana 24466 12.7 100.9 3 5.89
24306110 GTP-binding protein [Pichia angusta] 22561 13.8 100.9 3 5.48
303750 GTP-binding protein [Pisurn sativum] 22484 13.9 100.9 3 5.28
303732 GTP-binding protein [Pisum sativum] 22449 13.8 100.9 3 5.11
81634 GTP-binding protein ara-5 - Arabidopsis thaliana (fragment) 21708 14.3 100.9 3 5.30
92339 GTP-binding protein rablB  - rat 22176 13.9 100.9 3 5.55
7438439 GTP-binding protein SYPT - soybean 23997 12.8 100.9 3 4.94
466171 GTP-binding protein yptl 22462 13.8 100.9 3 5.47
82803
GTP-binding protein yptl - fission yeast (Schizosaccharomyces 
pombe) 23145 13.6 100.9 3 5.92
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32418088 GTP-BINDING PROTEIN YPT1 [Neurospora crassa] 26693 11.5 100.9 3 6.82
2500073 GTP-binding protein YPTC1 22584 13.8 100.9 3 5.94
466172 GTP-binding protein YPTM2 22461 13.8 100.9 3 5.88
401686 GTP-binding protein yptVl 22518 13.8 100.9 3 5.93
541978 GTP-binding protein, rag-like (clone vfa-yptl) - fava bean 22554 13.9 100.9 3 5.01
45360691 hypothetical protein MGC76044 [Xenopus tropicalis] 23083 13.9 100.9 3 8.21
38109427 hypothetical protein MG06962.4 [Magnaporthe grisea 70-15] 22448 13.9 100.9 3 527
34784624 MGC69101 protein [Xenopus laevis] 23110 13.9 100.9 3 8.52
34906164
putative GTP-binding protein [Oryza sativa (japonica cultivar- 
group)] 50107 6 2 100.9 3 9.83
21592670 putative Ras-like GTP-binding protein [Arabidopsis thaliana] 24070 13.0 100.9 3 7.63
38175435 putative ras-related protein [Oryza sativa (japonica cultivar-group)] 24026 13.0 100.9 3 7.68
34914060
putative RICl_ORYSA RAS-RELATED PROTEIN RIC1 
[Oryza sativa (japonica cultivar-group)] 22618 13.8 100.9 3 5.33
11558649 secretion related GTPase (SrgB) [Aspergillus niger] 22289 13.9 100.9 3 5.14
1053063 small GTP-binding protein 22542 13.8 100.9 3 5.89
1053067 small GTP-binding protein 22604 13.8 100.9 3 5.27
217841 small GTP-binding protein [Arabidopsis thaliana] 21609 14.4 100.9 3 5.30
7643790 small GTP-binding protein [Capsicum annuum] 22577 13.8 100.9 3 521
2808638 small GTP-binding protein [Daucus carota] 23940 13.0 100.9 3 7.63
1381678 small GTP-binding protein (Glycine max] 22410 13.9 100.9 3 5.12
1616614 small GTP-binding protein [Nicodana plumbaginifolia] 22502 13.8 100.9 3 5.50
15077428 small GTP-binding protein Y ptlp [Candida albicans] 23005 13.5 100.9 3 5.27
11558500 small GTP-binding protein YPTI [Hypocrea jecorina] 22407 13.9 100.9 3 5.47
40739629
YPT1_NEUCR GTP-binding protein yptl [Aspergillus nidulans 
FGSC A4] 22204 14.0 100.9 3 5.53
7533034 YptA [Aspergillus awamod] 22321 13.9 100.9 3 5.14
7438417 GTP-binding protein rabB - silkworm 22350 13.9 99.2 3 5.44
39588485 Hypothetical protein CBG01077 [Caenorhabditis briggsae] 22561 13.7 99.2 3 5.52
17558550 RAB family member (22.5 kD) (rab-1) [Caenorhabditis elegans] 22531 13.7 99.2 3 5.52
2500076 Ras-like GTP-binding protein YPTI 22278 13.9 99.2 3 7.60
40738692 ACT_BOTCI Actin [Aspergillus nidulans FGSC A4] 41682 9.6 97.7 3 5.54
46125915 ACTG_CEPAC Actin, gamma [Gibberella zeae PH-1] 42180 9.5 97.7 3 5.54
202547 iodothyronine 5" -monodeiodinase 30136 4.9 97.0 4 5.09
6063529 70 kDa heat shock protein [Capra hircus] 69824 3.0 96.1 2 5.51
11177910
testis-specific heat shock protein-related gene hst70 [Rattus 
norvegicus] 69486 3.0 96.1 2 5.44
38103539 hypothetical protein MG03982.4 [Magnaporthe grisea 70-15] 39700 10.1 96.0 3 5.62
45382561 GTP-binding protein [Gallus gallus] 23507 11.8 94.5 2 5.98
106185 GTP-binding protein Rab2 - human 23549 11.8 94.5 2 6.08
28556900 GTP-binding protein rab-2 homologue [Ciona intestinalis] 20015 14.2 94.5 2 6.92
18652793 vitamin K-dependent gamma-glutamyl carboxylase \Canus Uxtilt\ 93858 2.8 93.2 2 5.37
132270 Rubber elongation factor protein (REF) (Allergen Hev b 1) 14713 13.0 90.6 2 5.04
40787691 LOC395048 protein [Xenopus tropicalis] 56745 3.5 90.4 3 4.73
32822847 MGC64309 protein [Xenopus laevis] 56604 3.6 90.4 3 4.72
68288 carbonate dehydratase (EC 4.2.1.1) II - bovine (tentative sequence) 28963 11.6 90.1 2 7.93
30466252 carbonic anhydrase II [Bos taurus] 29096 11.5 90.1 2 6.41
46016008
Chain A, Crystal Structure Analysis O f  Bovine Carbonic 
Anhydrase Ii 28965 11.6 90.1 2 6.40
46016010 Chain C, Crystal Structure Analysis O f The Site Specific Mutant 29199 11.5 90.1 2 6.63
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(Q253c) O f Bovine Carbonic Anhydras
4557581 fatty add binding protdn 5 (psoriasis-associated) [Homo sapiens] 15155 13.3 89.4 2 6.60
28436918 P4hb protein [Xenopus laevis] 57980 3.5 88.7 3 4.81
2914482
Chain A, Complex O f The Second Kumtz Domain O f Tissue 
Factor Pathway Inhibitor With Porcine Trypsi 23460 13.5 88.6 5 8.26
1942351
Chain A, Crystal Structure O f The First Active Autolysate Form 
O f The Porcine Alpha Trypsin 13284 24.0 88.6 5 7.83
494360
Chain A, Trypsin (E.C.3.4.21.4) Complexed With Inhibitor From 
Bitter Gourd 23458 13.5 88.6 5 8.60
999627 Chain B, Porcine E-Trypsin (E.C.3.4.21.4) 8814 36.6 88.6 5 6.67
3183057 ARGININE KINASE (AK) 39077 9.5 87.7 3 7.12
24585671 CGI 7949-PA [Drosophila melanogaster] 13688 18.7 85.1 3 10.34
31195811 ENSANGP00000000106 [Anopheles gambiae] 10626 24.2 85.1 3 9.79
31194099 ENSANGP00000012781 [Anopheles gambiae] 11308 23.0 85.1 3 10.22
31239833 ENSANGP00000014150 [Anopheles gambiae] 13751 18.5 85.1 3 10.34
31196269 ENSANGP00000012046 [Anopheles gambiae] 14426 17.7 85.1 3 10.27
31194615 ENSANGP00000000003 [Anopheles gambiae] 15691 16.2 85.1 3 10.46
31239831 ENSANGP00000014080 [Anopheles gambiae] 17000 15.0 85.1 3 10.48
17561988 histone (his-4) [Caenorhabditis elegans] 15634 16.3 85.1 3 10.40
38564173 histone 2B [Drosophila sec he Ilia] 13212 19.3 85.1 3 10.32
39581593 Hypothetical protdn CBG01507 [Caenorhabditis briggsae] 13492 18.9 85.1 3 10.40
39583631 Hypothetical protein CBG10818 [Caenorhabditis briggsae] 13535 18.7 85.1 3 10.34
17562020 predicted CDS, histone (his-39) [Caenorhabditis elegans] 12702 20.5 85.1 3 9.99
6686553 putative H2B histone [Asellus aquatkus] 13764 18.7 85.1 3 10.39
37589438 MGC69157 protein [Xenopus laevis] 25098 7.5 85.0 2 6.70
3023913 Putative RAS-related protein COS41.2 24602 7.8 85.0 2 6.84
20306864 Keratin 23, isoform a [Homo sapiens] 48147 4.3 84.2 3 6.09
22001960 40S ribosomal protein SI5a 14735 13.1 83.9 2 9.89
24652557 CGI2324-PA (Drosophila melanogaster] 14732 13.1 83.9 2 9.84
17975567 CG2033-PD [Drosophila melanogaster] 14762 13.1 83.9 2 9.84
36142 ribosomal protein homologous to yeast S24 [Homo sapiens] 14707 13.2 83.9 2 10.23
18000277 ribosomal protein S15 isoform [Lapemis hardwickii] 14846 13.1 83.9 2 10.07
45504881 ribosomal protein SI5a [Danio rerio] 14830 13.1 83.9 2 10.14
12804561 Ribosomal protein SI 5a [Homo sapiens] 14770 13.1 83.9 2 10.14
1082767 ribosomal protein SI5a, cytosolic [validated] - human 14844 13.1 83.9 2 10.14
14165469
ribosomal protein SI5a; 40S ribosomal protdn SI5a [Homo 
sapiens] 14830 13.1 83.9 2 10.14
30109302 Rpsl 5a protein [Mus musculus] 15610 12.3 83.9 2 10.01
39595176 Hypothetical protein CBG03777 [Caenorhabditis briggsae] 103310 2.5 83.4 3 9.23
39595059 Hypothetical protein CBG17727 [Caenorhabditis briggsae] 20549 8.9 82.4 2 6.43
17136990 CG5409-PA [Drosophila melanogaster] 42003 6.4 81.8 3 5.63
12084563 Chain A, Crystal Structure O f Sec4-Gdp 19071 12.9 80.1 2 5.11
12084567
Chain A, Crystal Structure O f  Sec4-Guanosine-5"-(Beta,Gamma)- 
Imidotriphosphate 19131 12.9 80.1 2 5.11
23613148 GTPase, putative [Plasmodium falciparum 3D7] 22872 11.0 80.1 2 6.18
39645075 MGC68722 protein [Xenopus laevis] 16554 15.4 80.1 2 8.81
23479748 putative GTPase [Plasmodium yoelii yoelii] 25890 9.8 80.1 2 8.46
14318517
Secretory veside associated Rab GTPase that binds to Secl5p and 
is essential for exocytosis; Sec4p [Saccharomyces cerevisiae] 23491 10.2 80.1 2 6.62
9965598 peroxidoxin-2 [Litomosoides sigmodontis] 21320 7.8 79.2 2 6.41
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12751382 thioredoxin peroxidase [Brugu malayi] 18005 9.2 79.2 2 6.28
19698783 thiredoxin peroxidase [Acanthocheilonema viteae] 27703 6.1 79.2 2 5.10
2959746 putative SEC4 protein [Candida giabrata] 23666 10.2 78.4 2 6.62
3212313 Chain A, Artificial Mutant (Alpha Y42h) O f Deoxy Hemoglobin 15091 15.6 77.2 2 8.76
3212437 Chain A, R-State Human Caffoonmonoxyhemoglobin Alpha-A53s 15133 15.6 77.2 2 8.73
28277305 Vim4 protein [Xenopus laevis] 53507 3.5 76.8 2 5.12
32450567 Vim4 protein [Xenopus laevis] 53572 3.5 76.8 2 5.12
138532 Vimentin 4 53464 3.5 76.8 2 5.08
138531 Vimendns 1 and 2 52812 3.5 76.8 2 5.16
21357783 CG7768-PB [Drosophila melanogaster] 17760 7.3 75.8 2 8.32
45549139 CG9916-PA [Drosophila melanogaster] 24650 5.3 75.8 2 9.34
32450581 LOC398630 protein [Xenopus laevis] 20896 6.2 75.8 2 9.12
229953
Chain G, D-Glyceraldehyde-3-Phosphate Dehydrogenase 
(E.C.l.2.1.12) 35804 4 2 74.6 1 629
9967445 glyceraldehyde-3-phosphate dehydrogenase [Actinomucor elegans] 8694 17.5 74.6 1 4.81
39589064 Hypothetical protein CBG00820 [Caenorhabditis briggsae] 36229 4.1 74.6 1 8.24
39581573 Hypothetical protein CBG01479 [Caenorhabditis briggsae] 36376 4.1 74.6 1 7.68
38603063
putative cytosolic glyceraldehyde-3-phosphate dehydrogenase 
[Cryptomeria japonica] 15563 9.6 74.6 1 7.90
14423267 small GTP-binding protein Rab8 [Entamoeba histolytica] 16478 19.3 74.4 3 5.58
14423577 small GTP-binding protein Rab8 [Entamoeba histolytica] 22258 14.1 74.4 3 5.05
17647301 CG4886-PA [Drosophila melanogaster] 33255 4.0 74.2 2 5.72
7770087 arginine kinase [Sepioteuthis lessoniana] 39059 5.2 74.1 2 6.28
11465738 ORF199 [Porphyra purpurea] 22268 7.5 73.0 2 4.68
16945685 disulfide isomerase [Ostertagia ostertagi] 54972 2.8 72.9 3 4.93
9506669 keratin 24 [Homo sapiens] 55111 3.6 72.3 2 4.86
17565064 histone 3.3 (15.3 kD) (5N140) [Caenorhabditis elegans] 15340 10.3 71.0 2 11.40
15238430 histone H3 [Arabidopsis thaliana] 15582 10.1 71.0 2 1126
17137088 CG3269-PA [Drosophila melanogaster] 23546 5.2 70.7 1 5.98
6517192 Drab2 [Drosophila melanogaster] 23523 5.2 70.7 1 5.85
7438437 GTP-binding protein rab2 - rice 24903 4.9 70.7 1 8.74
7438383 GTP-binding protein rab2 - soybean 23155 5.2 70.7 1 7.70
7438379 GTP-binding protein RAB2A - Arabidopsis thaliana 22887 5.3 70.7 1 6.97
2500074 GTP-binding protein YPTC4 23583 5.2 70.7 1 7.01
7438438 GTP-binding protein yptm3 - maize 23027 5.2 70.7 1 6.96
549811 GTP-binding protein yptV4 (RAB2 homolog) 23682 5.2 70.7 1 7.01
39586261 Hypothetical protein CBG12011 [Caenorhabditis briggsae] 23635 5.1 70.7 1 622
38344743 OSJNBa0089K21.1 [Oryza sativa (japonica cultivar-group)] 23070 52 70.7 1 6.96
5738168
putative intermediate compartment protein [Tetrahymena 
thermophila] 23873 52 70.7 1 6.84
13397937 putative Rab2 GTPase [Plasmodium falciparum 3D7] 24394 5.2 70.7 1 6.33
16755592 small GTPase Rab2 [Nicodana tabacum] 23155 5.2 70.7 1 6.90
6624302 small GTP-binding protein [Carica papaya] 23294 5.2 70.7 1 8.43
33357681 putadve mitochondrial cyclophilin 1 [Botryodnia fuckeliana] 24210 8.1 70.6 2 9.14
39595509 Hypothedcal protein CBG04174 [Caenorhabditis briggsae] 40331 6.9 70.2 3 8.58
13879585 1110014C03Rik protein [Mus musculus] 11327 9.6 70.2 1 7.82
17561130
em p24/gp25L/p24 family (23.7 kD) (5L804) [Caenorhabdids 
elegans] 23665 4.4 70.2 1 7.06
39592002 Hypothedcal protein CBG23171 [Caenorhabdids bnggsae] 23618 4.4 70.2 1 7.02
16758214 integral membrane protein Tmp21-I (p23) [Rattus norvegicus] 24842 4.1 70.2 1 6.02
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32484216 MGC64264 protein [Xenopus laevis] 23761 4.4 70.2 1 5.81
32484308 MGC64308 protein [Xenopus laevis] 23976 4.3 702 1 6.92
6689664 p24 deltal putative cargo receptor [Xenopus laevis] 23930 4.3 70.2 1 6.92
6323630
Protein that forms a heterotrimeric comnplex with E rpl, Erp2p, 
and Emp24, member o f the p24 family involved in endoplasmic 
reticulum to Golgi transport; Erv25p [Saccharomyces cerevisiae] 24092 4.3 70.2 1 5.36
3087752 S31 protein (Cyprinus carpio] 14867 7.0 702 1 4.91
3915137
Transmembrane protein Tmp21 precursor (21 kDa 
Transmembrane trafficking protein) 23262 4.4 102 1 6.03
1063411 unnamed protein product [Xenopus laevis] 23771 4.4 102 1 5.69
37748485 Wu:fe06g04 protein [Danio rerio] 24426 4.3 70.2 1 6.37
23127071 ATTase involved in DNA repair [Nostoe punctiforme] 59730 2.3 69.5 2 5.06
202549 iodothyronine 5" monodeiodinase 54033 3.1 69.4 2 4.87
27806501
procoUagen-proline, 2-oxoghitaratc 4-dioxygenase [proline 4- 
hydroxylase], beta polypeptide [protei 57230 2.9 69.4 2 4.80
6981324
prolyl 4-hydroxylase, beta polypeptide; Protein disulfide isomerase 
(Prolyl 4-hydroxylase, beta po 56829 3.0 69.4 2 4.82
339647 thyroid hormone binding protein precursor 57069 3.0 69.4 2 4.82
24641150 CG32671-PA [Drosophila melanogaster] 22758 5.6 69.3 1 621
24641047 CG32678-PA [Drosophila melanogaster] 22830 5.6 69.3 1 621
20129057 CG9575-PA [Drosophila melanogaster] 22848 5.5 69.3 1 8.72
24641058 CG9807-PA [Drosophila melanogaster] 22934 5.6 69.3 1 5.76
4895063 GTP-binding protein [Trypanosoma cruzi] 23828 5.0 69.3 1 6.15
549813 GTP-binding protein yptV5 23038 5.4 69.3 1 5.73
39584751 Hypothetical protein CBG13205 [Caenorhabditis briggsae] 23329 5.3 69.3 1 8.54
6983543 LmRab7 GTP-binding protein [Leishmania major] 24134 4.9 69.3 1 527
33284843
SI:dZ146N9.2 (novel protein similar to human member o f RAS 
oncogene family (RAB35)) [Danio rerio] 8552 14.5 69.3 1 8.09
227879 cyclophilin 18995 8.4 69.2 2 8.65
32449722 ACTN1 protein [Xenopus laevis] 102992 1.1 69.0 1 522
38018016 brain-specific alpha actinin 1 isoform [Rattus norvegicus] 105405 1.1 69.0 1 523
17511011
arginine kinase family member (40.4 kD) (1K924) [Caenorhabditis 
elegans] 40357 6.9 68.5 3 8.57
14602206 predicted transcription regulator [Aeropyrum pernix] 16148 10.6 68.3 2 9.86
24641064 CG32673-PA [Drosophila melanogaster] 22871 5.6 67.6 1 6.30
1666188 ORF8(2) [Rhodococcus erythropolis] 51619 2.5 67.6 2 8.83
46249431 protein disulfide isomerase [Ancylostoma caninum] 54749 3.2 67.6 2 4.88
38109352 hypothetical protein MG06894.4 [Magnaporthe grisea 70-15] 144266 0.9 67.5 2 5.41
63389 fibroblast alpha actinin [Gallus gallus] 98415 1.2 67.4 1 5.32
3551774 alpha-glycerophosphate oxidase [Streptococcus pneumoniae] 66751 2.1 612 2 4.98
15901992 hypothetical protein [Streptococcus pneumoniae TIGR4] 66755 2.1 612 2 4.98
29437296 Actg2 protein [Mus musculus] 22441 9.9 67.2 3 5.32
15229955 actin 11 (ACTl 1) [Arabidopsis thaliana] 41648 5.3 612 3 523
3219763 ACTIN 53 37346 6.0 67.2 3 5.39
1669389 actin 8 41862 5.3 67.2 3 5.37
6636384 alpha-cardiac actin [Danio rerio] 41969 5.3 612 3 529
294852 alpha-musde actin 41511 5.4 6 12 3 5.47
15983789 A T3gl8780/M V Ell_16 [Arabidopsis thaliana] 38597 5.8 6 12 3 6.03
309090 A-X actin 41667 5.3 612 3 521
22725710 beta actin-like protein [Chelydra serpentina serpentina] 19351 11.7 612 3 5.49
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7766848
Chain A, Complex Between Rabbit Muscle Alpha-Actin: Human 
Gelsolin Domain 1 41998 5.3 67.2 3 5.17
229690 Chain A, Deoxyribonuclease I Complex With Actin 41523 5.4 67.2 3 5.09
20664362
Chain A, Polylysine Induces An Antiparallel Actin Dimer That 
Nucleates Filament Assembly: Crystal S 41273 5.4 67.2 3 5.46
39654752
Chain A, Structure O f Rabbit Actin In Complex With Kabinunide
C 41764 5.3 67.2 3 5.17
15825662 Chain A, Uncomplexed Actin 41875 5.3 67.2 3 5.10
15321578 fast muscle actin [Scyliorhinus retifer] 42002 5.3 67.2 3 5.16
39579170 Hypothetical protein CBG24445 [Caenorhabditis briggsae] 37606 5.9 67.2 3 5.71
39591126 Hypothetical protein CBG02161 [Caenorhabditis briggsae] 41059 5.4 612 3 5.09
39591127 Hypothetical protein CBG02162 [Caenorhabditis briggsae] 41087 5.4 612 3 5.09
39579169 Hypothetical protein CBG24444 [Caenorhabditis briggsae] 41597 5.3 67.2 3 5.20
45361557 hypothetical protein MGC75582 [Xenopus tropicalis] 42006 5.3 67.2 3 5.23
45360805 hypothetical protein MGC75697 [Xenopus tropicalis] 41957 5.3 67.2 3 5.22
28436790 MGC53823 protein [Xenopus laevis] 41992 5.3 67.2 3 522
2967678 smooth muscle gamma actin [Gallus gallus] 41876 5.3 67.2 3 5.31
4902905 unnamed protein product [Xenopus laevis] 42024 5.3 67.2 3 5.23
64509 unnamed protein product (Xenopus laevis] 41940 5.3 67.2 3 5.22
21357425 keratin complex 2, basic, gene 20 [Mus musculus] 57076 3.5 67.1 2 5.99
24158633 Chain A, Cyclophilin_5 From C. Elegans 19848 4.4 66.6 1 9.22
39584414 Hypothetical protein CBG19736 [Caenorhabditis briggsae] 22088 3.9 66.6 1 8.85
32484306 Ppib-prov protein [Xenopus laevis] 23845 3.7 66.6 1 9.30
212995 keratin 49724 3.3 65.5 2 5.27
29246691 GLP_9_1234_4455 [Giardia lamblia ATCC 50803] 120953 1.2 64.7 2 5.73
14245706 kinesin-like protein 6 [Giardia intesdnalis] 109871 1.3 64.7 2 5.62
39581425 Hypothetical protein CBG22522 [Caenorhabditis briggsae] 135073 0.9 64.1 2 8.86
45185754 ACR068Wp [Eremothedum gossypii] 209157 0.8 64.0 2 6.24
15897817
Glutamyl-tRNA -Gin amidotransferase, subunit B (gatB-2) 
[Sulfolobus solfataricus] 71490 2.2 64.0 2 5.91
34763462
hypothetical protdn [Fusobacterium nudeatum subsp. vincendi 
ATCC 49256] 96812 1.4 63.6 2 9.00
37362272 2-peptidylprolyl isomerase A [Danio rerio] 17390 9.1 63.5 2 8.87
45382027 S-cydophilin [Gallus gallus] 22399 16.9 63.2 3 9.40
15606629 hypothetical protein [Aquifex aeolicus] 28500 4.8 62.8 2 10.16
20808349
Transcriptional regulator o f sugar metabolism 
[Thermoanaerobacter tengcongensis] 27854 5.2 62.7 2 8.67
23110237
COG1012: NAD-dependent aldehyde dehydrogenases 
[Novosphingobium aromadcivorans] 53766 2.2 62.5 1 5.32
3334157
Pepddyl-prolyl ds-trans isomerase (PPIase) (Rotamase) 
(Cyclophilin) (Cyclosporin A-binding protein) 18273 8.7 62.1 2 8.36
41387680 phosphoenolpyruvate carboxylase [Chlamydomonas reinharddi] 131160 1.4 62.1 2 6.10
15078743 030L [Invertebrate iridescent virus 6] 60163 1.3 62.0 1 8.33
17543744
6-phosphogluconolactonase (30.4 kD) (4P533) [Caenorhabditis 
elegans] 30395 2.6 62.0 1 5.16
23028343
Asp-tRNAAsn/Glu-tRNAGln amidotransferase A subunit and 
related amidases [Microbulbifer degradans 2-40] 65729 1.1 62.0 1 5.07
15835008 ATP-dependent Q p  protease, subunit B [Chlamydia mundarum] 96544 0.8 62.0 1 5.43
23017454 COG 1201: Lhr-like helicases [Thermobifida fusca] 80264 1.0 62.0 1 6.39
20808304 hypothedcal protein [Thermoanaerobacter tengcongensis] 13082 5.8 62.0 1 4.59
37523779 probable ABC transporter ATP-binding protein [Gloeobacter 34946 2.2 62.0 1 8.89
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violaceus PCC 7421]
25309645 Y57G11C.3 [imported] - Caenorhabdids elegans 29057 2.7 62.0 1 5.26
27806469 pepddylprolyl isomerase B (Bos taurus] 22687 16.8 61.5 3 923
18025342 beta-D-xylosidase [Hordeum vulgare] 83476 2.6 61.4 2 6.36
42781880 acetyl transferase, GNAT family [Bacillus cereus ATCC 10987] 16641 6.9 61.2 2 5.84
14518283 C-type lectin CTL-2 precursor [Necator americanus] 19979 3.9 60.7 1 4.73
13647113 arginine kinase [Cellana grata] 38497 5.2 60.7 2 5.91
32562852
abnormal CHEmotaxis CHE-3, altered AVeRmectin sensitivity 
AVR-1, OSModc avoidance abnormal OSM-2, abnormal 
CAFfeine-resistance CAF-2, dynein heavy chain (che-3) 
[Caenorhabdids elegans] 473519 0.2 60.3 1 5.81
37520551 hypothedcal protein glr0982 [Gloeobacter violaceus PCC 7421] 126916 0.6 60.3 1 5.42
7499348 hypothedcal protein F18C12.1 - Caenorhabditis elegans 469369 0.2 60.3 1 5.79
38344927 OSJNBa0018M05.18 [Oryza sadva (japonica cultivar-group)] 521760 0.2 60.3 1 5.70
17512384 BC031593 protein [Mus musculus] 59144 4.4 60.2 2 7.10
22164776 cDNA sequence BC031593 [Mus musculus] 57517 4.5 60 2 2 7.55
23613877 hypothedcal protein [Plasmodium falciparum 3D7] 49524 4.6 60.2 2 4.75
6319146 H2A protein [Oryza sadva] 14485 6.5 59.9 1 10.18
15232536 histone H 2A .F/Z  [Arabidopsis thaliana] 14532 6.6 59.9 1 10.32
37534390 putadve histone H2A [Oryza sadva (japonica culdvar-group)] 14603 6.5 59.9 1 10.39
23053281 COG0117: Pyrimidine deaminase [Geobacter metallireducens] 39502 2.2 59.8 1 9.16
439534 guanine nucleotide regulatory protein 14418 16.0 59.8 2 8.86
1834381 first subunit o f lichenysin synthetase [Bacillus licheniformis] 402113 0.3 59.5 2 5.17
3080742 lichenysin synthetase A; LicA [Bacillus licheniformis] 402324 0.3 59.5 2 5.20
39582454 Hypothedcal protein CBG11853 [Caenorhabdids briggsae] 515694 0.2 59.3 1 5.98
46132850
COG1249: Pyruvate/2-oxoglutarate dehydrogenase complex, 
dihydrolipoamide dehydrogenase (E3) component, and related 
enzymes [Ralstonia eutropha JMP134] 49120 1.7 59.3 1 6.03
13182948 Msh4p-related protein [Candida glabrata] 101107 1.7 59.0 2 8.73
4929993
Chain A, Module-Substituted Chimera Hemoglobin Beta-Alpha 
(F133v) 15780 11.0 59.0 2 7.21
1942686
Chain B, (Alpha-Oxy, Beta-(C112g)deoxy) T-State Human 
Hemoglobin 15811 11.0 59.0 2 6.81
27574230
Chain B, Cyanomet Hemoglobin (A-Gly-C:vlmT-29f,H58q; 
BJD:vlm,L106w) 15962 11.0 59.0 2 6.75
2982014 Chain B, Cyanomet R hbl.l (Recombinant Hemoglobin) 15903 11.0 59.0 2 7.13
1942682 Chain B, Deoxy (Beta-(C93a,C112g)) Human Hemoglobin 15779 11.0 59.0 2 6.82
27574252
Chain B, Deoxy Hemoglobin (A-Gly-C:vlm; 
B ,Drvl m,C93arN108k) 15871 11.0 59.0 2 7.14
2981643 Chain B, Hemoglobin (Val Betal Met, Trp Beta37 Tyr) Mutant 15866 11.0 59.0 2 6.75
183855 hbbm fused globin protein ( beta chain sequence to base 268) 10922 15.8 59.0 2 6.17
229172 hemoglobin delta 15897 11.0 59.0 2 7.97
13432059 mutant beta globin [Homo sapiens] 12226 14.4 59.0 2 5.65
30268354 hypothedcal protein [Homo sapiens] 185707 1.5 59.0 2 5.87
24649452 CG5338-PB [Drosophila melanogaster] 17351 9.7 58.9 2 10.23
41054687 coated vesicle membrane protein [Danio rerio] 22915 4.5 58.8 1 5.08
1352660 Cop-coated vesicle membrane protein p24 precursor 22175 4.6 58.8 1 5.07
28277266 Rnp24-prov protein [Xenopus laevis] 22826 4.5 58.8 1 4.99
32399098 hypothetical predicted protein, unknown function 255333 0.8 58.7 2 5.44
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[Cryptosporidium parvum]
15616868
GTP-binding protein Era [Buchnera aphidicola str. APS 
(Acyrthosiphon pisum)] 32881 4.6 58.5 2 9.77
40744755 hypothetical protein AN2226.2 [Aspergillus nidulans FGSC A4] 269269 0.3 58.4 1 8.91
15607114 transcriptional regulator (TetR/AcrR family) [Aquifex aeolicus] 22245 3.6 58.4 1 8.51
28573140 CG33104-PA [Drosophila melanogaster] 25143 5.1 58.3 2 6.55
28573133 CG33105-PA [Drosophila melanogaster] 28158 4.5 58.3 2 6.25
15920300 963aa long hypothetical protein [Sulfolobus tokodaii] 112099 1.2 58.2 2 8.19
39596886 Hypothetical protein CBG02408 [Caenorhabditis briggsae] 79728 1.8 58.1 2 5.31
2459908 anon2A5 [Drosophila melanogaster] 31665 3.3 57.9 2 6.13
45550758 CGI0340-PA [Drosophila melanogaster] 32014 3 2 57.9 2 6.11
38233306 Translocase protein [Corynebacterium diphtheriae] 96033 1.9 57.9 2 4.91
205055 keratin K5 9390 15.2 57.8 1 5.34
15899583
3-hydroxyacyl-CoA dehydrogenase (hdb-2) [Sulfolobus 
solfatahcus] 41452 3.0 57.8 2 6.81
6730537 A Chain A, Crystal Structure O f Vip2 With Nad 45462 3.0 57.7 2 6.26
41407942 Lpd [Mycobacterium avium subsp. para tuberculosis str. klO] 48706 1.8 57.6 1 6.33
7435435 phospho-beta-galactosidase I - Lactobacillus gasseri 55131 4.1 57.3 3 5.32
38105643 hypothetical protein MG03637.4 [Magnaporthe grisea 70-15] 176753 0.8 57.2 2 8.69
39579623 Hypothetical protein CBG22322 [Caenorhabditis briggsae] 41252 5.6 57.2 3 5.88
21223342 putative regulatory protein [Streptomyces coelicolor A3(2)] 124243 0.8 57.0 2 6.91
13310482 axonemal dynein heavy chain 8 Dnahc8 [Mus musculus] 397608 0.3 57.0 2 5.80
31088005 DNA polymerase B1 [Addianus bnerleyij 100215 2.1 56.9 2 8.60
2982220 Rho-associated kinase alpha [Xenopus laevis] 159185 1.5 56.8 3 5.93
41386727 protein kinase C substrate 80K-H [Bos taurus] 60113 1.9 56.7 1 4.36
22970133 hypothetical protein [Chloroflexus aurantiacus] 78923 0.9 56.7 1 4.78
18640216 SPV130 DNA ligase-like ptorein [Swinepox virus] 64677 3.0 56.5 2 8.92
10799285 keratin 17 [Notophthalmus vihdescens] 24351 6.6 56.4 2 5.14
1752728
alpha-aminoadipyl-cysteinyl-valine synthetase [Lysobactcr 
lactamgenus] 411361 0.4 56.3 2 5.47
32363171 Histone H2B 12523 19.5 56.2 2 10.53
11466760 ORF464 [Marchanda polymorpha] 57130 4.7 56.1 2 1032
15615079 fibronecdn/fibrinogen-binding protein [Bacillus halodurans] 65143 4.2 56.0 2 8.97
23482768 chloroquine resistance marker protein [Plasmodium yoelii yoelii] 425780 0.3 55.8 2 8.95
7486705 hypothetical protein F8M12.17 - Arabidopsis thaliana 182928 1.3 55.8 2 8.84
37524286
hypothetical protein [Photorhabdus luminescens subsp. laumondii 
T TO l] 28560 3.8 55.7 2 7.82
18418335 armadillo/beta-catenin repeat family protein [Arabidopsis thaliana] 49758 1.5 55.6 1 4.82
10185816 auxin-induced protein TGSAUR12 [tulipa gesneriana] 11340 7.1 55.6 1 9.26
7485612 hypothetical protein FI 715.130 - Arabidopsis thaliana 73367 1.0 55.6 1 622
29831315
putative DJ-l/PfpI-fam ily transcriptional regulator [Streptomyces 
avermitilis MA-4680] 23861 3.0 55.6 1 4.77
34557268
TRANSCRIPTIONAL REGULATOR (LYSR FAMILY) 
[Wolinella succinogenes] 34548 2.3 55.6 1 8.91
2764623 95 kD basal apparatus-protein [Spermatozopsis similis] 90194 1.1 55.6 1 7.44
23477111 histone H 4 [Colletotnchum sp.] 6814 16.7 55.5 1 10.67
19851831 fatty acid synthase beta subunit [Aspergillus parasiticus] 210297 0.7 55.4 3 6.51
18146786 CYP1 [Vigna radiata] 18195 8.7 55.1 2 8.70
6323562
Mitochondrial peptidyl-prolyl ds-trans isomerase (cyclophilin), 
catalyzes the ds-trans isomerization o f peptide bonds N-terminal 
to proline residues; involved in protein refolding after import into 19906 8 2 55.1 2 8.81
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mitochondria; Cpr3p (Saccharomyces cerevisiae]
18376589 putative cyclosporin A-binding protein [Picea abies] 18255 8.7 55.1 2 8.39
15927529 hypothetical protein [Staphylococcus aureus subsp. aureus N315] 143071 1.1 55.1 2 5.07
23039735
COG0675: Transposase and inactivated derivatives 
(Trichodesmium erythraeum IMS101] 41298 3.0 55.0 3 9.94
17551432
putative protein, with a transmembrane domain (XO70) 
[Caenorhabditis elegans] 23336 3.5 54.9 1 5.54
7682378 DNA polymerase [Leishmania enriettii] 34661 4.9 54.8 4 8.78
23509787 hypothetical protein [Plasmodium falciparum 3D7] 113162 0.9 54.8 2 5.51
46102596 hypothetical protein FG00002.1 [Gibberella zeae PH-1] 75376 2.8 54.6 2 5.18
729278
PPIA_STRCH Peptidyl-prolyl ds-trans isomerase A (PPIase A) 
(Rotamase A) (Cyclophilin ScCypA) (Cyclophilin homolog) 17705 9.1 54.5 2 5.32
46096722 hypothetical protein UM01171.1 [Ustilago maydis 521] 61573 3.1 54.4 2 7.96
15900638
transcriptional regulator, TetR family [Streptococcus pneumoniae 
TIGR4] 21714 5.4 54.4 1 9.35
21358147 CG2358-PA [Drosophila melanogaster] 20967 4.3 54.3 1 8.80
28829085 hypothetical protein [Dictyostelium discoideum] 20132 4.5 54.3 1 6.51
23028043
CO G 1115: Na+/alanine symporter (Microbulbifer degradans 2- 
40] 47221 1.5 54.2 1 9.33
41152179 hypothetical protein MGC73211 [Danio rerio] 15932 8.2 54.0 2 1023
10121615 ribosomal protein S19 [Gillichthys mirabilis] 16176 8.2 54.0 2 10.18
16924231 ribosomal protein S19 [Homo sapiens] 17271 7.6 54.0 2 10.52
12963511 ribosomal protein SI 9 [Mus musculus] 16076 8.3 54.0 2 10.41
37779108 ribosomal protein S19 [Pagrus major] 16035 8.2 54.0 2 1022
34855342 ribosomal protein S19 [Rattus norvegicus] 54950 2.4 54.0 2 10.45
4506695 ribosomal protein S19; 40S ribosomal protein S19 [Homo sapiens] 16051 8.3 54.0 2 10.31
34194029 Rpsl9-prov protein (Xenopus laevis] 16040 8.2 54.0 2 10.25
46370702 cytochrome P450 [Ammi majus] 59689 1.3 53.7 1 8.28
15923083 hypothetical protein [Staphylococcus aureus subsp. aureus Mu50] 121704 1.0 53.5 2 5.81
32029187 C O G 5295: Autotransporter adhesin [Haemophilus somnus 2336] 225562 1.0 53.5 2 6.52
32401451 hypothetical protein FLJ90492 [Homo sapiens] 103769 1.6 53.2 2 9.03
6225121 60 ItDa chaperonin (Protein Cpn60) (groEL protein) 56623 4.8 53.2 1 4.85
33087653 60 kDa heat shock protein [Yersinia rohdei] 10449 27.1 53.2 1 4.64
6730400
Chain A, Crystal Structure O f An Isolated Apical Domain O f 
Groel 15702 17.8 53-2 1 4.86
38492781 Chain A, Crystal Structure O f Groel-Groes 55124 5.0 53.2 1 4.87
2624772
Chain A, Crystal Structure O f  The Asymmetric Chaperorun 
Complex GroelGROES(ADP)7 57162 4.8 532 1 4.85
11513555
Chain A, Crystal Structure O f The Hexa-Substituted Mutant O f 
The Molecular Chaperonin Groel Apical 20816 13.5 532 1 5.04
11513557
Chain A, Crystal Structure O f The Hexa-Substituted Mutant O f 
The Molecular Chaperonin Groel Apical 20818 13.5 53.2 1 5.04
20151221
Chain A, Gro-El Fragment (Apical Domain) Comprising Residues 
188-379 20692 13.5 53.2 1 4.79
18655582
Chain A, Solution Structure O f Apo Groel By Cryo-Electron 
Microscopy 57091 4.8 532 1 4.81
39654074
Chain A, Structural And Mechanistic Basis For Allostery In The 
Bacterial Chaperonin Groel; See Rema 57060 4.8 532 1 4.90
29726355 Chain A, Structural Basis For Groel-Assisted Protein Folding 57033 4.8 532 1 4.84
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From The Crystal Structure O f (Groel-K
37963076 chaperonin 60 (bacterium DRB3-204] 19493 14.1 53.2 1 4.67
7443844 chaperonin groEL-like protein - Weevil 57007 4.8 53.2 1 4.92
42629991
COG0459: Chaperonin GroEL (HSP60 family) [Haemophilus 
influenzae R2846) 57763 4.7 53.2 1 4.86
42630824
COG0459: Chaperonin GroEL (HSP60 family) [Haemophilus 
influenzae R2866] 57518 4.7 53.2 1 4.86
22121898 Cpn60 [Actinobacillus actinomycetemcomitans] 19601 14.1 53.2 1 4.58
2554660
Groel (Hsp60 Class) Fragment (Apical Domain) Comprising 
Residues 191-376, Mutant With Ala 262 Repl 22016 12.8 53.2 1 5.73
1942200 Groel (Hsp60 Class) Fragment Comprising Residues 191 - 345 16614 16.8 53.2 1 4.82
25988672 GroEL [Brenneria alni] 17257 16.0 53.2 1 5.39
388217 ORF [Yersinia enterocolitica] 19247 14.1 53.2 1 4.70
466577 Yersinia enterocolitica hsp60, cross-reacting protein antigen 57550 4.7 53.2 1 4.88
15228914 calmodulin-binding protein [Arabidopsis thaliana] 96856 0.8 53.1 1 8.07
11498141
DNA gyrase, subunit B (gyrB) [Archaeoglobus fulgidus DSM 
4304] 57399 1.4 53.1 1 9.04
23491367 hypothetical protein [Plasmodium yoelii yoelii] 19691 4.2 53.1 1 4.75
13474495 hypothetical protein mll5392 [Mesorhizobium loti MAFF303099] 56296 1.4 53.1 1 6.75
23027223
Predicted hydrolases or acyl transferases (alpha/beta hydrolase 
superfamily) [Microbulbifer degradans 2-40] 37323 2.1 53.1 1 5.05
12230403
Probable proline iminopeptidase (PIP) (Prolyl aminopeptidase) 
(PAP) 36452 2.2 53.1 1 5.81
42524833 proline iminopeptidase [Bdellovibrio bacteriovorus H D  100] 36039 2.2 53.1 1 5.86
17987891 PROLINE IMINOPEPTIDASE [Brucella melitensis] 38945 2.1 53.1 1 6.23
23501221 proline iminopeptidase [Brucella suis 1330] 36523 2 2 53.1 1 5.94
21328237 putative cardiolxpin synthase [Listeria monocytogenes] 56661 1.4 53.1 1 7.79
29826626
putative erythropotesis-stimuladng protein [Streptomyces 
avermidlis MA-4680] 35832 2.1 53.1 1 5.87
29831053
putative LuxR-family transcriptional regulator [Streptomyces 
avermidlis MA-4680] 43360 1.7 53.1 1 7.25
7670023 transcription factor-like protein [Arabidopsis thaliana] 95322 0.8 53.1 1 8.65
23238152 putative RNA-dependent RNA polymerase VP1 [Kadipiro virus] 138459 \ 2 53.1 8.08
37522961 hypothetical protein glr3392 [Gloeobacter violaceus PCC 7421] 22417 6.1 53.0 1 5.54
14422251 3-oxyacyl-[acyl carrier protein] reductase [Brassica napus] 33120 2.5 53.0 1 9.48
14422263 beta-oxyacyl-[acyl-camer protein] reductase [Brassica napus] 33650 2.5 53.0 1 9.50
7452557 hypothetical protein F18C5.4 - Caenorhabdids elegans 77991 1.6 52.9 2 9.06
15609992 gorA (Mycobacterium tuberculosis H37Rv] 49914 2.0 52.9 2 5.41
20334298 OmCLC-K [Oreochromis mossambicus] 74786 1.5 52.8 2 8.37
16804182
weakly similar to mannose-6-phosphate isomerase [Listeria 
monocytogenes EGD-e] 66326 1.7 52.7 1 5.07
410319 with local similarity to fsn (fly) and Ring3; putadve 24104 5.1 52.7 2 9.76
24650611 CG3339-PA [Drosophila melanogaster] 521251 0.5 52.7 2 6.11
42490751 agrin [Mus musculus] 198119 0.7 52.6 2 5.81
6754362 insulin receptor-related receptor [Mus musculus] 144653 1.7 52.5 3 6.20
32479251 ferritin G F2 [Crassostrea gigas] 19916 4.1 52.5 1 5.15
33333949 ferritin-like protein [Pinctada fucata] 23564 3.4 52.5 1 5.61
42524205
hypothedcal protein predicted by Glimmer/Cridca [Bdellovibrio 
bacteriovorus HD100] 34125 2.3 52.5 1 7.71
1169742 Soma ferritin 20128 4.0 52.5 1 5.16
46097791 hypothetical protein UM05150.1 [Usdlago maydis 521] 200332 0.6 52.4 2 9.47
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42526000
methyl-accepting chemotaxis protein [Treponema dendcola ATCC 
35405] 76539 1.4 52.4 2 5.19
23508722 hypothetical protein [Plasmodium falciparum 3D7] 130240 1.0 52.1 2 9.41
39588960 Hypothetical protein CBG15812 [Caenorhabditis briggsae] 223656 0.7 52.0 2 5.72
27763987 VAB-10A protein [Caenorhabditis elegans] 389314 0.4 52.0 2 5.56
27801756 VAB-10A protein [Caenorhabditis elegans] 389386 0.4 52.0 2 5.55
17511191
VAB-10A protein, Variable ABnormal morphology VAB-10 (vab- 
10) [Caenorhabditis elegans] 223000 0.7 52.0 2 5.72
42564167 C2 domain-containing protein [Arabidopsis thaliana] 83393 1.4 51.9 1 8.49
15894911 Protein from bacterioferridn family [Clostridium acetobutylicum] 27082 3.8 51.9 1 5.17
42820781 nonribosomal peptide synthetase [Brevibacillus brevis] 567103 0.2 51.8 2 5.10
23510237
erythrocyte membrane protein 1 (PfEMPl) [Plasmodium 
falciparum 3D7] 404955 0.6 51.8 3 6.06
33599734 putative aldehyde dehydrogenase [Bordetella bronchisepdca RB50] 49943 1.7 51.8 1 5.96
23484385 hypothetical protein [Plasmodium yoelii yoelii] 99075 1.4 51.7 2 9.24
39933239
possible GTP-binding proteins [Rhodopseudomonas palustris 
CGA009] 37720 2.3 51.7 2 7.74
15228825
pentatricopepdde (PPR) repeat-containing protein [Arabidopsis 
thaliana] 63968 2.0 51.7 4 6.57
22972523 hypothedcal protein [Chloroflexus aurandacus] 150874 1.4 51.6 2 4.72
13357827 valyl-tRNA synthetase [Ureaplasma urealydcum] 103324 1.5 51.6 2 8.19
23508095 hypothedcal protein [Plasmodium falciparum 3D7] 201243 0.9 51.1 2 8.51
25405912 protein F21D18.22 [imported] - Arabidopsis thaliana 297021 0.4 51.1 2 8.10
311664 [Saccharomyces cerevisiae] 77085 1.6 51.0 2 5.75
608567 Bdflp 76959 1.6 51.0 2 5.82
6648536 moesin [Xenopus laevis] 68092 1.6 51.0 1 5.91
18311295 conserved hypothetical protein [Clostridium perfringens] 34184 2.7 50.9 1 9.94
45549214 CG8779-PA [Drosophila melanogaster] 90688 0.9 50.8 1 5.33
7511976 neuromusculin - fruit fly (Drosophila melanogaster) 113055 0.7 50.8 1 5.24
28493316 transcripdonal regulator [Tropheryma whipplei str. Twist] 17958 6.3 50.7 2 6.46
23019737 Protoheme ferro-lyase (fenochelatase) [Thermobifida fusca] 38882 2.6 50.7 2 5.16
46135873 hypothedcal protein FG09452.1 [Gibberella zeae PH-1] 219305 0.7 50.6 2 7.09
45201184 AGRD89Cp [Eremothecium gossypii] 156043 1.2 50.5 2 6.06
16127350 A crB/A crD /A crF family protein [Caulobacter crescentus CB15] 109788 1.0 50.4 2 8.90
23509864 hypothedcal protein [Plasmodium falciparum 3D7] 35173 3.7 50.3 2 9.88
15672293
ABC transporter ATP binding and permease protein [Lactococcus 
lac us subsp. lacds] 73979 1.8 50.1 2 5.53
33300661 putadve binding protein 7a5 [Homo sapiens] 96578 1.1 35.0 2 6.43
24665073 CG32152-PA [Drosophila melanogaster] 60409 1.7 34.5 2 9.35
555026 core protein 55235 2.4 23.8 2 9.19
46193696
COG0143: Methionyl-tRNA synthetase [Rhodobacter 
sphaeroides] 64505 1.4 23.5 2 5.36
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8.4 A ppendix 4: Search results from  Conus textile and Conus 
ventricosus protease treatm ent.
fraction - 
number
Accessio
n
Number
Protein Description
Mass
P a )
Sequence
Coverage
Mascot
Protein
Score
Number
of
Peptides
P1
v-a07-e01 18416277
14-3-3 protein GF14 lambda (GRF6) (AFT1) 
[Arabidopsis thaliana] 27958 5.6 54.5 2 4.77
v-alO-blO 24620453 2MDa_l protein [Caenorhabdids elegans] 2052136 0.1 48.0 3 4.99
v-a07-c07 129378
60 kDa heat shock protein mitochondrial 
precursor (Hsp60) (60 kDa chaperonin) 
(CPN60) (Heat shock 60950 4.4 95.1 1 5.83
t-a09-bl0 9230281 60S ribosomal protein L2 (Nicodana tabacum] 18350 4.0 52.1 1 10.87
v-all-c02 5821952
A Chain A Retainer Strain As A Determinant 
O f Protein Structural Specificity 8560 11.8 51.5 1 6.56
v-a07-d02 224305 aenn 41542 4.5 92.3 1 5.30
v-a07-c01 113314
ACVS_EMENI N-(5-amino-5- 
carboxypentanoyI)-L-cy*teinyl-D-valine synthase 
(Delta-(L-alpha-aminoadipyI)-L-cysteinyl-D- 
valine synthetase) (ACV synthetase) (ACVS) 422192 0.3 56.0 4 6.01
t-a09-bl 1 134183
Adenosylhomocysteinase (S-adenosyl-L- 
homocysteine hydrolase) (AdoHcyase) 47053 2.8 52.4 1 5.97
t-a09-bl 1 3914953
Adenosylhomocysteinase (S-adenosyl-L- 
homocysteinc hydrolase) (AdoHcyase) 48735 2.7 52.4 1 6.15
t-a09-bl 1 21431841
Adenosylhomocysteinase (S-adettosyl-L- 
homocysteine hydrolase) (AdoHcyase) (Liver 
copper binding prot 47657 2.8 50.7 1 6.08
v-a07-c07 45187687 ADL186Cp (Eremothedum gossypii] 150320 0.8 56.0 2 6.29
t-a09-bl 1 45198761 AFR243Cp [Eremothecium gossypii] 49063 2.7 52.4 1 5.58
v-al0-cl2 45200825 AGL272Cp [Eremothedum gossypii] 58906 1.8 76.4 2 9.28
v-a!0-cl2 15889879
AGR_C_4757p [Agrobacterium tumefadens str. 
C58] 54590 1.4 54.7 1 6.51
v-a07-c07 21064097 ATl6985p (Drosophila melanogaster] 61520 4.3 95.1 1 6.28
v-a07-e01 14335138 AT5gl0450/F12B17_200 [Arabidopsis thaliana] 10287 15.6 54.5 2 4.90
v-a!0-cl2 2493020 ATP synthase alpha chain 54830 1.4 54.7 1 6.31
v-al0-cl2 6680748
ATP synthase H + transporting mitochondrial 
FI complex alpha subunit isoform 1 [Mus 
musculus] 59716 1.3 54.7 1 922
v-al0-cl2 32766606 A tp5al-prov protein [Xenopus laevis] 59911 1.3 54.7 1 9.13
v-a07-d02 309090 A-X actin 41667 4.5 74.8 1 5.21
v-a07-d02 6693629 B-acdn [Pagrus major] 41813 4.5 89.4 1 5.30
t-a09-bll 10241525
bK3216D2.1.1 (S-adenosy lhomocys teine 
hydrolase (SAHH) isoform 1) [Homo sapiens] 30852 4.2 50.7 1 5.12
v-a07-e01 27376704 bill 593 [Bradyrhizobium japonicum] 88438 1.0 52.4 2 5.18
v-a!0-cl2 30577817
CAD90949.11 LssE protein [Legionella 
pneumophila] 95729 1.5 52.1 2 7.82
v-a07-c07 24641191 CG12101-PA [Drosophila melanogaster] 60771 4.4 95.1 1 5.38
t-a09-bl0 17864318 CG1263-PA [Drosophila melanogaster] 27875 2.7 50.5 1 11.15
v-a09-b06 45549186 CG3385-PA [Drosophila melanogaster] 76451 1.7 54.0 2 8.57
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v-alO-cl2 24658560 CG 3612-PA (Drosophila melanogaster] 59384 1.3 54.7 1 9.09
v-a07-eOl 17137216 CG5771-PB [Drosophila melanogaster] 24230 5.1 57.6 1 5.53
v-a07-c07 45550132 CG7235-PC (Drosophila melanogaster] 61548 4.3 95.1 1 6.75
v-al0-cl2 1943080 Chain A Bovine Mitochondrial Fl-Atpase 55199 1.4 54.7 1 8.27
v-a07-d02 2914482
Chain A Complex O f The Second Kunitz 
Domain O f Tissue Factor Pathway Inhibitor 
With Porcine Trypsi 23460 3.6 54.4 1 8.26
t-a09-bl 1 13096481
Chain A Crystal Structure O f Recombinant Rat- 
Liver D244e Mutant S- Adenosyihomocysteine 
Hydrolase 47390 2.8 50.7 1 6.08
t-a09-bl 1 13096485
Chain A Crystal Structure O f S- 
Adenosylhomocysteine Hydrolase (Adohcyase) 
Complexed With A Potent 47323 2.8 50.7 1 6.25
v-a07-d02 1942351
Chain A Crystal Structure O f The First Active 
Autolysate Form O f The Porcine Alpha Trypsin 13284 6.4 54.4 1 7.83
v-alO-cl2 6729934 Chain A Rat Liver Fl-Atpase 55247 1.4 54.7 1 8.28
t-a09-bl 1 4139571
Chain A Rat Liver S-Adenosylhomocystein 
Hydrolase 47376 2.8 50.7 1 6.08
v-a07-e01 5821952
Chain A Rotamer Strain As A Determinant O f 
Protein Structural Specificity 8560 80.3 276.3 12 6.56
v-a07-e01 5107695
Chain A Solution Structure O f The Designed 
Hydrophobic Core Mutant O f Ubiquitin ld7 8580 56.6 251.9 11 6.56
t-a09-bl 1 4929854
Chain A Structure O f Human Placental S- 
Adenosylhomocysteine Hydrolase: 
Determination O f A 30 Selen 47364 2.8 50.7 1 5.93
v-a07-e01 13786827
Chain A Structure O f Recombinant Human 
Ubiquitin In Aot Reverse Micelles 8540 88.2 361.2 15 5.77
v-a07-d02 494360
Chain A Trypsin (E.C.3.4.21.4) Complexed With 
Inhibitor From Bitter Gourd 23458 3.6 54.4 1 8.60
v-a07-e01 42543202
Chain A X-Ray Structure O f  The Small G 
Protein Rabl la  In Complex With Gdp 21495 5.8 57.6 1 6.50
v-a07-e01 42543204
Chain A X-Ray Structure O f The Small G 
Protein Rabl la  In Complex With Gtpgammas 21480 5.8 57.6 1 6.50
v-a07-d02 999627 Chain B Porcine E-Trypsin (E.C.3.4.21.4) 8814 9.8 54.4 1 6.67
v-a07-d02 3318722
Chain E  Leech-Derived Tryptase 
InhibitorTRYPSIN COMPLEX 23457 3.6 54.4 1 8.26
v-a07-c07 306890 chaperorun (HSP60) 60986 4.4 95.1 1 5.70
v-a07-c07 21805770 chaperonin Cpn60 [Danio reno] 33309 8.1 95.1 1 9.13
v-a07-e01 21232833
choline dehydrogenase [Xanthomonas 
campestris pv. campestris str. ATCC 33913] 61406 1.8 56.5 3 6.26
v-al0-cl2 23000523
COG0056: FOFl-type ATP synthase alpha 
subunit [Magnetococcus sp. MC-1] 54600 1.4 53.0 1 5.27
v-al0-cl2 23015477
COG0056: FOFl-type ATP synthase alpha 
subunit [Magnetospirillum magnetotacticum] 54831 1.4 54.7 1 6.31
t-a09-bl0 23051982
COG0090: Ribosomal protein L2 
[Methanosarcina barkeri] 25713 2.9 52.1 1 10.43
t-a09-bl 1 23103453
COG0499: S-adenosylhomocysteine hydrolase 
[Azotobacter vinelandii] 72430 1.8 52.4 1 926
t-all-clO 41726013
COG0583: Transcriptional regulator 
[Dechloromonas aromatica RCB] 32829 2.3 52.9 1 5.52
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v-a07-c01 22956766
C O G 1009: NADHrubiquinone oxidoreductase 
subunit 5 (chain L) /Multisubunit N a+ /H +  
antiporter MnhA subunit [Rhodobacter 
sphaetoides] 103735 0.9 50.2 4 9.28
v-al0-cl2 45915510
COG1171: Threonine dehydratase 
[Mesorhizobium sp. BNC1] 45821 1.9 51.7 2 6.99
v-alO-cOl 22997572
COG2925: Exonuclease I [Xylella fasbdiosa 
Ann-1] 56045 2.7 52.4 2 6.16
v-a07-e01 46363489
COG5001: Predicted signal transduction protein 
containing a membrane domain an EAL and a 
G G D EF dom 76585 2.8 68.2 2 5.64
t-a09-c08 46113353
COG5001: Predicted signal transduction protein 
containing a membrane domain an EAL and a 
G G D EF domain [Exiguobacterium sp. 255-15] 104409 0.9 55.1 1 5.19
t-all-c02 12619439
conotoxin scaffold III/IV precursor [Coaus 
textik\ 7919 22.9 58.4 1 5.07
v-a07-c07 12619397
cono toxin scaffold III /IV  precursor [Conus 
vrntricosus\ 7393 25.4 51.1 2 4.51
v-a07-c01 12619623
cono toxin scaffold VI/VII precursor [Conus 
vrntricosus\ 8096 26.3 123.7 3 4.76
v-a09-cil 12619613
conotoxin scaffold VI/VII precursor [Conus 
ventricosus\ 7883 13.9 50.9 1 7.52
v-a09-cll 12619615
conotoxin scaffold VI/VII precursor [Conus 
ventricasus\ 7882 13.9 50.9 1 8.16
v-a!0-ct2 19745428
conserved hypothetical protein [Streptococcus 
pyogenes MGAS8232] 41667 2.2 23.7 2 6.23
t-a09-bl0 46101825
conserved hypothetical protein [Ustilago maydis 
521] 10666 7.0 52.1 1 12.25
t-a07-cl 1 21218683
conserved hypothetical protein SCJ 2.04c 
[Streptomyces coelicolor A3(2)] 48605 3.1 53.7 2 9.19
v-a07-d02 6230866 cytoplasmic acdn [Oiltopleura longicauda] 41672 4.5 92.3 1 5.23
v-al0-cl2 17507955
defective (57.8 ItD) (1N245) [Caenorhabdids 
elegans] 57752 1.3 54.7 1 8.98
v-a07-e01 2134996 desmoplakin I - human 309797 0.6 80.1 2 6.36
t-a09-c08 4758200
desmoplakin; desmoplakin (DPI DPII) [Homo 
sapiens] 331571 1.2 99.7 4 6.44
v-a07-e01 4758200
desmoplakin; desmoplakin (DPI DPII) [Homo 
sapiens] 331571 0.6 80.1 2 6.44
v-a07-e01 34764046
dGTP triphosphohydrolase [Fusobacterium 
nudeatum subsp. vincendi ATCC 49256] 64179 2.0 54.8 2 8.52
v-a07-e01 86248
dolichyl-diphosphooligosaccharide-protein 
glyco transferase (EC 2.4.1.119) glycosyladon 
site-binding chain precursor - chicken 56929 1.6 57.0 3 4.84
v-al0-cl2 32307378
ecdysteroid UDP-glucosyltransferase 
[Spodoptera frugiperda MNPV] 60598 1.5 38.2 2 6.61
v-alO-cOl 31204473 ENSANGP00000001527 [Anopheles gambiae] 244959 0.8 53.8 3 5.48
v-a!0-cl2 31210101 ENSANGP00000009989 [Anopheles gambiae] 59256 1.3 54.7 1 9.14
t-a09-b!0 31214173 ENSANGP00000010416 [Anopheles gambiae] 28967 2.7 49.5 1 10.91
v-a07-c07 31231072 ENSANGPOOOOOO14839 [Anopheles gambiae] 61924 4.3 95.1 1 5.56
v-a!0-cl2 31208079 ENSANGP00000020317 [Anopheles gambiae] 46810 2.9 57.2 2 9.36
v-a!0-cl2 31207617 ENSANGP00000020421 [Anopheles gambiae] 34353 3.0 53.5 1 9.14
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v-a07-e01 31209781 ENSANGP00000024287 (Anopheles gambiae] 24332 5.1 57.6 1 5.73
v-alO-cOl 15838616 exodeoxyribonuclease I [Xylella fastidiosa 9a5c] 56822 2.6 52.4 2 5.93
v-alO-cOl 28198698
exodeoxyribonuclease I (Xylella fasbdiosa 
Temeculal] 56849 2.6 52.4 2 6.16
v-z07-e01 38077190 expressed sequence A1507495 [Mus musculus] 56715 6.9 188.3 6 7.08
v-a07-e01 1405561 FSGTP1 [Fagus sylvarica] 23919 5.1 57.6 1 9.23
v-alO-cl2 11610624
GABA-A epsilon subunit splice variant [Rattus 
norvegicus] 45976 1.8 58.2 1 9.04
v-al0-cl2 11610626
GABA-A epsilon subunit splice variant [Rattus 
norvegicus] 45893 1.8 58.2 1 9.00
v-al0-cl2 11610622
GABA-A epsilon subunit splice variant (Rattus 
norvegicus] 94974 0.9 58.2 1 4.38
v-al0-cl2 2735329
GABA-A receptor epsilon subunit [Rattus 
norvegicus] 45436 1.8 58.2 1 9.26
v-al0-cl2 12831207
gamma-aminobutyric arid A receptor epsilon; 
gamma-aminobutyric acid (GABA-A) receptor 
subunit epsilon; gamma-aminobutyric acid 
(GABA-A) receptor subunit epsilon [Rattus 
norvegicus] 113220 0.7 58.2 1 4.41
v-a!0-cl2 13959374
Gamma-aminobutyric-acid receptor epsilon 
subunit precursor (GABA(A) receptor) 59180 1.4 58.2 1 9.48
t-a09-c08 29650759 gamma-catenin (Homo sapiens] 81665 4.7 83.2 3 5.75
v-a07-e01 11558850
11558850 |em b|C A C l 7% 1.11 vimenbn 
[Scyliorhinus stellans] 51948 2.9 44.0 3 5.04
v-a07-e01 14590469
14590469|ref|NP_142537.11 pyruvate kinase 
[Pyrococcus horikoshii] 53141 4.8 63.5 3 8.78
v-a07-e01 46127519
46127519|ref|XP_388313.l1 hypothebcal 
protein FG08137.1 [Gibberella zeae PH-1] 32158 3.8 57.8 2 5.21
l-a09-bl0 29246632
GLP_13_32668_33423 [Giardia lamblia ATCC 
50803] 27020 2.8 52.1 1 11.15
v-a07-e0t 45382295 glycosylabon site-binding protein [Gallus gallus] 56856 1.6 57.0 3 4.84
v-a07-e01 7438432 GTP-binding protein - garden pea 24088 5.1 57.6 1 5.65
v-a07-e01 21555752
guanine nucleotide regulatory protein putabve 
[Arabidopsis thaliana] 24039 5.1 57.6 1 5.59
v-alO-cl2 28630328
H + -transporting ATP synthase alpha subunit 
isoform 1 [Branchiostoma lanceolatum] 42659 1.8 54.7 1 8.92
v-a07-c07 31981679
heat shock protein 1 (chaperonin); heat shock 
protein 60 kDa; heat shock 60kDa protein 1 
(chaperon 60918 4.4 95.1 1 5.67
v-a07-c07 11560024
heat shock protein 60 (liver); heat shock 60kD 
protein 1 (chaperonin) [Rattus norvegicus] 60927 4.4 95.1 1 5.91
v-a07-e01 16801015
highly similar to carbamoyl-phosphate 
synthetase (catalybc subunit) [Listeria innocua] 117788 0.9 52.7 2 4.80
v-a09-e01 17565064
his tone 3.3 (15.3 kD) (5N140) [Caenorhabdids 
elegans] 15340 13.2 52.7 2 11.40
v-a09-e01 122007 His tone H2A 15823 13.4 52.8 2 10.66
v-a09-e01 15238430 his tone H3 [Arabidopsis thaliana] 15582 12.9 52.7 2 11.26
v-a07-d02 1197519 his tone H3 [Narcissus pseudonarcissus] 14396 7.8 92.8 3 11.12
v-a09-b06 1197519 his tone H3 [Narcissus pseudonarrissus] 14396 5.5 67.1 2 11.12
v-a09-e01 223582 his tone H4 11230 29.4 109.5 3 11.20
v-a09-b06 1708110 Histone H4 11450 17.5 80.0 2 11.48
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v-a09-e01 1708110 Hi* tone H4 11450 17.5 75.9 2 11.48
t-all-c02 23477111 histone H4 [Colletotrichum sp.] 6814 16.7 56.3 1 10.67
v-a07-d02 23477111 histone H4 [Colletotrichum sp.] 6814 16.7 54.5 1 10.67
t-all-c02 23476928 histone H4 [Glomerella acutata] 7256 15.6 56.3 1 10.94
v-a07-d02 23476928 histone H4 [Glomerella acutata] 7256 15.6 54.5 1 10.94
t-all-c02 23476924 histone H4 [Glomerella cingulata] 5696 20.0 56.3 1 10.96
v-a07-d02 23476924 histone H4 [Glomerella cingulata] 5696 20.0 54.5 1 10.96
t-al1-c02 23476926 histone H4 [Glomerella graminicola] 3812 29.4 56.3 1 11.36
v-a07-d02 23476926 histone H 4 [Glomerella graminicola] 3812 29.4 54.5 1 11.36
v-a!0-cl2 30585339
Homo sapiens ATP synthase H+ transporting 
mitochondrial FI complex alpha subunit 
isoform 1 car 59827 1.3 54.7 1 9.16
v-a07-e01 30584069
Homo sapiens RAB11A member RAS oncogene 
family'[synthetic construct] 24492 5.1 57.6 1 6.12
t-a09-bl 1 30584089
Homo sapiens S-adenosylhomocysteine 
hydrolase [synthedc construct] 47798 2.8 50.7 1 5.92
v-aQ7-c07 27735378 H spdl protein [Xenopus laevis] 59616 4.5 95.1 1 6.62
v-a07-c01 37533392
hypothetical protein [Oryza sativa (japonica 
cultivar-group)] 41979 2.9 50.7 4 7.21
v-alO-blO 40741499
hypothetical protein AN8655.2 [Aspergillus 
nidulans FGSC A4] 81447 1.1 54.3 2 6.39
v-a07-e01 39595276
Hypothetical protein CBG03904 
[Caenorhabdiu* briggsae] 23400 5.2 57.6 1 6.44
t-a09-bl0 39585332
Hypothetical protein CBG05588 
[Caenorhabdids briggsae] 28173 2.7 50.5 1 11.07
v-al0-cl2 39580722
Hypothedcal protein CBG08717 
[Caenorhabdids briggsae] 57667 1.3 54.7 1 8.98
v-alO-blO 39752855
Hypothedcal protein F12F3.2a [Caenorhabdids 
elegans] 700957 0.3 50.7 3 5.72
v-al0-cl2 31441843
Hypothedcal protein H28016.1c 
(Caenorhabdids elegans] 54121 1.4 54.7 1 9.10
v-a07-d02 38103539
hypothedcal protein MG03982.4 [Magnaporthe 
grisea 70-15] 39700 4.8 64.1 3 5.62
v-a07-c01 38107610
hypothetical protein MG09507.4 [Magnaporthe 
grisea 70-15] 76989 4.9 53.6 5 9.52
t-a09-bl0 41152307 hypothetical protein MGC73105 [Danio rerio] 28049 2.7 52.1 1 10.89
v-a07-c01 8745001
hypothedcal protein PI 295.15 [Leishmania 
major] 303147 0.3 51.5 4 6.33
v-alO-blO 46101547
hypothedcal protein UM05835.1 [Usdlago 
maydis 521] 136342 0.7 54.3 2 8.74
v-a07-c07 34875806
hypothedcal protein XP_212759 [Rattus 
norvegicus] 60967 4.4 95.1 1 5.91
v-a07-e01 7513694 IgG Fc binding protein - mouse (fragment) 109137 0.9 56.4 2 4.71
t-a09-c08 41529837
junction plakoglobin; gamma-catemn 
(plakoglobin) [Rattus norvegicus] 81749 4.7 83.2 3 5.75
v-a07-c01 34784398 Krtl-15 protein [Mus musculus] 49463 7.5 201.1 5 4.79
v-a07-e01 39850082 Krt2-4 protein [Mus musculus] 57817 10.4 278.6 9 8.09
v-a07-e01 38303961 Krt5 protein [Rattus norvegicus] 61788 14.4 374.6 13 7.60
t-a09-c08 38303961 Krt5 protein [Rattus norvegicus] 61788 8.2 288.2 7 7.60
v-a07-e01 40787691 LOC395048 protein [Xenopus tropic alls] 56745 1.6 55.3 3 4.73
t-a09-bt0 21228229 LSU ribosomal protein L2P [Methanosarcina 25729 2.9 52.1 1 10.14
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v-alO-blO 22966565
Methyl-accepting chemotaxis protein 
[Rhodospinllum rubrum] 46733 1.8 54.3 2 5.44
v-a07-c07 28436902 MGC53106 protein [Xenopus laevis] 50499 5.3 95.1 1 7.57
v-a07-c07 40647591
mitochondrial 60 kDa heat shock protein 
[Anemonia viridis] 62768 4.3 95.1 1 5.30
v-al0-cl2 14009437
mitochondrial ATP synthase alpha-subunit 
[Cyprinus carpio] 59528 1.3 54.7 1 9.33
v-a07-d02 28336 mutant beta-acdn (beta'-acdn) (Homo sapiens] 41786 4.5 74.8 1 5.22
v-a09-b06 790600 nervy 76512 1.7 54.0 2 8.83
v-al0-cl2 17227664
NP_484212.11 alpha-amylase [Nostoc sp. PCC 
7120] 70850 1.3 51.7 2 5.16
v-alO-cl2 29828972
NP_823606.11 putative two-component system 
sensor kinase [Streptomyces avermidlis MA- 
4680] 61446 1.7 52.7 2 5.44
v-all-c02 9634344
ORF123 v-ubiquidn [Spodoptera exigua 
nudeopolyhedro virus] 9358 11.3 51.5 1 8.04
v-al0-cl2 38345636
OSJNBb0048E02.6 [Oryza sativa (japonica 
cultivar-group)] 38421 2.3 51.7 2 10.33
v-a07-e01 28436918 P4hb protein [Xenopus laevis] 57980 1.5 55.3 3 4.81
t-a09-d)8 130257
PLAK_HUMAN junction plakoglobin 
(Desmoplakin 111) 81578 4.7 83.2 3 5.95
t-a09-c08 762885 Plakoglobin 81583 4.7 83.2 3 5.88
t-a09-c08 20336613 plakoglobin [Bos taurus] 81769 4.7 83.2 3 5.75
v-all-c02 10121776 polyprotein [bovine viral diarrhea virus type 2] 71690 3.3 64.7 2 9.17
v-a07-e01 1101011 polyubiquidn 87122 4.8 105.5 6 6.36
v-a07-e01 3789942
polyubiquitin [Saccharum hybrid culdvar H32- 
8560] 42642 13.6 216.5 11 8.43
v-al0-cl2 15828596 predicted coding region [Mycoplasma pulmonis] 64970 1.5 58.2 1 9.12
v-a07-c07 11386856
Probable 60 kDa heat shock protein homolog 2 
mitochondrial precursor (Hsp60) (60 kDa 
chaperonin) ( 61130 4.4 95.1 1 6.28
v-alO-cl2 15966789
PROBABLE ATP SYNTHASE ALPHA 
CHAIN PROTEIN [Sinorhizobium melilod 
1021] 54647 1.4 54.7 1 6.30
v-a07-e01 18376163
probable GTP-binding protein D rabl 1 
[Neurospora crassa] 23704 5.1 57.6 1 5.61
v-alO-blO 15240463
protein transport protein-related [Arabidopsis 
thaliana] 135746 1.0 53.6 2 5.44
t-a09-bl 1 19112372
putadve adenosylhomocysteinase 
[Schizosaccharomyces pombe] 47353 2.8 52.4 1 5.61
v-a07-e01 46359908
putadve GTP-binding protein [Oryza sadva 
(japonica culdvar-group)] 23987 5.0 57.6 1 6.13
v-al0-cl2 39933255
putadve H+-transpordng ATP synthase alpha 
chain. [Rhodopseudomonas palustris CGA009] 55143 1.4 54.7 1 6.14
t-all-clO 16264227
putadve L-xylulose kinase protein 
[Sinorhizobium melilod 1021] 54393 2.4 52.5 2 5.46
t-a09-bl 1 6320882
Putadve S-adenosyl-L-homocysteine hydrolase 
with a probable role in S-adenosyihomocysteine 
catabol 49094 2.7 52.4 1 5.83
v-all-c02 22549552 putadve ubiquitin [Mamestra configurata 11227 9.0 49.8 1 8.85
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nudeopolyhedrovirus B]
v-a07-e01 17507543
RAB family member (23.4 kD) (rab-11.1) 
[Caenorhabditis elegans] 23415 5.2 57.6 1 6.44
v-a07-e01 37788825 Rabl 1-la [Limulus polyphemus] 24358 5.1 57.6 1 5.70
t-a09-b!0 22758874 ribosomal protein L [Argopecten irradians] 28178 2.7 52.1 1 10.82
t-a09-bl0 12054507 ribosomal protein L2 [Glycine max] 27996 2.7 52.1 1 10.45
t-a09-bl0 32400873 ribosomal protein L2 [Triticum aestivum] 9558 7.9 52.1 1 11.68
t-a09-bl0 20089945
ribosomal protein L2p [Me thanosarcina 
acetivorans str. C2A] 25675 2.9 52.1 1 10.28
t-a09-bl0 5690416 ribosomal protein L8 [Anopheles gambiae] 28715 2.7 50.5 1 11.07
t-a09-bl0 3047007 ribosomal protein L8 [Aplysia califomica] 5747 13.2 52.1 1 11.89
t-a09-bl0 20069091 ribosomal protein L8 [Aplysia califomica] 9109 8.5 52.1 1 1129
t-a09-b!0 28200282
ribosomal protein L8 [Branchiostoma belchen 
tsingtaunese] 8543 9.1 52.1 1 11.78
t-a09-bl0 45384773 ribosomal protein L8 [Chinchilla lanigera] 16284 4.6 52.1 1 10.90
t-a09-bl0 40643032 ribosomal protein L8 [Crassostrea gigas] 10875 7.0 52.1 1 11.58
t-a09-bl0 15082586 Ribosomal protein L8 [Homo sapiens] 27993 2.7 52.1 1 11.03
t-a09-bl0 15293881 ribosomal protein L8 [Ictalurus punctatus] 28127 2.7 50.5 1 10.97
t-a09-bl0 16566710 ribosomal protein L8 [Spodoptera frugiperda] 27901 2.7 50.5 1 10.76
t-a09-b10 32880093 ribosomal protein L8 [synthetic construct] 28106 2.7 52.1 1 11.03
t-a09-bl0 4506663
ribosomal protein L8; 60S ribosomal protein L8 
[Homo sapiens] 28007 2.7 52.1 1 11.03
t-a09-b!0 17557310
ribosomal Protein Large subunit (28.2 kD) (rpl- 
2) [Caenorhabditis elegans] 28186 2.7 50.5 1 11.07
v-a07-e01 20903595 RIKEN cDNA 2310001L23 [Mus musculus] 62806 8.4 279.1 11 8.68
t-a09-c08 20903595 RIKEN cDNA 2310001L23 [Mus musculus] 62806 6.6 206.5 8 8.68
v-a07-c01 20903595 RIKEN cDNA 2310001L23 [Mur musculus] 62806 5.1 109.8 3 8.68
v-al0-c04 38091800 RIKEN cDNA 2310058N18 [Mus musculus] 48206 4.0 59.9 2 4.78
v-a07-e0t 19526922 RIKEN cDNA 4631426H08 [Mu* musculus] 48891 4.0 81.6 3 4.99
v-a07-eOl 25056305 RIKEN cDNA 4733401 LI 9 [Mus musculus] 50315 3.5 622 2 5.19
t-a09-bl0 38014625 RPL8 protein [Homo sapiens] 22886 3.3 52.1 1 10.56
t-a09-b11 178277 S-adenosylhotnocysteine hydrolase 47684 2.8 50.7 1 6.03
v-a07-c07 33636453 SD06594p [Drosophila melanogaster] 60758 4.4 95.1 1 5.38
t-a09-b!0 27685597
similar to 60S ribosomal protein L8 [Rattus 
norvegicus] 28139 2.7 52.1 1 10.79
v-a07-e01 38086180
similar to A430096B05Rik protein [Mus 
musculus] 156503 0.6 56.4 2 5.66
t-a09-bl 1 34852949 similar to A hey protein [Rattus norvegicus] 51886 2.5 52.4 1 5.65
v-at0-cl2 13938339
Similar to ATP synthase H + transporting 
mitochondrial FI complex alpha subunit 
isoform 1 cardi 44362 1.7 54.7 1 9.42
v-a!0-cl2 24660110
Similar to ATP synthase H + transporting 
mitochondrial FI complex alpha subunit 
iso form 1 cardi 60748 12 54.7 1 9.14
v-al l-c02 34854675
similar to caspase 3 apoptosis related cysteine 
protease [Rattus norvegicus] 36680 2.8 61.3 2 8.61
v-a07-d02 34876364 similar to CG31613-PA [Rattus norvegicus] 101471 6.9 262.0 7 10.58
v-a09-b06 34876364 similar to CG31613-PA [Rattus norvegicus] 101471 4.9 228.1 5 10.58
v-a09-e01 34876364 similar to CG31613-PA [Rattus norvegicus] 101471 6.8 211.9 7 10.58
t-alO-eOl 34876364 similar to CG31613-PA [Rattus norvegicus] 101471 5.0 155.0 6 10.58
t-all-c02 34876364 similar to CG31613-PA [Rattus norvegicus] 101471 2.1 80.4 2 10.58
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v-a09-cll 34876364 similar to CG31613-PA [Rattus norvegicus] 101471 1.8 64.2 2 10.58
t-a09-c08 34876364 similar to CG31613-PA [Rattus norvegicus] 101471 1.8 54.9 2 10.58
v-a07-e01 34875216
similar to Desmoplakin (DP) (250/210 kDa 
paraneoplastic pemphigus antigen) [Rattus 
norvegicus] 327589 0.6 80.1 2 6.45
t-a09-bl0 28829974
similar to Dictyostelium discoideum (Slime 
mold). 60S ribosomal protein L2 27503 2.7 52.1 1 10.69
v-a07-e01 34855405
similar to Fc fragment o f IgG binding protein; 
IgG Fc binding protein [Rattus norvegicus] 583032 0.2 56.4 2 5.40
v-a09-b06 34876396
similar to H3 histone family member I [Rattus 
norvegicus] 33259 11.7 115.5 3 11.00
v-a07-e01 38079884
similar to ribosomal protein S27a [Mus 
musculus] 13110 11.0 52.3 2 8.92
v-a07-e01 34879387
similar to ribosomal protein S27a [Rattus 
norvegicus] 17897 14.2 88.1 3 9.50
v-a07-e01 34873655
similar to RIKEN cDNA 4631426H08 [Rattus 
norvegicus] 79826 2.5 81.6 3 4.74
t-a09-bl 1 20861044
similar to S-adenosylhomocysteine hydrolase 
[Mus musculus] 26335 5.0 52.4 1 5.96
v-a07-e01 7108528 small GTPase [Mus musculus] 24387 5.1 57.6 1 6.23
t-all-clO 17987814
TETRATRICOPEPTIDE REPEAT FAMILY 
PROTEIN [Brucella melitensis] 66415 1.2 52.9 1 5.75
v-a07-e01 3789940
tetra-ubiquihn [Saccharum hybrid cultivar H32- 
8560] 34202 19.3 226.3 10 6.17
t-all-clO 23501306 TPR domain protein [Brucella suis 1330] 69274 1.1 52.9 1 6.23
v-a07-d02 136429 Trypsin precursor 24394 3.5 54.4 1 7.00
v-a07-e0t 10719701 ubiquitin (Scyliorhinus torazame] 19471 40.5 322.9 15 9.35
v-a07-e01 28194281
ubiquitin extension protein [Heterodera 
glycines] 11762 32.4 171.3 8 9.65
v-all-c02 33346945
ubiquitin/actin fusion protein [Gymnochlora 
stellata] 49352 4.5 78.8 3 5.03
v-a07-e01 33346927
ubiquitin/actin fusion protein 1 [Bigelowiella 
natans] 26376 20.9 248.7 10 4.83
v-all-c02 33346927
ubiquitin/actin fusion protein 1 [Bigelowiella 
natans] 26376 8.4 78.8 3 4.83
v-a07-e01 33346933
ubiquihn/achn fusion protein 1 [Lotharella 
amoeboformis] 25960 21.3 248.7 10 5.01
v-all-c02 33346933
ubiquihn/actin fusion protein 1 [Lotharella 
amoeboformis] 25960 8.5 78.8 3 5.01
v-a07-e01 33346939
ubiquihn/actin fusion protein 1 [Lotharella 
globosa] 26018 21.1 248.7 10 5.07
v-atl-c02 33346939
ubiquitin/actin fusion protein 1 [Lotharella 
globosa] 26018 8.4 78.8 3 5.07
v-a07-e01 33304714
ubiquihn/achn fusion protein 2 [Bigelowiella 
natans] 51097 10.9 247.0 10 5.31
v-all-c02 33304714
ubiquihn/achn fusion protein 2 [Bigelowiella 
natans] 51097 4.4 78.8 3 5.31
v-al l-c02 33346935
ubiquihn/achn fusion protein 2 [Lotharella 
amoeboformis] 25974 8.5 78.8 3 5.01
v-a07-e01 33346943
ubiquihn/achn fusion protein 3 [Lotharella 
globosa] 26275 21.0 248.7 10 4.90
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v-all-c02 33346943
ubiquidn/acdn fusion protein 3 [Lotharella 
globosa] 26275 8.4 78.8 3 4.90
v-a07-e01 29294722
Unknown (protein for MGC:55760) [Danio 
rerio] 24565 5.0 57.6 1 5.64
v-a07-e01 41056251
Unknown (protein for MGC:63565) [Danio 
rerio] 24103 5.1 57.6 1 6.22
v-a07-d02 45872608
Unknown (protein for MGC:76228) [Xenopus 
tropicalis] 41726 4.5 74.8 1 5.29
t-a09-c08 27364239 Unknown [Vibrio vulnificus CMCP6] 27405 3.3 51.9 1 11.24
v-a07-e01 21751806 unnamed protein product (Homo sapiens] 44670 9.0 188.3 6 5.07
v-a07-c01 21751806 unnamed protein product [Homo sapiens] 44670 6.0 87.6 5 5.07
v-atO-cl2 38422323
unnamed protein product [Magnetospirillum 
gryphiswaldense] 54610 1.4 54.7 1 6.10
v-a07-c07 51452 unnamed protein product (Mus musculus] 58833 4.5 95.1 1 5.48
v-al0-c04 12845122 unnamed protein product [Mus musculus] 33861 5.9 59.9 2 4.67
v-al0-c04 26343627 unnamed protein product [Mus musculus] 47111 4.1 59.9 2 4.75
v-a07-e01 12843679 unnamed protein product [Mus musculus] 55757 3.7 53.4 2 6.19
t-a09-bl 1 26344433 unnamed protein product [Mus musculus] 36017 3.7 52.4 1 6.08
v-a07-c07 1334284 unnamed protein product [Rattus norvegicus] 57890 4.6 95.1 1 5.35
t-a09-bl0 5063
unnamed protein product [Schizosaccharomyces 
pombe] 27099 2.8 50.5 1 10.86
v-a07-e01 28277305 Vim4 protein [Xenopus laevis] 53507 3.5 64.7 3 5.12
v-a07-e01 32450567 Vim4 protein [Xenopus laevis] 53572 3.5 64.7 3 5.12
v-a07-e01 138532 Vimendn4 53464 3.5 64.7 3 5.08
v-a07-e01 138531 Vimentins 1 and 2 52812 3.5 64.7 3 5.16
v-all-c02 20070031
v-ubiquitin [Mamestra configurata 
nudeopolyhedrovirus A] 11402 9.0 51.5 1 9.89
v-a07-e01 25463443
YPT7 protein homolog [imported] - yeast 
(Candida albicans) 32027 3.8 57.6 1 7.00
v-al0-cl2 22988880
ZP_00033940.11 COG1123: ATPase 
components o f various ABC-type transport 
systems contain duplicated ATPase 
[Burkholdena fungorum] 68123 1.3 51.7 2 9.36
v-a!0-c!2 23051406
ZP_00078165.11 COG1060: Thiamine 
biosynthesis enzyme ThiH and related 
uncharacterised enzymes [Methanosardna 
barken] 36307 2.5 35.5 2 5.96
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